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Abstract
Epidemiologically, the oral route of infection is the most relevant for natural transmission of
Transmissible Spongiform Encephalopathies (TSEs) within and between different species but
relatively little is known about how the infectious agent reaches the CNS once it has gained
access to the gastrointestinal (GI) tract. Although the ultimate target of infection is the CNS
there is evidence that the peripheral nervous system (PNS) and lymphoreticular system (LRS)
are involved in the peripheral pathogenesis of TSEs. Early experiments that traced the spread
of scrapie infectivity after parenteral or intragastic challenge of rodents suggested that the
infectious agent entered the CNS at the thoracic spinal cord and spread towards the brain.
Western blot analyses of protease-resistant PrP, the protein marker of TSE disease, narrowed
the entry site to thoracic spinal segments 4-9 and provided evidence of a further pathway that
permitted the infectious agent direct entry into the brain. The main aim of this project was to
define the neuroanatomical pathways by which the infectious agent gained access to the brain
and spinal cord after oral challenge of hamsters with 263K scrapie. Immunocytochemistry,
paraffin-embedded tissue blotting and selective bioassays of agent were used to identify the
location and temporal sequence of disease-associated PrP (PrPd) accumulation in the CNS,
PNS and enteric nervous system (ENS) of hamsters. To elucidate the temporal relationship
between the ENS and LRS in this model system, spleen and gut-associated lymphoid tissue
(GALT) were included. Results showed that invasion of the brain occurred directly via the
vagus nerve rather than by spreading along the spinal cord. The infectious agent reached the
CNS simultaneously by two pathways. One route accessed the thoracic spinal cord via the
intermediolateral cell column and another entered the dorsal motor nucleus of the vagus of
the brain. Thereafter spread occurred between interconnected neurones. By identifying and
quantifying the presence of PrPd in the CNS, vagal and splanchnic nerve circuitry and the GI
tract, it was possible to precisely identify routes and timing of neuroanatomical spread. PrPd
accumulated, in sequence, in target sites that accurately reflected known autonomic and
sensory relays. PrPd was observed in enteric and autonomic neurones prior to sensory
neurones suggesting that the infectious agent primarily utilised synaptically-linked autonomic
ganglia and efferent fibres to invade the CNS. Infectivity was present in the PNS at low to
moderate levels. Therefore, after ingestion of 263K scrapie, the PNS and specifically,
autonomic components of the vagus and splanchnic nerves are important in conveying the
infectious agent to target sites in the CNS. The temporal interaction between lymphoid cells
(follicular dendritic cells, macrophages, dendritic cells and Peyer's patch epithelium) and
enteric neurones suggested that lymphoid elements are sequentially involved in PrPd
processing. Existing evidence is compatible with the LRS being an optional mediator rather
than a key player in neuroinvasion in this experimental model but the early involvement of
GALT in oral pathogenesis requires further investigation.
x
Chapter 1: Introduction
1.0 Transmissible Spongiform Encephalopathies
Scrapie affects sheep and, less commonly, goats and is the most extensively studied member of a
group of transmissible diseases that affect a range of animal species and man (Table 1.1). These
include Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler syndrome (GSS) and kuru of
humans, bovine spongiform encephalopathy (BSE) of cattle, chronic wasting disease (CWD) of
captive or free-ranging deer and transmissible mink encephalopathy (TME) of captively-reared
mink. All these diseases, collectively called the transmissible spongiform encephalopathies
(TSEs), cause a progressive degeneration of the central nervous system (CNS) that is eventually
fatal. Transmissibility is a prerequisite for inclusion in the group. Scrapie, CWD, and TME occur
naturally and can be transmitted between and within flocks, herds or colonies. Sporadic CJD
(sCJD) is also naturally-occurring but there is no evidence of interspecies transmission. CJD can
also be contracted genetically (see Table 1.1) and while there are no equivalent inherited TSEs
recognised in animals, studies with natural and experimental scrapie of sheep have shown the
PrP gene is an important factor in disease susceptibility (Hunter et al., 1997a,b). Furthermore,
the susceptibility (or resistance) to scrapie displayed by animals that inherit particular PrP
genotypes have formed the basis for the National Scrapie Plan in which sheep are bred
specifically to prevent scrapie developing (Dawson et al., 2003).
The most recent additions to the TSE group have come about through accidental transmission. A
number of cases of CJD have occurred iatrogenically via treatment with human growth hormone
or dura mater grafts. Both these materials were derived from cadaveric tissues that were later
found to be contaminated with the CJD agent (Brown et al., 1992). However, it was the
emergence and transmission of a new TSE strain (Wells et al., 1987), subsequently shown to be
BSE, which has accounted for the majority of TSE cases. The United Kingdom BSE epidemic
has had devastating and far-reaching consequences for agriculture and man. BSE appears to have
been transmitted by ingestion of TSE-contaminated protein supplements derived from rendered
carcasses of sheep and cows. The original source of the strain or the conditions that permitted
the emergence of BSE remain unclear (reviewed by Collee and Bradley 1997a,b) but a link has
been found between the practise of feeding meat and bone meal (MBM- a protein supplement) to
cattle during the 1970s and 80s and the appearance ofBSE (Wilesmith et al., 1991,92). The BSE
agent was also transmitted to domestic cats, wild felines and a variety of zoo animals including
ungulates such as Kudu and Oryx (Kirkwood et al., 1990). Dogs that are fed a similar
commercially available diet to cats, and pigs which would have been exposed to contaminated
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MBM feed do not seem to be naturally susceptible to the BSE agent (Bradley 1996, Wells et al.,
2003). A current fear is the possibility that sheep that were also exposed to contaminated MBM
are at risk of contracting BSE. Scrapie and BSE of sheep exhibit a similar clinical appearance
that is not readily distinguishable and while scrapie does not appear to have crossed the species
barrier from sheep to man, there is no certainty that this will be the case with ovine BSE.
Equally concerning as BSE was the discovery in 1996 (Will et al., 1996) of a new variant of
CJD (vCJD) that affected young rather than ageing individuals. Strain typing experiments
showed convincingly that the strain of TSE that causes vCJD is BSE (Collinge et al., 1996,
Bruce et al., 1997, Hill et al., 1997) and that the most likely scenario for transmission of BSE to
man was through dietary exposure. The human TSEs do not appear to transmit easily from one
individual to another; the incidence of sCJD is low (approximately one case per million). Higher
incidences have been due to iatrogenic transmission (Brown et al., 1992) or to the cannibalistic
transmission of kuru, a TSE that was prevalent several decades ago in the Fore tribe of New
Guinea (Gajdusek, 1977). The eventual incidence of vCJD is still unknown. To date there have
been many cases of vCJD (143 to October 2003) but far fewer than at first envisaged and the
epidemic predicted by some seems less likely. Even so, given that all those affected were of the
same PrP genotype i.e. homozygous for methionine at codon 129 (Colm & Knight, 2002), and
that the percentage exposure may be very high, there are still concerns many of the population
may yet succumb.
The public alarm surrounding the appearance and persistence of BSE and vCJD has renewed
scientific interest in oral transmission of TSE. In the past, this route has been inadequately
documented. Consequently, the mechanisms of oral transmission and the routes by which the
agent accesses the CNS after it has gained entry to the gastrointestinal (GI) tract are poorly
understood. The object of the work undertaken in this thesis is to partly address this deficiency.
1.1 PrP and its involvement in TSEs
One of the most significant scientific advances in TSE research in the last 20 years was the
discovery of PrP (protease-resistant protein, prion protein).
PrP, a protease-resistant protein with a molecular weight of 27,000-30,000 (PrP27-30) was
discovered, purified and characterised by Stanley Prusiner and colleagues in the early 1980s
during experiments to identify the nature of the scrapie agent (Bolton et al., 1982, Prusiner et al.,
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1982a, 1983a,84, McKinley et al., 1983). A larger PrP protein of molecular weight 33,000-
35,000 (PrP33-35) was seen in Western blots of tissue extracts from both normal and infected
brain that had not been treated with proteinase K (PK). On PK treatment, it was found that while
PrP PrP33-35 from an uninfected animal was completely hydrolysed, the PrP33-35 derived from
infected animals was partially degraded to PrP27-30 (Oesch et al., 1985). Soon after purification,
the PrP gene was cloned and found to be encoded by the host genome (Oesch et al., 1985,
Chesebro et al., 1985). The gene was transcribed in equal quantities in both unaffected and
scrapie infected brain and apparently existed as two isoforms; the normal cellular form (PrPc
[cellular] or PrP-sen [sensitive to PK], that corresponded to PrP33-35) and a disease specific
form seen only in infected animals (PrPSc [scrapie] or PrP-res [resistant to PK], that
corresponded to PrP27-30)[Caughey et al 1991]. The primary amino acid structure of PrP was
shown to be the same in both infected and unaffected animals (Basler et al., 1986). Differences
between the isoforms occur in the protein's secondary and tertiary structure that determine
conformation. Fourier transform infrared and circular dichroism experiments have shown that
the structure of PrPc comprises around 43% a-helix and only 3% (3-sheet while PrP50 retains
34% a-helix but incorporates a greatly increased (43%) amount of [3-sheet (Pan et al., 1993).
During pathogenesis, PrPc is post-translationally converted to PrPSc (Borchelt et al., 1990). The
mechanism by which these changes in structure occur is unknown but has lead to the prion
hypothesis which asserts that scrapie and related diseases result from aberrations of PrP protein
conformation and that the altered protein alone comprises the infectious agent (see 1.2 Nature of
the Agent).
PrP27-30 was originally identified as being the major component of fibrillar structures, initially
termed scrapie-associated fibrils [SAF] (Mertz et al., 1981) or prion rods (Prusiner et al., 1983b,
Diringer et al., 1983b) that were isolated from detergent-treated tissue extracts of scrapie-infected
brains. SAFs (now usually referred to as PrP& fibrils) have been detected in all TSE-infected
tissues tested. The fibrils are products of in vitro purification but ultrastructurally they resemble
the fibrillar arrays seen in amyloid plaques of scrapie-infected rodents (Bendheim et al., 1984,
Jeffrey et al., 1994). Presence of PrP50 fibrils, amyloid plaques and other forms of PrP-related
pathology in tissue preparations are often used to provide confirmation of infection.
During the course of the disease the modified or disease associated forms of proteinase K
resistant PrP (variously termed abnormal or pathological PrP, PrPres, PrP80, PrPd, PrP*)
accumulate in the CNS and a variety of extraneural tissues of experimental and naturally
occurring TSEs (Bruce et al., 1989,94a; McBride et al., 1992,98,99, Farquhar et al., 1994, Foster
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et al., 1996, Lasmezas et al., 1996, van Keulen et al., 1996, Beekes & McBride, 2000 and several
others).
The diverse nomenclature used to denote PrP isoforms can be confusing. PrP may be identified
by a variety of techniques such as Western blotting, electron microscopy or
immunocytochemistry (ICC). The term PrPSc is commonly used as a pseudonym for both
immuno-positive PrP deposits detected by these techniques and the infectious agent itself.
However, this term identifies the protease treated product (partially PK-resistant PrP) of a
biochemical procedure. The antibodies that are available recognise both cellular and disease
specific PrP and although several different forms of PrP can be distinguished in fixed
immunostained tissue sections these cannot be definitively identified as being protease resistant.
Therefore, in this thesis the term PrPd will be used to describe the disease-associated forms that
are observed in PrP-immunolabelled tissue sections, i.e. those forms that are exclusively found
in tissues from infected animals.
When disease-associated forms have been shown to be associated with infectivity, as is the case
with the hamster model used in this project, (Beekes et al., 1996, Baldauf et al., 1997) they may
also be considered surrogate markers for an infectious agent. In order to show such correlation,
infectivity and the accumulation of PrP& were quantified in samples of brain and spinal cord
taken from hamsters culled at various times after oral administration of 263K scrapie. PrP50 was
quantified by computerised densitrometric analysis of PK-treated dot blots and compared against
a calibration curve constructed from samples of known protein values. The agent titre was
determined by bioassay of tissue homogenates from the same samples used for assessment of
protein and measured by dose-response curves according to recognised methods (Kimberlin &
Walker 1977, Prusiner et al., 1980). Mathematical comparison of PrP50 and infectivity showed
that 106 molecules of PrP& approximated to one infectious unit.
1.1.2 Function of PrP
1.1.21 The role of PrP in unaffected animals
Despite the attention given to the study of PrP during TSE pathogenesis, relatively little is
known about the normal function(s) of cellular PrP. PrPmRNA and protein are widely expressed
in the CNS (Kretzschmar et al., 1986, Manson et al., 1992) and to a lesser degree in a number of
adult and embryonic peripheral tissues (Oesch et al., 1985, Caughey et al., 1988, Bendheim et al.,
1992, Manson et al., 1992). In addition to the brain (DeArmond et al., 1987, Bruce et al., 1989,
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94a, Nakamura et al., 2002, Ford et al., 2001), PrPc has been identified in several types of cells
in a variety of visceral organs including the GI tract (Shmakov et al., 2000, Lemaine-Vieille et
al., 2000, Pammer et al., 2000), kidney (Manson et al., 1992, Fournier et al., 1998),
lymphoreticular system (McBride et al., 1992, Fournier et al., 1998, Ritchie et al., 1999, Brown et
al.,2000), lung (Bendheim et al., 1992), muscle (Brenner et al., 1992, Brown et al., 1998, Gohel et
al., 1999), adrenal, liver, pancreas, testes, thymus and salivary glands (McBride et al., 1992,93,
Farquhar et al., 1994; Brown et al.,2000). Expression of PrPc has also been detected on blood
cells, platelets and endothelial cells of a number of mammalian species, albeit at variable levels
(Hill et al., 2000, Cashman et al., 1990, Simak et al.,2002). The association with a broad range of
cell types exhibiting different physiological functions suggests that the role of PrP may be
diverse.
The structure of the gene is known and can provide clues to its function. PrP has been highly
conserved throughout evolution and is present in a number of species (Westaway & Prusiner
1986, Wopfner et al., 1999). To aid the search for possible functions, gene targeting was used to
produce mice in which PrP was ablated. In two lines, NPU Prnp''' (Manson et al., 1994a) and
Zurich Prnp'' (Biieler et al., 1992) ablation of the gene does not adversely affect development of
PrP null mice nor appear to result in any obvious phenotypic deficits (Biieler et al., 1992,
Manson et al., 1994a). The reason for this may be that Prnp is so crucial that the lethal
consequences of its loss are alleviated by gene compensation. Although these mice breed and
behave normally, lack of PrP does elicit a number of subtle abnormalities including perturbation
of sleep and circadian rhythms (Tobler et al., 1996, Sanchez-Alavez et al., 2000) and a reduced T
lymphocyte response (Mabbott et al., 1997). In another two lines, ICM Prnp'' (Moore et al.,
1995) and Japan Prnp ' (Sakaguchi et al., 1996) the mice showed signs of progressive cerebellar
ataxia in maturity. This phenotype appears to be due to overexpression of a related gene, Prnd,
whose product is a protein called doppel (Moore et al., 1999) rather than a lack of PrP
expression.
Given the high levels of PrP found in the CNS it is unsurprising that many of the observed
deficiencies have been ascribed to the functionality of neuronal transmission (Collinge et al.,
1994, Manson et al., 1995, Colling et al., 1996, Carleton et al.,2001), survival, differentiation and
memory formation (Graner et al.,2000) and axon growth (Sales et al.,2002). There is
accumulating evidence showing that PrPc is expressed at the synapse. Initial reports using
electrophysiology claimed differences in long term potentiation between PrP knockout mice and
controls (Collinge et al., 1994, Manson et al., 1995). However, other studies either show some
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disparity with these findings (Brenner et al., 1992, Herms et al., 1995, Curtis et al.,2003) or
suggest that this function is not the most significant or only role for PrP at this location. Due to it
having been found both pre- and post synaptically (Herms et al., 1999, Sales et al., 1998, Foumier
et al.,2000) other possible functions include an involvement in intracytoplasmic membrane
recycling and trafficking (Gohel et al., 1999) or as a physiological post-synaptic receptor
(Askanas et al., 1993).
A major role for PrPc may be in promoting neuronal survival by suppressing programmed cell
death. The presence of PrPc, in vitro, seems to protect against apoptosis (Kuwahara et al., 1999,
Bounhar et al.,2001). Recent attention has focused on the copper-binding capability of PrPc and
its association with the protective effects of antioxidants (Brown et a/., 1997a,b; Pauly & Harris,
1998). There is evidence to show that PrPc is sensitive to various forms of physiological stress
including the damage caused by exogenous copper, hydrogen peroxide, reactive oxygen species
and oxidative stress (Brown et a/., 1997a,b, 1998, 2002, Herms et al., 1999, Guentchev et al.,
2000, Milhavet et al.,2000, Klamt et al., 2001, Wong et al.,2001). Collectively, these
observations suggest a neuroprotective role for PrPc.
1.1.2ii The role of PrP during TSE infection
The role of PrPc is interesting but with no obvious vital function its significance lies in providing
insights into TSE disease. PrP is fundamental to the development (Biieler et al., 1993, Manson et
al., 1994a) and our understanding of scrapie and related diseases. PrP knockout (PrP_/ ) and
transgenic mouse models have been greatly used to study TSE pathogenesis. PrP nulls do not
develop scrapie nor replicate the infectious agent (Bueler et al., 1993, Prusiner et al., 1993
Manson et al., 1994a). Consequently, the presence of PrP is crucial to TSE pathogenesis.
Experiments grafting wild-type brain grafts into PrP null mice have shown that PrPc must be
present for the disease to develop and spread (Brandner et al., 1996). Engrafted mice did not
succumb to infection even though the transplanted tissue developed lesions typical of scrapie
neuropathology. Scrapie survival is also influenced by PrP gene dosage (Manson et al., 1994b).
Studies comparing wild-type (WT) PrP+/+ mice with PrP heterozygotes (PrP+/) showed that while
the incubation period was shorter in WT, both the amount and pattern of PrPSc deposition
appeared equivalent in both groups. Hence, the level of PrPc in the brain does not determine the
extent of PrP& deposition achieved at the end-stage of disease.
Many studies have used a synthetic fragment of PrP5*, PrP106-'26,0r PrP^ extracts (Brown 2000,
Haik et al., 2000) to demonstrate the neurotoxicity of PrPSc and there is also mounting evidence
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to show that neuronal death is indirectly linked to the upregulation of microglia during TSE
infection (Bate et al., 2001; Brown 2001). Conversion of PrPc to PrP50 activates microglial cells.
These release damaging free radicals that in turn may increase the sensitivity of neuronal cells to
oxidative stress. It may be that the innate neuroprotection afforded by PrPc is insufficient for
infection-weakened neurones to withstand the free radical challenge.
1.2 The nature of the scrapie agent
The nature of the agent that causes scrapie and related diseases has been the focus of much
debate and speculation for many years. Once scrapie had been established as an experimental
model in rodents it became clear that the properties of the agent did not fit with established
criteria for how infectious diseases were known to behave. For example, the TSE pathogen is
transmissible, replicates and exists as many strains with genetically stable phenotypes
(Dickinson & Outram 1979). One strain, 87A has also been shown to mutate to form a separate
strain (ME7) over serial passage (Bruce & Dickinson 1987). These properties are consistent with
the activity of viruses yet the pathogen causing TSEs displays extreme physicochemical stability
and cannot be as effectively inactivated. Scrapie is resistant to inactivation by dry heat, ultra¬
violet light, ionising radiation and chemical treatment by proteases and viricides (Kimberlin et
al., 1983a, Brown et al., 1986, Taylor et al., 1996a, Somerville et al., 2002). The agent also
appeared to spread through the body in a virus-like fashion but at very much slower rates than
convential neurotropic viruses such as Herpes Simplex or Reovirus, taking weeks or months
rather than days to reach its target (Kimberlin & Walker 1980,82,86, Kimberlin et al., 1983b,
Fraser & Dickinson 1985).
PrP50 extracted from infected brains copurifies to varying extents with infectivity (Diringer et al.,
1983a, Somerville et al., 1986, Beekes et al., 1996). While infectivity and PrP& ratios correlate
well in some cases (Bolton et al., 1982, Beekes et al., 1996), in others the level of infectivity is
inconsistent with the amount of detectable PrP50 (Somerville & Dunn 1996, Lasmezas et al.,
1997, Manson et al., 1999, Barron et al.,2001). Despite extensive biochemical analyses and
electron microscopy, no scrapie-specific virus has been seen (or recognised) in tissue
preparations - while the disease-associated protein is usually very evident.
Over the years, several theories were proposed that sought to resolve biological inconsistencies
and explain the structure of the agent. An early theory advanced was that the infectious agent
could be encoded by a viroid and, as in plants, could be a simple nucleic acid of very small size
(Deiner 1973). Another idea suggested that the infecting agent was a conventional virus that
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replicates, initially in the lymphoid system, and spreads to the CNS where it induces amyloidosis
(Diringer et al., 1984,1991). For some researchers the parallels with virus-causing diseases
remain compelling (Rowher 1991, Manuelidis 1994). The two fields of thought that gain most
scientific support are the virino hypothesis (Dickinson & Outram 1979, 88; Bruce & Dickinson
1987) and the prion or 'protein only' hypothesis (Prusiner et al., 1982b, 91, 97). Evidence for
both is strong and robustly defended.
The virino hypothesis proposes that the infectious agent is an informational hybrid with
contributions from both the scrapie strain and the host it infects. Many strains of TSE exist and,
as stated previously, these specify or encode a range of characteristics (clinical signs, incubation
period, targeting of pathology) in the host (Bruce & Fraser 1991, Bruce et al., 1991). Supporters
of the virino hypothesis believe that that the infectious agent must be able to encode the
information for strain variation and must also include properties that enable it to evade
destruction by the host's own immune system. Although PrP is clearly important in TSE
pathogenesis, it is disputed whether the protein alone can carry the information required to
specify the observed strain diversity. Before the discovery of PrP, Dickinson who originally
proposed the virino hypothesis, had suggested the existence of replication sites that were formed
from Sine encoded protein - which has now been shown to be PrP (Moore et al., 1999). The
current hypothesis proposes that the infectious particle or virino be comprised of nucleic acid
that is bound to and protected by PrP host protein. Such a molecule would have the ability to
differ structurally between strains and contain a strain specific genome whose capability to
replicate was independent of its host. To explain the current lack of detection, the nucleic acid
must be small. This is physically possible (Rowher 1984) and if enveloped by PrPc there would
be no requirement to encode viral coat proteins. The presence of nucleic acid is key to the virino
hypothesis as this is the only molecule known to biology that is capable of replication and
transfer of genetic information. The opposing viewpoint argues that strain specificity can be
accounted for by differences in conformation and glycosylation of PrP^.
The suggestion that the unconventional properties of scrapie might be caused by an
unconventional biological agent was first advanced as early as 1967 by JS Griffith (Griffith
1967) who proposed that the scrapie agent was a self-replicating protein derived from a normal
cellular protein. It was known that protein was an important part of the pathogen; scrapie
infectivity is reduced by treatments that denature, disaggregate or destroy proteins (Hunter GD
1979, Millson GC & Manning EJ 1979, Rohwer RG et al., 1979, Lataijet R 1979). UV
irradiation had identified the target molecule as being extremely small and this had cast doubts
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on the existence of a scrapie-specific nucleic acid (Alper et al., 1967) which by the early 1980s
was still eluding isolation. On his identification of a unique 27-30Kd protein that co-purified
with the scrapie agent (Bolton et al., 1982, Prusiner et al., 1982a), Prusiner challenged existing
scientific dogma by claiming that scrapie was caused by prions - 'novel proteinaceous infectious
particles' that lacked nucleic acid (Prusiner 1982b). According to the original prion hypothesis,
prion protein (PrP), was the sole component of the infectious agent. Prusiner suggested that
scrapie and related diseases result from aberrations of PrP protein conformation, i.e. some insult
(genetic or biochemical) triggers host neuronal PrP to refold from the normal largely a-helical
form to the predominantly [3-pleated sheet disease-causing form. PrP50 then catalyses ongoing
conformational change by recruitment of susceptible PrPc. With time, the existence of scrapie
strains was universally accepted and the theory was adapted to fit the evolving research. If the
agent were to consist purely of PrP, the phenotype of each strain must be inherent within this.
Accordingly, prion strains were suggested to be encrypted through differing PrP& conformers
(Prusiner 1991). The incubation-prolonging effect of the species barrier was argued as being due
to mismatches between host PrPc and the PrP& of the inoculum (Prusiner et al., 1990).
Transgenic mice expressing chimeric PrP were used to test this theory. An initial experiment in
which the species barrier to hamster scrapie was reduced in mice expressing hamster PrPc
appeared to bear this out (Scott et al., 1989, Race et al., 1995). The anomalies that arose from
extending this theory to humans (Telling et al., 1994,95) were suggested to be explained by the
existence of protein X (Telling et al., 1995, Prusiner & Scott, 1997) a host ligand that could
interact with PrPc in a species dependent manner. That is, mouse protein X would compete more
favourably and bind more efficiently with mouse PrPc than it would with human PrPc. Despite
this, inconsistencies remain and the mechanism by which the disease-specific form(s) are created
from and interact(s) with host PrP to cause disease remains to be established.
When it was first proposed, the idea that scrapie could be caused solely by an infectious protein
was radical. Many scientists remain unconvinced and the nature of the causative infectious agent
remains unproven even though extensive work has been carried out or is in progress to test
individual hypotheses experimentally. The ability to separate infectivity from PrP^ is seen as an
argument against the prion hypothesis. The extent to which PrP& can be separated from
infectivity has been shown to be dependent on the chemical treatment or temperature to which a
strain is subjected (Manuelidis et al., 1987, Shaked et al., 1999, Wille et al.,2000, Somerville et
al., 2002). This has lead to the suggestion (and counter argument) that only a proportion of PrP80
(designated PrP*) is infectious (Weissmann 1991, Aguzzi & Weissmann 1997). The requirement
of PrP for disease development (Biieler et al., 1993, Manson et al., 1994a) appears to support the
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protein-only theory. The prion hypothesis was partially upheld with the in vitro conversion of
PrPc to the protease-resistant form (Kocisko et al., 1994) but, crucially, to date, synthesised
PrP& has not been able to transmit infectivity.
1.3 Scrapie: Disease characteristics
Natural scrapie has a long incubation period ranging from several months to years. Onset is slow
and there are no visible indicators of early infection. During this time the infectious agent
replicates in the CNS and extraneurally, and through time the affected individual displays
obvious neurological dysfunction and, eventually, dies. The clinical phase is short in comparison
to the protracted asymptomatic period and is characterised by ataxia (abnormal gait), pruritis
(itching) and recumbency (inability to stand). There is no cure and no therapeutic intervention
that significantly affects the lethal outcome.
The name 'scrapie' is an old Scottish word and describes the infected animal's tendency to
scrape or scratch itself against fence posts and similar objects, resulting in bald patches on the
fleece. Scrapie has been a farming problem for at least 250 years and has been the subject of
scientific interest for around fifty. As such it is the most understood of the TSEs or prion
diseases. In the past these diseases were called the transmissible degenerative encephalopathies
and unconventional or slow viral encephalopathies. These names describe the hallmarks of the
diseases, that is; their transmissibility, neurodegenerative pathology, slow progression and the
unusual nature of the pathogen that infects the host.
Although these diseases are infectious, there is no classical immune response, no inflammatory
pathology and no antibodies are produced. However, as is discussed later in section 1.5.1 a
functioning immune system is necessary for peripheral infection in some models and it now
appears that although the agent does not elicit an overt immune reaction, the lymphoreticular
system (LRS) may influence peripheral pathogenesis in a more subtle fashion. The host cellular
protein PrP has been implicated in lymphocyte activation (Cashman et al., 1990, Mabbott et al.,
1997). There is also evidence that complement cascade components facilitate peripheral
pathogenesis (possibly by mediating the retention of PrP in FDC networks) because complement
depletion significantly delays onset of scrapie (Klein et al., 2001, Mabbott et al., 2001). In
addition, disease-induced cytokines such as prostaglandin E-2, interleukin-1 beta and tumour
necroisis factor-alpha are present in the brains of mice with experimental scrapie and co-localise
with areas of PrPd deposition and astrogliosis. The extent of cytokine gene expression or
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production appears to relate to the degree of reactive gliosis which, in turn, may contribute to the
development of scrapie pathology (Williams et al., 1997a, Brown et al., 2003).
Intra-species transmissibility was first demonstrated in 1939 by intra-ocular challenge of sheep
with a spinal cord homogenate derived from natural scrapie (Cuille & Chelle 1939). Another
early, but accidental transmission of natural scrapie provided clues to the resistance of the agent
to chemical decontamination. Sheep that had been treated against louping ill subsequently
developed scrapie through contamination of the formalin-inactivated lymphoid tissue that was
used as a vaccine (Gordon 1946). Scrapie is transmissible both horizontally among the flock and
vertically from ewe to lamb, and from the early 1960s has been transmitted experimentally to a
number of laboratory rodents including inbred mice and hamsters (Chandler 1961,63, Marsh &
Hanson 1977) in which the disease can be studied more easily, quickly and in controlled
conditions (Dickinson & Fraser 1979).
1.4 Experimental rodent models of scrapie and strain identification
Several experimental rodent scrapie strains have been selected from the mixture of isolates that
occur in the natural disease. Serial passage of natural scrapie over many generations, mainly
through inbred mice, have produced single strains that can be differentiated from each other by
their differing disease characteristics (Dickinson & Meikle 1971, Dickinson & Fraser 1977,
Dickinson & Outram 1988, Fraser 1976, 79; Bruce & Fraser 1976, Bruce & Dickinson 1987).
Around 20 different scrapie strains have been isolated. The main criteria by which individual
strains can be identified are by the highly reproducible incubation periods and the defined
patterns of vacuolar pathology. The particular clinical signs displayed during the course of the
disease (Bruce & Fraser 1976, Bruce et al., 91, Carp et al., 1984) and physicochemical
properties (Kimberlin et al., 1983a, Somerville et al., 2002, Taylor et al., 2002) are additional
useful indicators. More recently, and controversially, a technique called glycoform analysis has
been used to distinguish TSE strains (Parchi et al., 1995, Collinge et al., 1996, Hill et al., 1997,
Somerville et al., 1997, Somerville 1999) although the relationship between PrP glycoform and
TSE strain remains to be identified.
1.4.1 Incubation period
Scrapie survival depends on the scrapie strain and the genotype of the host it infects. The major
influence on the length of the incubation period is the exerted by the Sine (Scrapie incubation)
gene. This discovery in the 1960s (Dickinson et al., 1968) was due to the recognition that in any
experimental rodent model, the period of time from infection to death was extremely predictable.
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Sine has two alleles, s7 and p7, and exerts precise control over the timing of scrapie incubation
in rodents. Each scrapie strain has a highly repeatable, tightly controlled incubation period in
each of the three Sine genotypes. Mice homozygous for the Sine genotype s7s7 have short
incubation periods when infected by, for example, the ME7 strain. Mice carrying p7p7 alleles
have much longer incubations with this strain of scrapie and those of s7p7 heterzygotes lie in
between (Dickinson et al., 1968, Dickinson & Meikle 1971, Dickinson & Fraser 1979). Sip, the
ovine homologue of Sine, fulfils the same function in sheep (Dickinson & Outram 1988).
Since these early studies, evidence has amassed showing that the host encoded protein PrP is
involved in the genetic control of pathogenesis. Experiments were initially undertaken in an
attempt to reveal the molecular basis for Sine control of incubation period. DNA sequencing and
restriction fragment length polymorphism (RFLP) analyses showed close genetic linkage
between the Sine and PrP genes (Carlson et al., 1986, Westaway et al., 1987). Mice with Sine s7
and p7 genotypes encoded PrP proteins that differed at residues 108 and 189 of the PrP gene,
Prnp (Westaway et al., 1987). This close linkage was shown to be maintained using RFLP
analysis of congenic mice that differ only at the Sine locus providing strong evidence that Sine
and Prnp were very probably same gene (Hunter et al., 1992). Recent gene targeting
experiments have now proved that Sine and Prnp are the same (Moore et al., 1998) and that PrP
is the product of Sine but the way in which this gene controls the phenotypic properties produced
has yet to be proven. This discovery and the prominence of PrP (gene and protein) in TSE
pathogenesis have overshadowed Dickinson's early work and usage of the Sine terminology is
now obsolescent. In current literature, Sincs? and p? alleles are commonly referred to as Prnp" and
Prnpb, respectively.
1.4.2 Vacuolar Pathology
In tissue sections, vacuolar degeneration (commonly referred to as vacuolation) appears as tiny
holes in the neuropil of both grey and white matter. This resemblance gives rise to the alternative
terms of spongiform degeneration, spongiosis, or the media-coined, 'spongebrain', that describes
the microscopic appearance but not the texture of the brain. Vacuolation differs in severity and
distribution according to the experimental scrapie rodent model. The variation is dependent
mainly on the strain of scrapie but genotype of recipient and routes of challenge also play a part
(Fraser & Dickinson 1973, Fraser 1979). If these variables are kept constant, the pattern of
vacuolation is predictable and reproducible and can act as a 'fingerprint' for that model. The
distribution and severity of vacuolar pathology can be represented in graphic form as a lesion
profile that is individual to each scrapie strain. Vacuolation is assessed using light microscopy
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by scanning haematoxylin and eosin (H&E)-stained sections of brain from mice culled at the
terminal stage of scrapie. The vacuolar lesions in 9 grey and 3 white matter areas are assigned a
'score' on a scale of 0-5 where 0 represents no lesion and 5 the most severe spongiosis. The
resulting profile is formed by the line that joins the points of the average of the scores from the
individual areas. Lesion profiles are produced by combining the scores from six or more brains,
as groups of this size are required to give reproducible and statistically significant results.
Within the invariable parameters described above both incubation period and vacuolar pathology
remain constant from passage to passage and when taken together can serve to identify a scrapie
model. This method of strain typing has been used at NPU for more than 30 years resulting in a
'tried and tested' reliable system. Such is the accuracy and reproducibility of NPU strain typing
that, given the experimental scrapie model, the length of scrapie incubation can be calculated
with confidence. Conversely, if the incubation period and pattern of pathology (lesion profile)
are known, it is possible to correctly predict the strain of scrapie that caused the death of the
animal. The use of this methodology enabled Fraser, Bruce and colleagues to show that BSE was
a previously unrecognised strain of TSE (Fraser et al., 1992a) and that this same strain was also
responsible for the accidental spread to domestic cats and exotic ruminants (Bruce et al., 1994b,
Fraser et al., 1994). Bruce was also able to show that vCJD victims died from an agent that was
indistinguishable from BSE and conclude that the most likely scenario for developing the
disease was from dietary exposure to BSE (Bruce et al., 1997). As well as showing similarities
between BSE and vCJD, strain typing showed that vCJD was distinguishable from sporadic
CJD. Lesion profiles from the brains of dairy farmers who died of CJD were consistent with
sporadic and not vCJD thereby showing that these individuals did not contract the disease
(vCJD) through an occupational link with BSE-infected cows (Bruce et al., 1997).
1.4.3 Glycoform analysis
This method uses the differing degrees to which PrP is glycosylated and the resulting PrP glycoform
banding patterns that are obtained by gel electrophoresis to distinguish between TSE strains.
Glycoform analysis was used as a diagnostic tool to differentiate sporadic from vCJD (Collinge et
al., 1996) and to confirm that BSE and vCJD were the same strain (Hill et al., 1997). PrP has two N-
glycosylation sites and can exist as mono, di or unglycosylated forms. Normal cellular PrP (PrPc) is
glycosylated at both sites while PrP50 varies in the degree of glycosylation (Parchi et al., 1995,
Somerville et al., 1997). While the diversity of glycosylation patterning that is seen between scrapie
strains indicates that glycosylation is controlled by the TSE strain, the heterogeneity of glycosylation
found in different brain regions of the same infected animal shows that control is also exerted by
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host factors (Kascsak et al., 1985, Somerville et al., 1997,99). In addition, as was shown with
sporadic CJD, the degree of PrP50 glycosylation can also depend on PrP genotype and clinico-
pathological presentation (Parchi et al., 1995). Differences in glycoform patterning have also been
found between CNS and lymphoid tissues from infected individuals, between brain and spleen of
139A scrapie-challenged mice (Rubenstein et al., 1991) and within brain and tonsil of vCJD patients
(Hill et al., 1999). For these reasons glycoform analysis has not been universally accepted as an
alternative way to distinguish strains. However, as strain-typing methods are dependent on lengthy
transmission experiments, glycoform analysis provides useful supporting data.
1.5 Neuropathology of rodent scrapie.
Macroscopically, the brains of clinically affected rodents, animals and humans appear normal.
Microscopically, there are four pathological features that characterise the neuropathology of
scrapie and related diseases. These include glial activation that mainly involves a lesion-related
increase in size and number of astrocytes (Deidrich et al., 1991, Bruce et al., 1994a, DeArmond
et al., 1992, van Keulen et al., 1995) and microglia (Williams et al., 1997b, Peyrin et al., 1999),
and neurone loss (Fraser 2002). In one model in which the sequence of neurodegeneration has
been characterised, neuronal loss is preceded firstly by PrPd deposition then by loss of synapses,
axon terminals and dendritic spines and then gliosis (Fraser 2002). Apart from PrPd, none of
these are specific indicators of TSE disease and occur generally in response to neurological
disease or trauma. However, astrogliosis is closely associated with disease-associated PrP (PrPd)
deposition (Bruce et al., 1994a) and as such can be a useful indicator of early specific scrapie
pathology when PrPd is difficult to detect (McBride PA, unpublished observation). The
remaining two features, vacuolar degeneration and cerebral amyloidosis, are key to the
diagnostic identification of TSEs.
The appearance and distribution of vacuolar pathology has been described previously in
conjunction with its role in strain identification (see section 1.4.2)
The other classical lesion associated with scrapie pathology is the presence of cerebral amyloid,
notably, in the form of plaques. The term 'amyloid' meaning 'starch-like' is a general
classification of fibrillar proteins of 6-1 Onm that form insoluble aggregates in normal
physiological conditions and contain a beta-pleated sheet secondary protein structure. This
protein conformation binds the dye Congo red and produces a green birefringence when stained
histological sections are viewed with polarised light (Puchtler et al., 1962). The typical plaque is
round and composed of a central core of radiating amyloid fibrils and an outer corona. Scrapie
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plaques are very similar to senile plaques found in brains of Alzheimer's disease (AD) patients
but the major amyloid proteins derive from biochemically distinct classes that can be
distinguished from each other immunocytochemically. In AD the core protein is Afl, while
scrapie plaques are principally composed of PrPd. As with vacuolation, when mapped in H&E-
stained tissue sections, the distribution of amyloid plaques in the brains of intracerebrally
challenged mice, depends on the scrapie model. Some models produce large numbers while in
others there are few or no discernible plaques (Bruce 1976). The fact that plaques are not always
present in naturally occurring or experimental TSEs shows that this feature alone is not reliable
as a diagnostic indicator.
1.5.1 PrP-related pathology
Historically, scrapie diagnosis was carried out by examination of formalin-fixed, H&E-stained
sections. However, the isolation of PrP allowed the production of antibodies and by the late
1980s there were an increasing number of publications in which the developing technique of
immunocytochemistry (ICC) was used as a diagnostic tool. Early studies identified PrP-
containing amyloid plaques in several TSEs including experimental scrapie of rodents, human
TSEs and natural and experimental scrapie of sheep (Bendheim et al., 1984, DeArmond et al.,
1985, Roberts et al., 1986, Kitamoto et al., 1987, Wiley et al., 1987, McBride et al., 1988,
Millar et al., 1993). Nevertheless, it became apparent that only a proportion of the PrP present
was being visualised. PrPd or PrPSc could be identified by EM or Western blotting in extracts of
affected brains from all scrapie strains including those where no plaques had been observed by
H&E or ICC staining. This suggested that in addition to plaques, other forms of PrP pathology
existed. The extent, distribution and heterogeneity of PrPd pathology was revealed by the use of
PLP (periodate-lysine-paraformaldehyde) fixation (McLean & Nakane 1974) coupled with a
short processing cycle. After this fixative was adapted for use by incorporating very low
concentrations of paraformaldehyde (2% instead of the prescribed 10% volumes), a far greater
range and quantity of PrPd was revealed compared to standard formalin fixation (Bruce et al.,
1989, McBride et al., 1992,93,98). The carbohydrate preserving property of PLP was well suited
for PrP glycoprotein.
The sensitive ICC methods developed at NPU have been used to identify, map and compare
distributions of host (PrPc) and PrPd in tissues from a variety of rodent scrapie models (Bruce et
al., 1989,94a, McBride et al., 1992,93,98,99, Manson et al., 1992,94b, Ritchie et al., 1999;
Brown et al., 1999, Beekes & McBride 1998), natural scrapie and BSE (Foster et al.,
1996,2001). In immunolabelled sections of terminally-affected mouse brain, a variety of
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different forms of PrP pathology can be identified (Figure 1.1). As well as in amyloid plaques,
PrPd can be seen as randomly-distributed irregular aggregates of varying size, within or
surrounding astrocytes, as dense inclusions within microglia, encircling cell bodies in specific
neuronal groups or tracking along neuronal processes and blood vessels. The most predominant
and pathogenically significant form of PrPd is the diffuse granular deposition that is widespread
within particular areas of the CNS (DeArmond et al., 1987,97, Bruce et al., 1989,94a, Beekes &
McBride 98). PrPd is targeted to and associated with neurones in precise anatomical locations.
This type of cerebral amyloid-related pathology is not found in AD or other amyloidogenic
neurodegenerative diseases and is therefore a unique distinguishing feature of TSE pathology.
The importance of diffuse PrPd was revealed in time course studies showing that this type ofPrP
pathology is seen very soon after inoculation or challenge - between lA and '/5 of the way
through the incubation time in the models studied. Even at this early stage the protein is
accurately and consistently observed in small groups of neurones in specific CNS sites (Bruce et
al., 1994a, Beekes & McBride 1998, McBride et al., 1998) suggesting that scrapie strains
recognise and selectively target certain groups of neurones for replication but the underlying
mechanism for such selectivity is unknown at present.
In the mouse models tested, the manifestation of PrPd, vacuolation and the onset of clinical
disease occur sequentially (Bruce et al., 1989,94b)[Table 1.2], Amyloid plaques do not appear
before diffuse PrPd but can be found at a relatively early stage in infection confined to the corpus
callosum and other ventricle associated sites (Bruce 1976, Bruce 1981). In contrast to plaques,
diffuse PrPd co-localises with areas of intense vacuolation (Bruce et al., 1994a), neuropil damage
(Jeffrey et al., 1997) and by association, almost certainly with replication of the scrapie agent.
The ubiquitous association of PrPd with infectivity has more recently been called into question
with the finding that significant levels of infectivity can be present in brains without detectable
PrPd or PrPSc (Lasmezas et al., 1997, Manson et al., 1999).
PrPd can be seen consistently and reproducibly within particular rodent models of TSE but
differs in distribution pattern between models (Bruce et al., 1989,94a &b; Brown et al., 2003).
Diffuse PrPd is located in specific neuroanatomical areas and the patterns of distribution
observed at the terminal stage of disease can be used to identify strains (Figure 1.1). The patterns
exhibited by mouse strains such as ME7, 87V, 79A, 22A, 22L (Bruce et al., 1989,94a &b),
mouse-adapted BSE and vCJD (Brown et al., 2003) and hamster 263K (Beekes & McBride
1998) show differences in area targeted extent of relative deposition and glial involvement.
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1.5.2 Visualisation of PrPc in tissue sections.
Several PrP antisera are available from a number of donor species (mice, hamsters, sheep and
cows) that recognise the full-length protein or fragments of it. The structural similarities of PrP
allow many of the antibodies to recognise PrP in a variety of species as well as the one that
supplied the antigen. There are no antibodies that can specifically identify PrPc and PrPd in
tissue sections and this can be a problem when ICC is used as a diagnostic tool. PrPc can be
removed by a variety of pretreatments that include autoclaving at 121°C and immersion in both
undiluted formic acid and concentrated guanidine thiocyanate (Bell et al., 1997). These
procedures are harsh but appear to be largely effective on human and ruminant tissues. On less
robust rodent tissue such treatments can produce artefacts that lead to false positives or
uninterpretable results (P. McBride, unpublished observation). However, experimental protocols
have been developed that allow PrPc and PrPd in the CNS of rodents to be distinguished by their
differing physical appearance. Whereas PrPd is seen in the variety of (largely) extracellular
forms described above, in immunolabelled tissue sections PrPc is intracellularly located and
appears as a homogenous, finely granular form in unaffected neurones (Bruce et al., 1989,
Beekes & McBride 1998). In the CNS of uninfected mice and hamsters, PrPc immunolabelling
can be seen only within a proportion of neuronal cell bodies. The greatest number of PrPc-
containing neurones are found in the brainstem and grey matter of spinal cord but some are also
commonly found in the thalamus, hippocampus and dentate gyrus (DeArmond et al., 1987, Bruce
et al., 1989, Beekes & McBride 1998).
Outwith the CNS differentiation between different forms of PrP remains problematical.
Identification of the diseased-state is particularly important in, for example, lymphoid or
gastrointestinal tissues because these feature prominently in peripheral pathogenesis. The
difficulty can be overcome by use of the recently introduced Paraffin Embedded Tissue (PET)
blotting technique. PET blot pretreatments involve incubating sections for several hours in
proteinase K to destroy PrPc and leave only the proteinase K-resistant PrP (Schultz-Schaeffer et
al., 2000a).
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Figure 1.1 Disease-specific forms of PrP
Amyloid plaques - cored or diffuse
Irregular aggregates
Punctate deposits - synapses, neuronal processes
Perineural accumulations
Neuronal inclusions
Glia - astrocytes, microglia
Diffuse - neuroanatomically targeted
. V
&#£ ■









J? 13 . •? '%HP i ' •' *v •' . *4tJa?






Types of PrP pathology commonly
observed in experimental models
of rodent scrapie; A, plaques; B
irregular aggregates; C perineuronal
deposits; D, microglia (arrows),
astrocytes (arrowhead); E, PrPd
labelling cerebellar Purkinje cell
processes (a feature of ME7 scrapie
pathology) and punctate deposits (*)
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Figure 1.2 Pattern of PrP immunolabelling in ME7 (A) and 87V (B)
terminally-affected brain. Diffuse accumulations are prominent and
neuroanatomically located in brains from both scrapie strains but
areas of targeting differ. With ME7, PrPd is widely distributed but
some regions are more heavily labelled than others, e.g. CA3 region
of hippocampus and dentate gyrus (dg ). 87V scrapie is very precisely
located in the CA2 region of the hippocampus and thalamic nuclei
(T). Plaques (in box) are also typically numerous with this strain.
The ovals show regions of aggregated PrP and circles, PrP-encircled
neurones.
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Table 1.2 Relationship of scrapie-related pathology to incubation period.
Sequence of events occurring in Prnpb (Sine p7) mice after intra-cerebral
injection of 87V scrapie brain homogenate. The onset of pathology and
clinical signs are reproducible and consistent. Disease-associated PrP
(PrPd) appears some weeks before vacuolation and both occur long






















^— First clinical signs
m— Terminal disease
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1.6 Peripheral pathogenesis
Until recently, the majority of studies examining the pathogenesis of the TSEs used genetically
unaltered rodent models of experimental scrapie. Initially, experiments employed the
intracerebral (i/c) route of infection. Although far from mimicking 'natural' infection, this route
answered some scientific questions but it was soon recognised that more biologically relevant
routes should be examined.
Although the ultimate target of TSE infection is the CNS there is evidence that both the LRS and
the peripheral nervous systems (PNS) are involved in pathogenesis prior to CNS invasion. After
oral or peripheral infection, neuroinvasion may occur directly via the peripheral nerves that
innervate the GI tract or other visceral organs. Indirect neural spread is also likely following
initial replication in lymphoid organs such as spleen or gut-associated lymphoid tissue.
Haematogenous spread is possible but existing evidence suggests that this route does not
contribute significantly to CNS infection in rodent (Dickinson et al., 1969, Casaccia et al., 1989),
or goat scrapie (Hadlow et al., 1974, Pattison et al., 1961), TME of mink (Marsh et al., 1973)
and in kuru, sCJD (Gibbs & Gajdusek 1972, Gajdusek 1977) or vCJD patients (Armstrong et al.,
2003). The role of viraemia in BSE remains unclear (Houston et al., 2000). 'Selection' of the
route that ultimately leads to neuroinvasion may be dependent of several factors including TSE
strain and dose. Nevertheless, it has become convenient to refer to strains that show a propensity
to direct neuroinvasion as 'neurotropic' and those that replicate in the LRS prior to CNS
invasion as Tymphotropic'. Possible pathways of neuroinvasion are outlined in Figure 1.3.




peripheral nerves LRS blood
22 Chapter 1: Introduction
1.6.1 The lymphoreticular system in TSE pathogenesis.
Early studies measuring infectivity levels after intraperitoneal challenge (i/p) of mice with the
Chandler strain (Eklund et al., 1967) or in natural scrapie (Hadlow et al., 1982) showed that,
outside the CNS, the highest titres of infectivity are found in spleen and lymph nodes. After oral
or peripheral routes of infection, several TSE agents replicate in lymphoreticular system (LRS)
prior to CNS invasion (Fraser et al., 1992b, Kimberlin & Walker 1979,88,89a, Ehlers et al.,
1984, Farquhar et al., 1994, Mabbott et al., 1998).
A functioning immune system has been shown to be necessary for TSE infection after peripheral
challenge. Severe combined immunodeficient (SCID) mice which lack mature T and B
lymphocytes (and, by association, follicular dendritic cells) resist peripheral infection with a
mouse adapted strain of CJD (Kitamoto et al., 1991), nor do they develop scrapie when infected
with ME7 (or ME7-equivalent) and fail to replicate infectivity in their spleens (O'Rourke et al.,
1994, Fraser et al., 1996, Lasmezas et al., 1996). Engraftment of syngeneic bone marrow from
immunocompetent donors restores susceptibility to ME7 infection and replication in spleen
(Fraser et al., 1996).
Splenectomy and genetic asplenia extend the incubation period in many rodent models if the
spleen is removed before or shortly after i/p infection (Fraser & Dickinson 1970,78, Dickinson
& Fraser 1977). Infectivity measurements of spleen fractions suggested that non-lymphoid cells
could possibly support scrapie replication (Clarke & Kimberlin 1984). Also, as ionising
radiation has no effect on the incubation period of peripherally infected mice, it was concluded
that cells involved in scrapie pathogenesis were post-mitotic, long-lived cells which do not
depend on stem cell replacement (Fraser & Farquhar 1987, Fraser et al., 1989). Recent studies
have demonstrated the importance of follicular dendritic cells (FDCs) in peripheral pathogenesis.
These cells are radiation resistant and support scrapie replication in the spleen of mice (Brown et
al., 1999, Montrasio et al., 2000). Studies infecting tumour necrosis factor (TNF)-a or
interleukin (IL)-6 deficient mice and lymphotoxin beta receptor (LTflR) treated mice also sustain
FDC involvement (Mabbott et al., 2000a,b, Manuelidis et al., 2000) in TSE pathogenesis. These
mice either lack FDCs or germinal centre support for FDCs. The presence of both T and B
lymphoctyes in the lymphoid tissues of these transgenic mice support the evidence that
lymphocytes are probably not central to their extended survival after peripheral challenge.
Both cellular and disease specific forms of PrP are associated with FDC in spleen, mesenteric
and gut associated lymph nodes (Kitamoto et al., 1991, McBride et al., 1992, Ritchie et al.,
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1999, Beekes & McBride 2000, Jeffrey et al., 2000). Though these studies suggest that PrP-
expressing FDCs are key players, the mechanisms for peripheral replication, uptake and transfer
of agent are likely to be complex and strain dependent. For instance, as FDCs rely on B cells for
survival and maturity, the studies carried out so far cannot exclude the involvement of radiation-
resistant, terminally-differentiated B lymphocytes (Blattler et al., 1997, Klein et al., 1997). Other
cells such as macrophages (Beringue et al., 2000) and migratory dendritic cells (Huang et al.,
2002) are also putative participants.
While many of the studies examining LRS participation in peripherally-aquired TSEs have been
conducted using rodent models, the lymphoid system appears to have an equally important role
in natural and experimental scrapie (van Keulen et al., 1996,99, Andreoletti et al., 1999,2000,
Heggebo et al., 2000, Schreuder et al., 1998), CWD (Sigurdson et al., 1999, Williams & Millar
2002), BSE in sheep (Foster et al., 2001, Jeffrey et al., 2001a) and possibly also vCJD (Hilton et
al., 1998, Collinge etal., 1999, Hill et al., 1999).
Despite this, there are examples where an intact immune system does not appear to be crucial for
neuroinvasion. After intragastric or oral infection of mice with 139A or hamsters with 263K
scrapie, replication in the spleen is not necessary for CNS infection or disease progression. In
these studies, elevated brain infectivity titres preceded those of the spleen (Casaccia et al., 1989,
Beekes et al., 1996) and splenectomy did not extend the incubation period (Kimberlin & Walker
1977,86,89a,b, Beekes et al., 1996). Transgenic mice that expressed hamster PrPc in neuronal
but not lymphoid cells were susceptible to i/p or orally administered hamster scrapie (263K)
even though infection was not established in the spleen (Race et al., 2000). Also, in hamsters
intraneurally infected with HY, a hamster-adapted strain of TME, PrP^ was detected in spleens
only after being observed in brain suggesting that in this rodent model too, CNS infection is LRS
independent (Bartz et al., 2002). In addition, there is a striking lack of LRS involvement in BSE
pathogenesis (Wells et al., 1998) and although PrP has been found in association with lymphoid
tissues from vCJD patients (Hilton et al., 1998, Collinge et al., 1999, Hill et al., 1999),
transmission studies have indicated that the LRS may not have a primary involvement
(Manuelidis et al., 2000). Furthermore, even with the lymphotropic strain ME7, SCID mice do
sometimes succumb to peripheral challenge particularly if high doses are given (Fraser et
al., 1996, Lasmezas et al., 1996, Mabbott et al., 2000a). In these experiments using SCID mice,
incubation periods were shorter than expected and either no infectivity or no PrP^ was detected
in spleen. Taken together these findings show that after peripheral exposure, including oral
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challenge, CNS invasion and disease progression can occur in the absence of LRS infection. An
alternative way for this to occur is by way of peripheral nerves.
1.6.2 The peripheral nervous system in TSE pathogenesis
The idea that peripheral nerves could serve as conduits for infectious spread was first suggested
by sciatic nerve transection studies and by experiments showing that, after peripheral challenge,
extraneural replication could be bypassed if the infectious agent was injected directly into nerves
(Kimberlin & Walker 1980, Kimberlin et al., 83b,c,87). Infectivity can spread along linked
neuroanatomical relays from outwith (Bartz et al., 2002,03) or within the CNS (Fraser &
Dickinson 1985, Scott et al., 1989,1992, Muramoto et al., 1993, Ingrosso et al., 1999) and it has
also been reported that PrPc (Borchelt et al., 1994) or PrP& (Bartz et al., 2002) can be
transported along peripheral nerve axons. Substantial amounts of infectivity have been found in
a number of fore and hind limb peripheral nerves of scrapie sheep (Groschup et al., 1996), and in
many peripherally-challenged rodent models, neural targeting of infectivity shows a pattern that
is consistent with spread along peripheral nerves supplying the viscera (Kimberlin et al., 1983b,
Kimberlin & Walker 86).
In his experiments measuring the onset and spread of infectivity in rodent CNS, Kimberlin et al
proposed that after oral or peripheral challenge, the scrapie agent spread to the spinal cord from
abdominal viscera along sympathetic nerves (Kimberlin & Walker 80, 82, 86, 89b). This theory
has been supported by studies showing that the incubation period of intraperitoneally infected
mice can be extended by chemical or immunological sympathectomy (Glatzel et al., 2001) and
by findings presented in this thesis demonstrating the presence of PrPd in spinal cord
sympathetic neurones (McBride et al., 2001).
Regardless of whether replication in lymphoid organs is a prerequisite, for disease to develop the
infectious agent needs to be transported from peripheral sites to its ultimate target, the CNS.
There is persuasive evidence for the involvement of the PNS in peripherally acquired TSEs
affecting a variety of species including natural and experimental scrapie (Hadlow et al., 82,
Kimberlin et al., 1983b, Lasmezas et al., 1996, Groschup et al., 1996,99, Baldauf et al., 1997,
Beekes & McBride 1998, McBride & Beekes 1999, van Keulen et al., 1999,2000, Glatzel &
Aguzzi 2000), BSE (Wells et al., 1998), experimental CJD (Muramoto et al., 1993) and vCJD
(Niewiadomska et al., 2002; Haik et al., 2003).
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From the accumulated data, the relative importance of either system in establishing infection
appears to differ according to TSE model. The contribution of the LRS has largely been
addressed using SCID and other types of immune-deficient mice. Separating the two interacting
systems is not easy but this is now being addressed using transgenic mouse models. Experiments
using transplantation and adoptive transfer of PrP-expressing tissue into PrP null mice were
undertaken to provide better evidence of PNS involvement in peripheral infection (Blattler et al.,
1997, Glatzel & Aguzzi 2000). Engraftment of PrPc-expressing cells into PrP"'" mice restored
infectivity and PrP& accumulation in lymphoid tissue but did not promote neuroinvasion. This
suggested that another non blood-bome component; i.e. peripheral nervous tissue was also
required for agent transportation (Blattler et al., 1997). Studies using transgenic (Tg) mice have
supplied more formal proof that neuroinvasion can occur independently of LRS involvement.
Oral or peripheral 263K infection of Tg mice generated to express hamster PrP in PNS but not
LRS compartments developed clinical scrapie. Therefore PrP expression in peripheral nerves
(under control of the Neurone-Specific Enolase promoter) was sufficient for the transferral of
infectivity from peripheral sites such as the gut to the CNS (Race et al., 2000). The LRS was
neither required as a site of replication nor for transferral of agent to the CNS.
1.6.3 Oral infection
It has long been recognised that the most likely way for lambs and sheep to become infected
with scrapie is via the GI tract (Pattison et al., 1974, Hadlow et al., 1982) and this route is now
generally accepted as the cause of BSE in cows (Wells et al., 1998). TSEs are also recognised in
wild species, e.g. TME of mink and CWD of mule deer and elk and although the mode ofnatural
spread has not been formally proven in these animals, oral or alimentary transmission is
suspected (Hartsough & Burger 1965, Hadlow & Karstad 1986, Williams & Young 1980, Marsh
& Bessen 1993). Nevertheless, transmission of natural scrapie to sheep or goats could occur via
scarification of gums or skin as this has been shown to be an efficient route of establishing
infection (Carp 1982, Taylor et al., 1996b). There are reports of scrapie outbreaks occurring in
'scrapie-free' flocks kept on pastures that previously housed scrapie infected animals (Palsson
1979) possibly reflecting the continuing participation of a long-departed contaminant such as
infected placenta or rotting flesh (Brown & Gajdusek 1991). In man, kuru was reportedly spread
by ritualistic cannibalism (Gajdusek 1977, Cervenakova et al., 1998) but the extent of this
practise has been challenged (Taylor 1989). Skin scarification was subsequently suggested as a
probable cause with route of entry via cut or abraded skin (Liberski & Gajdusek 1997, Goodfield
1997). The oral route of infection assumed a greater significance when BSE, and then vCJD,
were reported. The overwhelming data linking the two diseases (Bruce et al., 1997; Hill et al.,
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1997) strongly suggests that both cows and human sufferers contracted their illness through
eating material infected with TSE agent. However, relatively little is known about how the
infectious agent reaches the CNS once it has gained access to the gut. Apart from the alimentary
tract being a potential site of early infection and diagnosis, this information is vital for
therapeutic intervention in these diseases.
As is the case for PNS involvement, the number of publications addressing the extraneural
distribution of infectivity or PrPd after oral infection has grown rapidly since the arrival of BSE
and vCJD. Studies including those generated from this body of work show that the ENS and gut
associated lymphoid tissues are early players in oral pathogenesis of these diseases (Wells et al.,
1994, 98, Andreoletti et al., 2000, Beekes & McBride 2000, Heggebo et al., 2000, 02, 03, van
Keulen et al., 2000, Jeffrey et al., 2001a, McBride et al., 2001, Bons et al., 2002, Terry et al.,
2003). Nevertheless, many questions remain unanswered not least the mechanism(s) of uptake
and the associated cellular interactions. Thus, though the PNS, LRS and ENS are implicated in
TSE peripheral pathogenesis, the relative contribution and interaction between these systems is
likely to be multifactorial and strain dependent.
1.7 Aims
Previous approaches addressing the dynamics of spread showed that in a number ofperipherally-
challenged rodent models of scrapie, infectivity (Kimberlin & Walker 1982,86,89b), and PrPd
(Beekes et al., 1996, Baldauf et al., 1997) was first detected in central portions of the thoracic
cord. The infectious agent subsequently spread to the brain and other parts of the spinal cord in a
pattern that was consistent with propagation along the autonomic nerves that innervate the
visceral organs. However, there was limited information about the neural pathways involved in
spread of TSE agents after natural routes of infection. In addition, little attention had been paid
to the GI tract and information about possible sites and mechanism of agent uptake agent was
lacking even though the most probable portal of entry of the TSE agent is through the alimentary
tract.
This study aims to investigate PNS involvement in oral infection and define any neuronal
pathways employed by the infectious agent during routing from the GI tract to the CNS. PrP
immunocytochemistry was used in conjunction with paraffin-embedded tissue (PET) blotting
and selective infectivity bioassays to determine the temporal and spatial location of PrP in the
CNS, PNS and ENS of hamsters orally-challenged with 263K scrapie. PrPdis used as a marker
for infection as previous experiments have shown that there is a close correlation between PrPd
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and the infectious agent in the rodent model of scrapie used in this study (Beekes et al., 1996,
Baldauf et al., 1997).
The first experiment focuses on the sites of PrP deposition in brain to elucidate and locate
neuroanatomical region to which PrPd is targeted at the early stages of infection (Chapter 2).
This chapter also reports the sequential development and cellular association of PrP pathology.
Subsequent to this, a detailed study examines the temporal appearance and ensuing accumulation
of PrP in the circuitry of the vagus and splanchnic nerves (Chapter 4). These nerves innervate a
number of visceral organs including spleen and lymph nodes. Gut-associated lymphoid tissue
(GALT) and the enteric nervous system (ENS) of the small intestine is also included (Chapter 5)
as these are possible sites of uptake of TSE agent and can link directly or indirectly with the
CNS. The difficulties associated with excision and microscopic presentation of peripheral
components from hamsters necessitated a pilot study to ensure the feasibility of the proposed
techniques (Chapter 3).
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Chapter 2: Temporal and spatial targeting of PrPd in the CNS of 263K-
fed hamsters
2.0 Introduction
Although the oral route of infection has long been established in experimentally dosed sheep and
goats (Pattison & Millson 1961, Pattison et al., 1972,74) prior to the renewed interest through
BSE, there had been relatively few publications reporting oral challenge of rodents with scrapie.
Also, due largely to the inefficiency of the route or inadequacy of dose, even fewer of those has
provided meaningful results (Zlotnik & Rennie 1962, Kimberlin & Walker 1979,86 Carp 1982,
Prusiner et al., 1985). However, in the 1970s and 80s Richard Kimberlin and co-workers carried
out a series of experiments measuring the onset and spread of infectivity in the brain and spinal
cord of rodents after various peripheral routes of infection including intragastric challenge
(Kimberlin & Walker 1979,80,82,86,89b, Cole & Kimberlin 1985). These findings suggested
that the infectious agent firstly accessed the CNS at the mid-thoracic cord and then spread
upwards towards the brain. Later studies focusing on the oral route and using Western blot
analysis and protease-resistant PrP (PrP80) as a marker for infectivity (Beekes et al., 1996,
Baldauf et al., 1997) supported these early findings and localised the entry to thoracic segments
T4-T9. In addition, other observations (Kimberlin & Walker 1982, Muramoto et al., 1993, van
Keulen et al., 1995) suggested the existence of a further pathway that, after peripheral challenge,
permitted the infectious agent direct entry into the brain. Support for this was provided by
Western blot analysis of brain homogenates taken from intraperitoneally infected hamsters that
had been culled at successive points through the scrapie incubation period. Results from this
study indicated an alternative independent route that by-passed the spinal cord and entered the
brain via the medulla (Baldauf et al., 1997) but there were no previous reports describing the
specific location of the entry site. The medulla is a large area and while PrP80 can be
demonstrated very satisfactorily using Western blotting the method is limited in that it can detect
only the presence or absence of the protein within a sample of homogenised tissue. Therefore, in
order to localise disease-specific PrP (PrPd) precisely, in this study, immunocytochemistry (ICC)
was used. This technique allows the specific identification of a protein in tissue sections
prepared to retain their original appearance and cellular morphology. As with Western blotting,
the desired protein is detected using an antibody-antigen reaction that has been tagged by a
chromagen but unlike Western blotting, the protein can be visualised in situ so individual cells
and their associated components can be identified along with their precise location.
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The aim of this first experiment was to identify the presence and anatomical location of PrPd
within the brain and spinal cord ofhamsters orally-infected with 263K scrapie. To achieve this, a
time-course study was employed with brain and spinal cord being collected at points throughout
the incubation period. While bioassays are the method of choice for detection of scrapie agent
they require large numbers of laboratory animals and are very time consuming. ICC can be used
to elucidate sites of infection by using disease-associated forms of PrP as surrogate markers for
infectivity. As was explained in Chapter 1, a close correlation between infectivity and PrP80 has
been previously established in this animal model (Beekes et al., 1996, Baldauf et al., 1997).
After ICC, the presence, physical appearance and temporal deposition of PrP were assessed
using light microscopy. Kimberlin had proposed that spread to the spinal cord from peripheral
sites occurred along sympathetic nerves (Kimberlin and Walker 1988). Although it was known
that neurones were key targets for scrapie pathology, there was little or no information about the
specificity of targeting after oral infection, i.e. the actual groups of neurones that were involved.
It was hoped that this approach would provide information to aid identification of the neuronal
pathways that had been used to reach and invade the CNS after oral challenge possibly by
helping to confirm this hypothesis or at least by clarifying the involvement of the medulla in oral
pathogenesis.
2.1 Materials and methods
Outbred Syrian Golden hamsters were infected with 263K scrapie by feeding lOOp.1 of a 10%
brain homogenate prepared from a pool of hamster brains terminally-infected with 263K agent.
Each measured dose of inoculum was placed on a food pellet of standard laboratory diet and left
for a few minutes to be absorbed. To ensure each hamster received the correct dosage,
cagemates were separated and given their prepared food pellet in individual cages. Prior to this,
the hamsters had been deprived of food overnight and the pellets were either eaten readily or
within the next one to two hours. On being reunited, the hamsters quickly integrated and the
temporary separation had no effect on their subsequent social behaviour. Groups of four
hamsters were culled by C02 euthanasia at 84, 91, 98, 105, 113, 119, 126, 133 days post
infection (dpi) and at 156 dpi, when they had reached the terminal stage of disease. Four
uninfected controls were culled when they were between 180 and 210 days of age.
The brain and spinal column (excluding the most caudal lumbar and sacral regions) were
removed and immersion fixed in paraformaldehyde-lysine-periodate (PLP) overnight. After
fixation, two of the brains were bisected mid-sagitally along the longitudinal fissure. The other
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two brains were trimmed coronally into five pieces according to the standard levels used in our
laboratory for vacuolar lesion profiling (Figure 2.1 A). The spinal column was cut transversely
into seven pieces, each containing multiple segments of cervical (C) or thoracic (T) cord. The
pieces corresponded to vertebrae segments Cl-3, C4-7, Tl-3, T4-6, T7-9, T10-11, T12-13
(Figure 2.1B&C). The cord pieces were then marked at their cranial ends with Indian ink and,
along with the brain pieces, dehydrated in alcohol over another six hours and embedded in
paraffin wax. The seven segments were processed separately and embedded together in one
block. To ensure that each piece could be individually identified they were positioned in wax
according to a pre-arranged design. When viewed under the microscope each piece was
identifiable by its location within the block (Figure 2.ID). The sagittally and coronally sliced
pieces ofbrain were similarly embedded in individual blocks (Figure 2. IE & F).
'Sets of adjacent sections were cut at six microns thick, floated onto a warm water bath and dried
in an oven at 37°C. One section was stained with haematoxlyin and eosin to enable the cellular
morphology to be assessed. Another was stained with cresyl violet and Luxol Fast Blue
(CV/LFB) to aid the neuroanatomical identification of cell types. Two others were used for PrP
immunolabelling (one to which PrP antibody was applied and one that was used as a serum
control) and two were kept as spares in case the immunolabelling had to be repeated.
Immunolabelling was carried out according to the 'Indirect' method using the mouse anti-
hamster monoclonal antibody, 3F4 (Kascsak et al., 1987) to label PrP and diaminobenzidine
(DAB) to visualise the reaction product. Prior to immunostaining sections were treated with
formic acid for 10 minutes to enhance staining (see Appendix 2 for full description of method).
PrPd was mapped according to its location using an atlas (Stereotaxic Atlas of the Golden
Hamster Brain: Morin and Wood: Eds, Academic Press)
Due to the lack of contrast and paucity of early deposition, computerised image analysis could
not be employed as an aid to quantification therefore the accumulation of PrPd observed in
immunolabelled sections was scored using light microscopy according to the following criteria:
+ Punctate deposition on surface of, within and/or in the adjacent neuropil of individual or
small groups of neurones. Deposition very focal. Visible only at high magnification.
*
Up to this point, the procedures were carried out in Berlin by my collaborator, Michael Beekes, after
appropriate histopathology training by the author. All subsequent procedures were carried out at the
Neuropathogenesis Unit.
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++ Similar cellular appearance and location but greater numbers of individual neurones
involved within single groups. More groups included. Extracellular distribution is more
extensive but remains localised to associated neurones.
+++ Deposition diffusely granular in appearance and associated with large numbers of
neurones and many groups. Substantial extracellular accumulations deposited widely
within neuroanatomical areas.
M I I Very heavy deposition characterised by many protein aggregates. Extensive granular
deposition throughout most regions. Easily observed at low magnification.
Immunolabelled sections were examined without prior knowledge of the experimental status of
the animal.
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2.2 Results
2.2.1 Temporal appearance and topography of PrP in the CNS of 263K-challenged and
uninfected hamsters
Results are summarised in Tables 2.1 and 2.2 and Figures 2.2A and B. The onset of PrPd
deposition varied between individual animals as did the extent of deposition within a group of
animals from a given time point, i.e. tissues from the earliest time points did not necessarily
contain the least labelling nor later time points the most. This occurrence reflects the biological
variation between animals observed previously in similar experiments. The temporal progression
of deposition was, therefore, only apparent when results from all cases were viewed overall. For
this reason, 'snapshots' of individuals were not representative of the timing of events so results
from Figures 2.2A and B and Table 2.1 are pooled to show the trend of spread and accumulation
over time. Though the timing of PrPd deposition was variable, the location of initial deposition
and sequence of subsequent target sites was very consistent (Tables 2.1 and 2.2). The results
correspond to the sequential appearance and distribution of PrP50 in the brain and spinal cord that
was determined previously by Western blotting (Beekes et al., 1996).
2.2.1i Brain
Figures 2.2A and B show pictorial representations of PrP in sagittal (A) and coronal (B) brain
slices. Coronal and sagittally sliced brains were employed to maximise the visualisation of PrP
and demonstrate its 3-dimensional distribution more effectively. (A) shows the initial target sites
in the medulla and the subsequent caudal to rostral direction of spread and (B) compares the
distribution of PrPd at early and terminal stage of disease. Table 2.1 shows the sequence of the
brain areas in which PrPd appeared against time.
PrPd was first detected at 91dpi in the medulla of all four hamsters. The first target site for PrPd
deposition was in the dorsal nucleus of the vagus nerve (DMNV) followed immediately
afterward by the adjacent commissural portion of the solitary tract nucleus (SN) [Figures
2.3A&B]. Very often both these sites were labelled but when compared, the DMNV was
consistently more heavily labelled and contained a wider distribution of PrPd within the nucleus
than the SN (see figure 2.3C). Also, in one brain from the earliest group of 91dpi, PrPd was
present in small amounts in the DMNV but lacking in the SN suggesting that PrPd was deposited
in the DMNV before the SN. Shortly after this, PrPd was located in the superior vestibular
nucleus and in the gigantocellular nucleus of the reticular formation. Labelling extended through
the SN towards the area postrema although this was itself negative. Subsequently, PrPd was
observed in several other nuclei of the medulla, predominantly those of the vestibular network or
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Table 2.2 Distribution and accumulation of PrPd in spinal cord segments of
individual hamsters culled in groups throughout the incubation period
Dpi Cl-3 C4-7 Tl-3 T4-6 T7-9 T10-11 T12-13
84 - - - - - - -
84 - - - - - - -
84 - - - - - - -
84 - - - - - - -
91 - - - + + - -
91 - + ++ + ++ + -
91 - + + + ++ + -
91 - + + + - - -
98 - - _p - - - -
98 - - - - + - -
98 - - - + - - -
98 - - - - - - -
105 - - _p - - - -
105 + _p + + ++ - -
105 - - - + ++ - -
105 - - - + + + -
113 - _p + + + + -
113 - - - - - - -
113 + + +p ++ ++ + +
113 - - _p + - - -
119 - +p - + ++ + -
119 ++ ++ ++ +++ +++ +++ +
119 ++ ++ +++p +++ ++++ +++ ++
119 - - - - - - -
126 - - - - - - -
126 - _p _p ++p + - -
126 + +p + ++ +++ ++ +
126 - - - - - - -
133 ++ ++ ++p ++p ++ + +
133 ++ ++ ++ +++ +++ +++ ++
133 ++ + ++ +++ +++ ++ ++
133 +++ +++ +++ ++++ ++++ +++ +++
156 EP +++ P+++ ++++ ++++ ++++ +++ +++
156 EP ++++ +++ ++++ ++++ ++++ ++++ +++
156 EP ++++ ++++ p++++ ++++ ++++ ++++ ++++
156 EP +++ +++p +++ ++++ ++++ +++ +++
3, p: DRG present adjacent to cord segment; P: +ve, p: -ve; EP: endpoint of disease
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Figure 2.2A Sequence of PrPd targeting in the CNS. Selected mid-sagittal slices cover the range
between the first appearance at 91dpi and terminal disease. Distribution (shaded areas)
represents the trend of accumulation rather than the absolute pattern at a given timepoint.
Greater intensity of colour denotes greater deposition. Note: Labelling is present simultaneously
and independently in medulla (DMNV) and thoracic cord; Spread occurs in a caudal to cranial
direction. Cx, cortex; Cb, cerebellum; Med, medulla; Mb, midbrain; T, thalamus
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Figure 2.2B Scheme of PrPd deposition in coronal brain slices. At endpoint, (right column) the heaviest
deposition (darker red shading) is frequently found in sites where deposition occurred first (left column).
Abbreviations: caudal to rostral; SN; solitary tract nucleus, DMNV; dorsal nucleus of vagus nerve, SpVe;
spinal vestibular nucleus; CeN; Cerebellar nucleus, SuVe; superior vestibular nucleus, Gi; gigantocellular
nucleus, RMg; Raphe magna, Med GN; Medial geniculate nucleus, RN; red nucleus, SN; substantia nigra,
VM; ventromedial thalamic nucleus, FrCx; frontal cortex
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the reticular formation; the spinal and medial vestibular nuclei, the parvocellular reticular
nucleus, the inferior and dorsal accessory olives and the lateral paragigantocellular nucleus.
Deposition then extended into the medial and interposed nuclei of the cerebellum (Figure 2.3D),
pons and midbrain (raphe and pontine nuclei of the reticular formation and red nucleus) [Figure
2.3E], By comparing the brain maps from individual hamsters, spread from the initial site of
entry (DMNV) to the midbrain occurred very quickly - between approximately 91 dpi and 113
dpi. The spread of infection to subsequent target nuclei was so rapid that a clear temporal
separation was not possible. Nevertheless, the trend of further spread was in a caudal to cranial
direction Figure 2.2A). At 113 dpi, PrPd could be detected for the first time in the thalamus
(ventromedial thalamic nucleus) and by 119 dpi it was throughout the thalamus and in the
hypothalamus, medial geniculate nucleus, and in the parietal, cingulate and frontal cortex. At
133 dpi deposition was still located in defined anatomical areas but was considerably more
widespread within them. By 156 dpi, when the disease had reached its clinical stage, PrPd was
distributed throughout almost all brain areas (Figure 2.3F).
2.2.1ii Spinal cord
The temporal appearance, segmental distribution and accumulation of PrPd in spinal cord of
individual animals are shown in Table 2.2. Figure 2.2A shows a pictorial representation of the
relationship between accumulation in the spinal cord and brain.
As with brain, the first deposits of PrPd were seen at 91dpi in grey matter of vertebral segments
T4-T9. Early labelling was observed in segments T4-6 and T7-9 but the comparatively heavier
deposition seen on a number of occasions in segment T7-9, suggests that PrPd appeared here
first. Thereafter, PrPd was deposited in both cranial and caudal directions being observed next in
segments Tl-3 and T10-11 and then in C4-7. The temporal appearance of protein in these
segments occurred almost concurrently or within days of each other and was observed in all or
most of these segments between 91dpi and 113dpi. The rapid pace of events made a precise
temporal separation difficult and it was not clear whether PrPd deposition at the later sites was a
consequence of spread from adjacent segments or separate points of entry. PrPd appeared last in
C1-C3 and T12-13, the most cranial and most caudal segments, but in one case all cord segments
were positively labelled by 113dpi, albeit at low levels of accumulation (Table 2.2, Figure 2.6
and text of section 2.2.2).
As the spinal cord was cut longitudinally rather than transversely, it was difficult to accurately
identify specific nuclei in which deposition occurred. This was especially so with early cases but
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in later stages of infection, deposition was very widespread with both dorsal and ventral horns
being affected. In the main, PrPd accumulated around grey matter neurones (Figure 2.4A). White
matter remained largely unlabelled (Figure 2.4B). Nerve roots abutting brain or attached to
dorsal root ganglia (DRG) were unlabelled and even at end-stage disease the lack of white
matter staining visibly contrasted with the heavily stained neurones (Figure 2.4B,C).
2.2.1 iii DRG
Dorsal root ganglia had not been included specifically but some had remained attached to
segments of the spinal cord. When these were present, the location and extent of PrP labelling
was recorded. DRG were present, albeit few in number, in time-points ranging from 98 dpi to
156dpi. PrPd was first detected within the large sensory DRG neurones at 113dpi (Table 2.2).
Deposition was very scant at this and all other time-points except end-point (Figure 2.4C). In all
cases, PrPd was seen in DRG only when the corresponding section of spinal cord also contained
PrPd. Furthermore, accumulations were always more plentiful in cord than in the DRG. In
several cases DRG were negative for PrPd but the associated section of cord was positive but
there were no instances where the reverse was seen. This suggests that PrPd first appeared in
spinal cord and then in adjacent DRG. As the two are linked together it seems plausible that
263K scrapie initially entered the spinal cord and spread via adjoining nerve roots to DRG.
2.2.2 Dynamics of PrP accumulation in CNS during the incubation period
Deposition was scored according to the described criteria to indicate the relative amounts of
protein in the different areas at various time-points. The score took into account the cellular and
regional distribution of PrPd accumulation. This was important because PrPd was often present in
several different areas of the same brain or cord. Figure 2.5 gives examples of PrPd deposition
and the accumulation that is typically observed over time. Each has been chosen to illustrate how
the microscopic assessment relates to the assignation of scores.
At the first time-point at which PrPd could be detected (91dpi), deposition was in or around only
a very few neurones (scored one '+'), [Figure 2.5A]. Scores, reflecting the level of
accumulation, rose slowly over time but remained low (mostly around '++') even when PrPd was
present in multiple sites (Figure 2.5B). Even at the relatively late stage of 126dpi (endpoint of
incubation was 156dpi), the brains and spinal cords of two of the four hamsters culled at this
time had little or no detectable PrPd. Apart from two hamsters culled at 119dpi, levels of PrPd did
not rise significantly until 133dpi. In the last 4 weeks of the incubation period, there was a sharp
rise in the amount of PrPd present (Table 2.2). Accumulation was rapid, and at the end-stage of
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disease very heavy deposits were easily evident at low magnification in all brains and cords
(figure 2.5D). However, in the most rostral brain regions, e.g. the frontal and olfactory lobes of
brain and the most cranial cervical (CI -4) and caudal thoracic (T12-13) segments of spinal cord
remained less heavily stained than the rest of the CNS.
The dynamics of accumulation mirrored the clinical course of the disease. For most of the
incubation period animals were asymptomatic of disease. This was followed by a short clinical
phase of only a few weeks in which animals exhibited neurological signs and physical deficits.
This could be interpreted that the clinical symptoms arise from PrPd-induced neuronal
dysfunction.
As PrPd deposition correlates with infectivity these results suggest that in the CNS, levels of
infectivity are slow to rise and reach significant levels only in the latter stages of the disease.
These findings compare favourably with the previous correlative studies (Beekes et al., 1996).
The sharpest rise in infectivity occurred in the latter stages of disease but infectivity rose steadily
from around 90 days. Infectivity assays are very sensitive indicators of infection and ICC is
likely to be comparatively less so. Nevertheless, even allowing for reduced sensitivity, the
scoring method applied here provides a useful indicator of the trend of infection. Although
scores from individual areas were initially low the number of sites containing PrPd was slowly
increasing thereby adding to the cumulative amount of protein and, by association, replicative
capacity.
The estimated amount of PrPd present in a specific area served as an indicator of the timing of
deposition. Areas with substantial accumulations scored higher and were presumed to be at a
more advanced stage of pathogenesis than areas where diffuse or less aggregated forms of PrPd
existed. This was borne out by the results. Progressive accumulation was a consistent feature of
advancing incubation period. The first sites in which PrPd was observed (initially the DMNV,
SN and medullary nuclei) always received low scores. As time progressed these 'early' sites
contained more PrPd and consequently received higher scores than more rostrally located brain
areas e.g. nuclei ofmidbrain or thalamus in which PrPd was present for the first time. At terminal
stages of disease the greatest levels of accumulation were seen in those sites in which PrPd had
been detected first. Similarly, scores of'+' and '++' predominated in early timepoints while the
preponderance of high scores (+++ and Mil) occurred late in the incubation period. In the CNS
of one hamster culled at an early time-point the pattern of deposition was temporally more
advanced than was usual i.e. deposition was already present in several regions. Nevertheless,
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PrPd was still more abundant in the DMNV and SN and accordingly obtained higher scores than
other regions.
When the amount of PrPd found in the brain of individual hamsters was compared with that seen
in the spinal cord of the same animal, the levels corresponded very well. For example if a brain
contained either scant or abundant PrPd accumulations, deposition in the corresponding spinal
cord was equally restricted or widespread. The trend of accumulation was also comparable both
within and between groups of animals. This consistency of results gives credibility to the method
used to estimate PrPd deposition and showed that it was a useful indicator of progression of PrP
pathology.
2.2.3 Summary of Results from 2.2.1 and 2.2.2
Results from temporal appearance and topography show consistently that PrPd is first located in
the DMNV. The reproducibility of this finding together with the progressive accumulation in
this site suggests that after oral challenge the 263K agent accesses the brain at this location and
subsequently replicates here. In short, the DMNV is an early 'target site' for the scrapie agent in
this rodent model.
2.2.4 Cellular and physical appearance of PrP in CNS of unaffected and infected hamsters
2.2.4i PrP in unaffected hamsters
In common with previous findings in mice (Bruce et al., 1989, McBride et al., 1998) in mock-
infected control hamsters host PrP (PrPc) was seen distributed throughout the CNS but only
within a proportion of neuronal cell bodies. The greatest number of positively stained neurones
was in the brainstem and grey matter of spinal cord but a few were also commonly found
scattered in the thalamus and the hippocampus, in particular in the dentate gyrus. The cytoplasm
of these cells stained mainly light brown (conferred by the DAB chromagen) but the intensity of
the brown labelling varied, perhaps reflecting PrPc 'turnover' or physical state. PrPc was of
uniform appearance as opposed to granular (Figure 2.6A) but staining was always less intense
and differed markedly from any of the (largely extracellular) disease-associated forms found in
orally challenged animals. PrPc positive neurones were occasionally seen in infected hamsters.
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Figure 2.3 PrP immunolabelling (brown) in the brain. A,B & C. Early (91dpi) target
sites (coronal sections); A) DMNV, B) central portion of SN, C) DMNV and medial SN
at 105dpi. When compared, deposition is more abundant in DMNV than SN. The
underlying hypoglossal nucleus (HN) is unlabelled. D.Cerebellum. Medial vestibular
nucleus (arrow) is an early target site. Flere at 156dpi neurons of the granular layer (g)
are also heavily labelled. E. Pattern of spread in caudal brainstem (119dpi). Labelling is
fairly extensive but targeted to particular nuclei of reticular formation including the
gigantocellular nucleus (Gi), pontine reticular nucleus (Po) and red nucleus (RN)
showing. Labelling in DMNV and SN is extensive compared to the unstained adjacent
area postrema (arrow). The medial and interposed cerebellar nuclei are also visible
(arrowhead). F. Low-power sagittal view showing distribution at endpoint of disease.
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Figure 2.4. PrPd immunolabelling in the spinal cord. A. Low power view showing
distribution in thoracic segment (T) 7-9 at endpoint of disease. Grey matter (centre) is
extensively and abundantly labelled. In comparison, white matter (on either side) is
relatively spared. A nerve root (arrow) is unlabelled. B. Splanchnic nerve root entering
Tl-3 segment (156dpi). Grey matter (GM) is positive, white matter (WM) barely positive
but the root (NR) is negative. C. DRG from segment T4-6. Even at 133dpi, PrP is seen
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Figure 2.5. Dynamics of PrPd accumulation. Relative amount of PrPd accorded by the
scoring criteria. A. '+' (98dpi), B. '++' (113dpi), C. '+++' (113dpi), D. '++++'
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Figure 2.6. PrP immunolabelling of neurons in spinal cord from A; an unaffected hamster,
B, C, scrapie-challenged hamsters - early stages of infection. A. Cells display the range of
'homogenous', ungranulated labelling characteristic of PrPc, B. The intense cytoplasmic
labelling of 'reactive' neurons (arrows), C. A mixture of PrP-labelled neurons typically
observed at early stages of 263K infection including those showing early granulated PrPd
(long arrow) and a PrPc-containing cell (short arrow). Bar; A = 30pm, B,C = 22.5pm
C" ,
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2.2.4H Cellular localisation of PrP in early stages of infection
Deeply stained neurones exhibiting a similar intracellular distribution of PrP were regularly seen
in sections of brain or spinal cord from early time-points. The cytoplasm of these cells, termed
'reactive' neurones to distinguish them from 'normal' neurones found in CNS of uninfected
controls, stained more intensely than those of unaffected hamsters and also lacked the overt
granularity associated with PrPd-labelled neurones (Figure 2.6B). Reactive neurones were
located in close proximity to normal neurones but were also seen in mixed populations with
early PrPd-positive cells (Figure 2.6C and see below). Such neurones were present during only a
short phase concurrent with the appearance of early forms of PrP cellular pathology and possibly
represent an in-vivo reflection of neurones in a transitional stage of PrPc conversion to PrP50.
In scrapie-challenged hamsters several of the previously described types of PrPd were present
including plaque-like aggregates, glia-associated forms and neuroanatomically-targeted granular
diffuse accumulations. However, the physical appearance and cellular location of PrPd followed
a distinct (and previously unreported) temporal sequence of events (Figure 2.7A-F). Apart from
the frequent but variable presence of reactive neurones, PrPd was first seen as punctate deposits
localised within and at the cell surface of only one or two individual neurones. The inclusions
had the particulate appearance consistent with compartmentalisation in endosomes or lysosomes.
Sometimes, several tiny deposits were aggregated on the neuronal membrane producing
discretely labelled arcs or rings of protein (Figure 2.7B). The number of inclusions seen within
individual cells increased progressively over a short period of time, as did the overall numbers of
such neurones (Figure 2.7C). Soon afterwards, PrPd deposits were observed outside the neurone
in the neuropil (Figure 2.7D). Initially the extracellular deposits were immediately adjacent to a
particular neurone. Next, punctate labelling was seen in the near proximity and later it was
arrayed more widely around the cell body (Figure 2.7E). Concurrent with this the accumulations
also appeared to increase slightly in staining intensity. This is probably because small deposits
were beginning to aggregate and were more obvious.
PrPd was detected firstly associated with only a few precisely localised neurones. As incubation
time progressed more cells in the same area were labelled until several cells exhibited the types
of cellular PrP pathology described above. Although there was variation in the onset of disease
in individual animals, this pattern of pathology was a consistent early observation that was
repeated at a later time in other CNS nuclei. The temporal reproducibility indicates that both the
physical changes associated with individual cells and the subsequent involvement of other cells
were part of an ongoing train of events that reflected the developing disease process.
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Figure 2.7. Progression of PrP cellular pathology. High power of individual neurons to
show appearance of PrP in an unaffected hamster (A); the early pattern of PrPd
development (B,C,D,E); and at a late stage (F) in incubation period. Bar = 10pm
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Table 2.3 PrPd-pathology of neurones: Sequence of cellular changes and





































Gradual accumulation of PrPd in neuropil with formation of aggregates.
Glia-associated PrPd in evidence: Microglia with PrPd inclusions
133dpi
approx
Rapid accumulation of diffuse granular PrPd
160dpi
Endpoint
Abundant extracellular deposition in almost all areas. Diffuse granular PrPd with
many large aggregates. Absence of activated neurones.Absence of intraneuronal
PrPd. Frequent presence of PrPd -encircled neurones i.e PrPd on cell membrane
Many glia-associated deposits including activated microglia
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2.2.4iii Localisation of PrPd with disease progression
With increasing incubation, a greater number of positively labelled foci were present, located as
described, in confined neuroanatomical sites. PrPd accumulations became more obvious and
widespread within the early target areas and then more generally throughout the CNS. Within
established foci, the PrPd appeared progressively more 'grainy' and consolidated. Intensely
stained punctate deposits, probably representing the expression of PrPd at synapses were
numerous but became less common with time. This may have been due to the degeneration of
neuronal circuitry or because they were obscured among the larger granular deposits and
aggregates. These latter forms eventually predominated and formed the characteristic pattern
that was a feature of end-stage disease (Figure 2.7F). Neurones with intracellular inclusions
became rarer and at the terminal stage of disease these were rarely, if ever, encountered. None of
the types of PrPd described above were seen in uninfected controls. The sequence of the PrP-
associated cellular pathology and progression of accumulation are summarised in Table 2.3.
2.2.5 Neuroglial cell involvement in PrP pathology
The majority of PrP labelling was associated with neurones but a variety of glial cells were
involved with PrP pathology (Figure 2.8). PrPd was within and/or accumulated around
astrocytes, microglia, ependymal cells lining ventricles and choroid plexus (ependymocytes and
choroidal epithelial cells). PrPd was also found along the glial limiting membranes of ventricles
and pia mater, and was associated with CNS radial oligodendroglia and satellite cells of the
DRG. Blood vessel walls were also labelled via PrP-positive astrocytic end feet that bridge both
capillaries and neurones.
The temporal involvement of glia in 263K pathogenesis began very early in the incubation
period. Progression of glial involvement was similar to that described previously for neurones;
initial deposits and cell numbers were small but both deposition and types and numbers of
affected glia increased with time. Glia-associated PrPd was observed in sections of both brain
and spinal cord at the first time-point of 91dpi and corresponded to areas of early neuronal
targeting. PrPd labelling was initially confined to individual astrocytes (Figure 2.8A) that were
closely proximal to brainstem or thoracic spinal neurones. PrPd was first seen in the
gigantocellular nucleus of the medulla but also around central canal ependymal cells of mid-
thoracic spinal cord segments (Figure 2.8B) and soon afterwards in ependymocytes lining the 4th
ventricle. As well as these elements, from around 113dpi, the external walls of blood vessels
(Figure 2.8C) and pia mater were also labelled (Figure 2.8C, D). With time, ventricles, BVs and
pia mater became progressively more heavily stained due to PrPd accumulating around
48 Chapter 2: PrP targeting in brain and spinal cord
astrocytes of the closely attached glial limitans. Microglia containing PrPd inclusions were
apparent, after extracellular deposition was evident (Figure 2.8D) indicating that these cells had
probably phagocytosed PrPd from the neuropil. PrPd was seen surrounding the cell bodies and
long processes of radial oligodendroglia in white matter and at late stages of the disease the
appearance of the protein 'tracking' along white matter fibres was a common pathological
feature in the spinal cord (Figure 2.8E). However, compared to grey matter, PrPd was seen to a
much lesser extent in oligodendrocytes or Schwann cells of white matter tracts and there was no
evidence of PrPd accumulation in nerves (Figure 2.8C and see Figure 2.4A&B). Glia outnumber
neurones tenfold, therefore it is reasonable to presume that PrPd was predominantly expressed by
neurones and that while glia may have a role in transportation, neurones rather than glia were
preferentially responsible for agent replication.
Although glial (but more specifically astrocytic) staining was observed from the earliest time-
points it was never present prior to neuronal PrPd deposition. Similarly, in DRG, PrPd was
present first at 113dpi in both the large sensory neurones and associated satellite glia. Mostly
both neurones and satellite cells were labelled but sometimes DRG neurones containing granular
PrPd were seen directly adjacent to unlabelled satellite cells (Figure 2.8F) indicating that PrPd
association with satellite cells occurs very shortly after neuronal involvement. As glial activation
occurred after PrPd deposition it is likely that astrocytes, microglia and satellite cells were
responding to rather than initiating the related pathology.
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Figure 2.8. Glial involvement in PrP pathology. A: PrPd-labelled astrocyte-like cell
(arrow) adjacent to neurone in parvocellular reticular nucleus (105dpi). B: Accumulation
along the central canal at segment T7-9 (133dpi). C: Deposition around blood vessel
(bv) walls at T10-11. D: Pia mater of the frontal cortex. PrPd is deposited along the glial
limitans (gl) and appears to be internalised by microglia (arrow). E: PrPd 'tracking in'
white matter of T4-6 segment at 133dpi. PrPd extends from the gray matter (RHS) across
WM tracts to pia mater (arrow) on LHS. F: Thoracic DRG (133dpi) with several PrPd-
laden sensory neurones. Adjacent satellite cells (arrows) are also strongly labelled. Bar:
A,D = 10pm; B,C,E = 60pm; F = 30pm
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2.3 Discussion
Previous studies investigating spread of the scrapie agent from the periphery to the brain and
spinal cord have used either infectivity assays or Western blotting. This study employed ICC to
identify specific sites of PrPd accumulation and trace the temporal deposition of PrPd. The
advantage of this methodology over these others is that, in contrast to results obtained from
homogenised small samples, whole slices of brain are available for viewing under a microscope
and individual or groups of cells can be identified by morphology and location. In TSE studies
disease-related pathology can be visualised and assessed in the differing areas and cell types.
This approach revealed several important findings.
1. After ingestion of 263K scrapie, PrPd, the surrogate marker of the infectious agent, reached
the CNS by two independent pathways. Targeting to brain and cord occurred simultaneously
showing that the brain could not have been affected by spreading along the cord.
2. The precise locations of the initial cerebral target sites were identified providing strong
evidence that the vagus nerve is a primary pathway to the brain in this model. In addition,
the temporal and neuroanatomical targeting suggested that the infectious agent initially
spreads along motor rather than sensory pathways of the vagus.
3. The rapid temporal sequence of targeting to spinal cord suggests multiple points of entry via
splanchnic nerve branches.
4. The pattern of targeting within the brain is indicative that spread is not random but occurs
along defined synaptically linked neuronal circuitry.
5. The physical appearance and cellular location of the earliest PrPd deposition in neurones
followed a distinct sequence of events. This is the first report showing the evolution and
progression of PrP pathology at the cellular level.
2.3.1 Evidence that 263K scrapie reaches the CNS by two independent pathways
The data showed that the 263K agent reached the CNS by two main routes; one that entered at
the mid-thoracic level of spinal cord and the other entering the medulla at the DMNV. This is in
contrast to previous work reporting that, after peripheral or intragastric challenge of rodents with
139A or 263K scrapie strains, the infectious agent entered the CNS at the thoracic cord and
reached the medulla by upward spread (Kimberlin and Walker 1988). In this study, PrPd was
initially observed simultaneously in both DMNV and mid thoracic cord and the amount of PrPd
deposition in the two sites was comparable. This indicates two independent points of entry. The
idea that PrPd/infectivity spreads towards the cranium via cell to cell transfer within the grey
matter also appears to be ruled out by the observed temporal pattern of deposition: PrPd is well
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established in the medulla before it is observed in the cranial portion of spinal cord. It is also
unlikely that early infection of the DMNV and SN occurs via ascending (or descending) white
matter tracts of the thoracic cord as these are not directly linked. These data strongly indicate
that infection enters the brain via anatomical projections outside the CNS and the most likely
conduit is the vagus nerve.
Haematogenous spread is also a possibility but this is not suggested by the systematic nature of
the targeting or the lack of labelling in brain sites such as the area postrema in which the blood
brain barrier is compromised. Although the DMNV/SN complex lies adjacent to the area
postrema, this was not an early target site and was not even greatly labelled at late stages of the
disease.
Kimberlin and co-workers reported that after a variety of peripheral routes of infection
(intraperitoneal, intravenous, subcutaneous and intragastric) scrapie infectivity was detected in
the spinal cord before being found in the brain (Kimberlin & Walker 1979,80,82). Much of
Kimberlin's peripheral pathogenesis work used the Chandler (139A) strain of scrapie but he
reported similar findings with intraperitoneal 263K infection in hamsters (Kimberlin & Walker
1986). In contrast, the findings presented here do not point to a single route of entry but clearly
indicate that, at least after oral challenge, the infectious agent reaches the CNS by two routes.
The data concurs with the early studies that entry is via the thoracic cord but does not support
Kimberlin's assertion that the agent reached the brain by upward spread.
There are a number of possible explanations for the discrepancies between the findings in this
study and the early work. Kimberlin and co-workers tested the dynamics of agent replication
during the early stages of disease. The studies consisted of infectivity assays - measuring
incubation periods of groups of serially culled mice that had been injected with pooled spinal
cord or brain. In his early experiments (Kimberlin & Walker 1979), the assay tissues were
derived from homogenised whole brain and much of the cord. In the study presented here, PrPd
was found earliest in discreet areas of the CNS; the most caudal portion of the brain in the
DMNV and SN and in T4 and T9 of spinal cord. Although Kimberlin's findings apply to a
different scrapie strain, the dynamics of oral 263K pathogenesis have remarkably similar
parallels and given the existing comparability between the sets of data, it is reasonable to
presume that the early PrPd deposition found in oral 263K may mirror that of 139A infectivity. If
this were assumed to be the case, the portion of assay material derived from a whole brain would
contain little or no PrPd/infectious agent. It is therefore probable that any infectivity present
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would have been undetectable. It is also possible that infectivity was not detected in the brain
assays because the DMNV/SN complex was not included in the assay sample. This region is
located in the most caudal position in the brain (see Figure 2.2a) and being less accessible is
often missing or damaged at removal. In later more comprehensive studies (Kimberlin & Walker
1980,82), where multiple samples of brain and cord were assayed, the indicators of independent
entry to the medulla were present, i.e. infectivity was present simultaneously in thoracic cord
and in medulla and appeared in cervical cord after the medulla.
Apart from the discussed disparity, all other findings from Kimberlin's experiments agree with
those seen with 263K oral challenge. Though the data was generated using different scrapie
strains, infectivity and PrPd were both seen first in thoracic spinal cord and medulla and
temporal, geographical and pathological dynamics of both are also in accord. Combined these
provide strong evidence that after peripheral routes of infection a) the agent initially accesses the
spinal cord at the thoracic level, b) subsequent spread occurs along neural pathways in a caudal
to rostral direction within both cord and brain. The fact that the pattern of infection is so similar
in both scrapie strains also raises the possibility that there may be a common mechanism of
peripheral neural routing but this must be formally tested using a wider range of TSE strains.
2.3.2 Evidence that the vagus nerve is a primary pathway to the brain and that early
spread occurs along motor pathways
Two pieces of data that provide significant indicators that spread to the medulla and thoracic
cord initially occurred along motor rather than sensory fibres of the vagus and splanchnic nerves.
Firstly, the initial target site appears to be the DMNV followed closely by the SN. In one brain
from the earliest group of 91dpi, PrPd was present in small amounts in the DMNV but lacking in
the SN. Even though PrPd was mostly present in both DMNV and SN, when the relative amount
of PrPd was compared, the DMNV was consistently more heavily labelled than the SN. As the
amount of PrPd present in a specific area served as an indicator of the timing of deposition this
indicated that PrPd was deposited in the DMNV before the SN.
The DMNV contains the neuronal cell bodies of vagal efferent (motor) fibres leaving the brain.
Vagal fibres running to the brain (vagal afferents) have their cell bodies in the nodose ganglion
but these do not terminate here and run on to the SN where they synapse with interneurones that
project directly to vagal motor neurones of the DMNV (Card et al., 1993, Standish et al., 1994).
The vagus nerve innervates the gastrointestinal tract including the stomach, small intestine and
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parts of the large intestine so the most plausible explanation for PrPd deposition in the DMNV
and SN is by spread of ingested 263K scrapie after uptake from the alimentary tract. Therefore,
neuroanatomically, the sequence of target areas can best be explained by infection spreading
along autonomic vagal efferents to the DMNV and subsequently to the SN. This would require
the infectious agent to travel in a retrograde direction towards the cell body, a mode of spread
that has several precedents in neurotropic viruses such as pseudorabies virus (Card et al., 1993,
Standish et al., 1994) and Herpes Simplex Virus Type 1 (Krinke & Dietrich 1990). However, the
infectious agent could travel from the gastrointestinal tract directly to the SN along visceral
vagal afferents. The agent could also travel from the pharynx, larynx and tongue via the other
cranial nerves such as the hypoglossal, facial and trigeminal but primary spread along these
routes is not suggested by the targeting or timing of PrPd deposition. The possible routes by
which 263K scrapie reaches the brain from the GI tract are illustrated in Figure 2.9.
Secondly, PrPd immunolabelling of DRG was found only after PrPd was firmly established in
grey matter of the associated thoracic segment. In several cases, DRG were negative for PrPd but
the corresponding cord segment was positive but there were no instances where the reverse was
seen. Sympathetic (motor) efferents of splanchnic nerve branches leave the thoracic cord and
synapse in the prevertebral ganglia before reaching the alimentary tract targets. Splanchnic
efferents travelling towards the cord have their cell bodies in the sensory neurones of the DRG.
As thoracic grey matter rather than DRG was labelled first, initial spread along sympathetic
rather than sensory fibres is indicated but the data supporting this is fairly limited and a more
far-reaching study is required to ascertain this.
2.3.3 The temporal sequence of targeting to spinal cord suggests multiple points of entry
via splanchnic nerve branches
Entry via the thoracic portion of the spinal cord indicated that the infectious agent (or PrPd, its
surrogate marker) had travelled along the nerves supplying the GI tract i.e. the splanchnic nerve.
The splanchnic nerve is highly branched and descending branches give rise to the greater, lesser
and lumbar splanchnic nerves. The greater splanchnic nerve branches leave the cord from
segments T5-9, synapse in the coeliac ganglion and then travel on to supply the stomach, small
intestine, spleen, adrenal, kidney and liver. Lesser splanchnic nerves leave cord segments at T7-
13, synapse in the superior mesenteric ganglion and innervate the ascending colon. The lumbar
branches leave via T13, LI and 2, synapse in the inferior mesenteric ganglion and supply
descending colon, sigmoid colon and rectum. Studies examining the segmental distribution of
retrogradely labelled sympathetic preganglionic neurones (IML neurones -see below) showed






































































that most peripheral sympathetic ganglia received a dominant input from a single thoracic or
lumber spinal cord segment. Also, the more caudally located peripheral ganglia received input
from neurones located more caudally (Strack et al, 1988). Although the sections of cord
constituted multiple segments of cord, this rostro-caudal topographical organisation was
suggested in the results. The location and timing of PrPd appearance shows that the greater
splanchnic nerve branches are significant conduits in early peripheral pathogenesis.
Consequently, after oral infection uptake of the infectious agent is most likely to occur from the
stomach and small intestine but branches supply the ascending colon also probably contribute to
the observed thoracic cord invasion.
The pieces of cord taken in this study were dissected from thoracic vertebrae Tl-3, T4-6, etc,
and these don't always correspond exactly to that of an excised cord. This is because the
vertebral column continues to grow after the spinal cord has stopped so that an adult rodent
spinal cord terminates at about the first sacral vertebra. Thus, the most caudal cord segments are
situated slightly more cranial to the corresponding vertebra. Nevertheless, the pieces correspond
closely enough to show that the data supplied in Table 2.2 parallels that of the anatomy.
PrPd was seen first in segments T4-9 but the amount of deposition was generally greater in T7-9
so it is probable that PrPd accumulation (and by association, agent replication) occurred in this
area before T4-6. However there was very little temporal separation between the appearance of
the protein in T4-9 and in adjacent segments located cranially of caudally to this. The close
timing of events could be explained by there being multiple points of entry to the thoracic cord.
Access via a number of nerve roots would fit with the highly branched anatomy of the
splanchnic nerve. Nevertheless, the temporal delay observed in PrPd reaching the most caudal
and cranial segments might be the consequence of cell-to-cell spread between neurones situated
in adjacent segments. In either event, the most likely sites for access and spread are via neurones
of the intermediolateral cell column (IML) as these nuclei contain the cell bodies of outgoing
splanchnic nerve fibres and form internal links with other IMLs located caudally and rostrally
(Rubin & Purves 1980).
2.3.4 Orally-transmitted 263K spreads along defined synaptically-linked neuronal
populations
As with targeting to the CNS, the pattern of spread within the CNS was equally precise. The
temporal sequence of targeted sites and the ultimate pattern of PrPd accumulation were extremely
consistent. Spread occurred in a caudal (medulla) to rostral (forebrain) direction with early
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targets containing substantially greater accumulations than the most rostrally situated parts of the
forebrain and olfactory lobes. The explanation for this is probably not that these areas are
privileged (non-infectable) sites but that before the olfactory lobe was reached, key neurones in,
for example, the thalamus were terminally disabled causing the animal's death. The pattern of
spread from the medulla to prominent nuclei in the cerebellum, pons, midbrain and thalamus
(Figure 2.10) followed well-established neuroanatomical pathways (Andrezik & Beitz 1985,
Flumerfelt & Hrycyshyn 1985). Even though timing varied between individuals, the location of
PrPd deposition was invariable; occurring in distinct neuronal groups in the (approximate) order"
listed is Table 2.1. This consistency is significant as it shows that PrPd deposition does not occur
randomly. Further, the location of the sites and the sequence in which targeting was observed
(Figure 2.11) closely reproduces that seen in the transneuronal retrograde spread of the
pseudorabies neurotropic virus after intragastric administration of the virus to rats (Enquist et al.,
1994). This observation strongly suggests that spread of 263K scrapie also occurred along
synaptically linked neuronal pathways.
2.3.5 The physical appearance and cellular location of PrPd followed a temporal sequence.
The disease-associated changes that were visualised in and around individual neurones was a
new finding. As illustrated in Figure 2.7, the subtle changes in physical appearance and cellular
location of PrPd that were observed early in the incubation period followed a distinct temporal
sequence that was consistent with a progressive pathological process. The earliest pathology was
observed as intraneuronal PrPd inclusions. Inclusion-containing neurones were frequently found
in the most recent sites of PrPd deposition but absent thereafter suggesting that this is a transitory
stage of PrP pathology.
The most obvious (and extensively reported) form of PrP pathology is the widely distributed
extracellular accumulations of granular PrPd that are seen in advanced stages of the disease
process. Intraneuronal PrPd is an end-stage pathological feature in the brains of natural and
experimental scrapie or BSE infected sheep (Foster et al., 1996, Ryder et al., 2001, Jeffrey et al.,
2001b) or cows with BSE (Wells & Wilesmith, 1995). In addition, punctate neurone-associated
extracellular PrPd has been reported early in the pathogenesis of other strains of scrapie such as
ME7 and 87V (Bruce et al., 1989,94a, McBride et al., 1998) but the intracellular and membrane-
"
Due to their close proximity and the rapidity with which sequential PrPd-labelled sites appeared, it
would be difficult to separate the various nuclei into a precise temporal order without using large numbers
of animals. However, this is perhaps unnecessary, because retrograde labelling experiments have shown
that these are linked neuroanatomically (Loewy 1995, Card 1994, Enquist 1994).
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associated forms were not apparent. These discrepancies may be due to the various PrP
antibodies recognising different epitopes but another possibility is that, as previously suggested,
they reflect differential PrP processing between strains (Jeffrey et al., 2001b, Gonzales et al.,
2003). Only one antibody, 3F4, was used in this study so this possibility couldn't be assessed
here. However, in this model a range of PrP pathology was consistently observed but neurones
exhibiting the types of PrPd illustrated in Figure 2.7B-E were only prominent in early stages of
the incubation period. It is, therefore, possible that the pattern of pathology associated with
individual neurones reflects the underlying biochemical changes in the cell. For example, the
focal cell-surface PrPd and the compartmentalised intracellular PrPd that follows may represent
an in-vivo equivalent of the membrane 'rafts' (Vey et al., 1996) and the subsequent trafficking
within endosomes/lysosomes.
It is unclear whether the 'reactive' neurones described in section 2.2.4ii are disease specific
because, apart from an increased staining intensity, they resembled PrP-labelled uninfected
neurones. Without appropriate antibodies that can discriminate between normal and abnormal
forms of PrP, the qualitative difference in PrP expression observed in reactive neurones can only
be speculative. The observed staining may reflect, for example, early conformational changes
between normal and disease-associated forms, differences in PrP glycosylation or PrPc
upregulation in response to cellular stress. Similarly labelled neurones have also been seen in
normal mice at sites of injury; around the needle track of intracerebrally mock-infected mice (P.
McBride, unpublished observation) or areas of anoxia-induced stroke (McLennan et al,
manuscript in preparation) perhaps signifying that PrPc performs a protective role in these
situations. New evidence indicates that PrPc responds to various forms of physiological stress
including the damage caused by exogenous copper, hydrogen peroxide and oxidative stress
(Herms et al., 1999, Brown et al., 1997a,b, Guentev et al., 2000, Wong et al., 2001). Taken
together these studies support a neuroprotective function. Even so, reactive neurones were only
observed in brains of scrapie-challenged hamsters during a short phase either before or
concurrent with the first appearance of PrPd-labelled cells and it may be that these are exhibiting
the very earliest stages of PrP cellular pathology.
In this study, as with other rodent models (Bruce et al., 1989, 94a, McBride et al., 1998), the
greatest abundance of PrPd was found in or around neurones but from the earliest stages of
disease, PrPd was also associated with a variety of glial cells including astrocytes and microglia.
The involvement of glia in TSE pathogenesis is discussed in Chapter 6.
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Figure 2.10
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2.4 Summary
The aim of this study was to use immunocytochemistry to identify the early sites of abnormal
PrP deposition in the brain and spinal cord and then map the location of subsequent
accumulations as the incubation period progressed. As well as providing some new insights into
the cellular pathology elicited by oral 263K infection, results have indicated the probable routes
by which the 263K agent reaches the brain and spinal cord once it has been taken up from the
gastrointestinal tract. Identification of initial PrPd target sites demonstrated conclusively that the
peripheral nervous system and specifically, the vagus nerve are important in dissemination of
infectious agent after peripheral infection. There is now strong evidence implicating the vagus
nerve as the link between the brain and the gut and indirect evidence that the splanchnic nerve
was the spinal cord conduit. In the next chapters studies are undertaken that examine the detail
of vagal and splanchnic nerve circuitry in an attempt to elucidate the involvement of these
nerves after oral infection of 263K scrapie.
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Chapter 3: Neuroanatomical routing hypothesis: Pilot experiments
3.0 Introduction
In Chapter 2, the location and temporal sequence of PrPd deposition was determined in brain and
spinal cord ofhamsters that had been orally exposed to 263K scrapie.
Results indicated that after being taken up by the gastrointestinal tract, 263K scrapie reached the
brain by spreading along the vagus nerve. The earliest sites for PrPd deposition were situated in
the medulla - in the DMNV and SN. Both these regions innervate the gastrointestinal tract. The
GI tract is also supplied by the splanchnic nerve via neurones that originate in the
intermediolateral cell column (IML), a nucleus situated in mid to lower segments of thoracic
spinal cord. In the cord, PrPd was first found around grey matter neurones of mid-thoracic
segments but due to the plane of section it was not possible to establish the precise neuronal
populations involved. Therefore, even though the IML could not be specifically identified,
splanchnic nerve participation was strongly suggested but more definitive evidence of IML
involvement was required.
In addition to the clear evidence involving the vagus nerve in peripheral spread of the 263K
agent, there was some data that provided clues into the possible direction of early spread. The
timing and sequence of deposition suggested that PrPd was present in the DMNV prior to the SN.
Also, although DRG had not been excised specifically, the ganglion was sometimes present
attached to the cord segment by its corresponding nerve root. PrPd was present in a number of
DRG sections but only after deposition was established in the associated cord segment. Taken
together, the data suggested that initial spread might have occurred along efferent (motor) rather
than afferent (sensory) fibres.
Although the study described in Chapter 2 focused only on the target sites in the CNS, the data
generated provided enough information to hypothesise further about the neuroanatomical routing
of infection after the agent has gained access to the gastrointestinal tract. This hypothesis was
described diagrammatically in Figure 2.9.
In order to establish splanchnic nerve involvement and to verify this hypothesis of spread, it
would be necessary to use the same rodent model of oral challenge to look for the presence of
PrPd in both the CNS and the PNS components identified as being potentially involved in the
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routing of 263K scrapie. This, in turn, would depend on being able to;
1) Identify and dissect out such components at post mortem
2) Ensure the presence and correct orientation of all excised tissues/CNS areas on the
microscope slide
3) Fix and process the tissues to preserve both PrP protein and cellular morphology
4) Identify the various tissue components/regions and cell types and interpret findings using
microscopy
As the points listed above presented practical difficulties, a pilot experiment using uninfected
hamsters was undertaken to establish if the proposed plan of work was realistic.
The aim of this Chapter is to describe the procedures carried out in the pilot study, how they
were devised, why they were necessary and the degree of success that was achieved.
3.1 Identification and dissection of rodent tissues
The proposed plan required the successful removal of brain, spinal cord with DRG attached,
small intestine, spleen, salivary glands, left and right nodose ganglion (NG), left and right vagus
nerve and the coeliac and mesenteric ganglion complex (CMGC) from groups of orally-infected
hamsters culled throughout the incubation period.
Removal of brain, spleen and salivary glands was not problematical due to existing experience
of rodent post-mortem procedure therefore these organs were not included in the dissection
trials. However, neither my collaborator, Dr. Michael Beekes, nor myself had experience in PNS
micro-dissection so were taught to locate, recognise and excise the tissues by Dr. Walter Schulz-
Schaeffer of Gottingen University in two sessions at the Robert Koch Institute in Berlin.
Assistance was also sought from neuroanatomy books that included; Stereotaxic Atlas of the
Golden Hamster Brain: Edited by Morin and Wood, Academic Press; The Rat Nervous System,
Volume 2, Hindbrain and Spinal cord, Edited by George Paxinos, Academic Press; Grays
Anatomy, Thirty-Eighth Edition, Churchill Livingstone. Due to the small size of the tissues, in
situ identification and removal required a dissecting microscope and specialised surgical
instruments.
Spinal cord and DRG: As one of the main aims of the project was to compare the amount of
PrPd deposition found in spinal cord segments with corresponding DRGs, the cord had to be
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removed intact along with DRGs and connecting nerve roots (Figure 3.1). Access to DRG is
impeded because the spinal cord and DRG are in close proximity to one another and tightly
surrounded by bones of the vertebral column. Using the dissecting microscope, the encapsulating
bones had to be carefully snipped away with small bone nippers. The nerve roots are
approximately 0.05mm in diameter and very delicate. If these are cut the DRG become separated
from the cord and cannot be retrieved. Each of the twenty-one cord segments and forty-two
DRG had to be exposed and sequentially removed by working up the length of the vertebral





hamster brain and spinal
cord. The eight cervical
and thirteen thoracic
segments are shown giving
rise to a pair of spinal
nerves and dorsal root
ganglion.
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Vagus nerve and NG: Similar difficulties existed for vagus nerve and NG removal. The vagus
runs almost the length of the body; arising in the medulla oblongata and coursing down to the
base of the abdomen, supplying the heart, lungs, stomach, liver, pancreas, spleen, and several
portions of the gastrointestinal tract on its way. For this study, only the cervical portion of the
vagus was to be removed. This lies in the neck and runs closely parallel to the carotid artery. An
initial difficulty was learning to locate and recognise the vagus among the many other nerves
present in the neck. Its small size and delicate nature also presented an obstacle to excision. The
ganglion contains the cell bodies of the vagus nerve so it was important that this was also
dissected out. However, the NG is embedded in, and protected by a pocket of bone situated near
the ear socket making an undamaged removal a difficult and lengthy procedure. Details of vagus
nerve/NG dissection are provided in Appendix 1.2.
CMGC: The most difficult component to locate and dissect was the CMGC. The cervical vagus,
NG and DRG are small but, with experience, can be recognised using the dissecting microscope.
The CMGC cannot be seen even when using the microscope and had to be identified using
associated organs and blood vessels as cues. The CMGC lies on the abdominal aorta, adjacent to
the kidney and adrenal gland. It is supported on one side by the superior and inferior mesenteric
arteries and the coeliac artery and on the other side by the renal artery and ovarian/testicular
arteries (Figure 3.2). There are three major ganglia in the CMGC; the coeliac ganglion and the
superior and inferior mesenteric ganglia. In larger species these may be removed individually but
in rodents, the ganglia are so closely connected that they cannot be separated and must be
excised as one entity. The CMGC was dissected out attached to the complex of blood vessels
described above and in Appendix 1.3.
Small intestine: Pieces of small intestine were being included in the proposed study because they
contain ganglia and nerves of the enteric nervous system (ENS) and gut-associated lymphoid
tissue (GALT). It was of interest to include Peyer's patches (PP) and mesenteric lymph nodes
because in several rodent models of scrapie the LRS has been shown to play a key role in TSE
peripheral pathogenesis. Although PP and ganglia would be present in a chosen sample of GI
tract, it was reasoned that a better representation of the 'in vivo' anatomy would be achieved if
jejunum and ileum could be dissected out and preserved in a manner that maintained the natural
structure of the gut loop formations. The nerves, blood and lymphatic vessels that supply the gut
loops run together in branching cords. Mesenteric lymph nodes are often located at the centre of
the loops. All these components are supported by a fragile membrane of connective tissue that
spans the loop and holds the structure together (see Figure 3.5A). The practicalities of gut loop
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Figure 3.2 Location of the coeliac and mesenteric ganglion complex (CMGC) and
associated blood vessels of a female rodent. Adapted from 'The rat nervous system,
Volume 2, Hindbrain and Spinal Cord', 1985, Edited by George Paxinos
removal were tested in the pilot study. Jejunal and ileal gut loops were carefully removed and
mounted on card for immobilisation during fixation. After fixation, the gut contents were gently
flushed out using a syringe. During processing the pieces were further supported by filter paper
'envelopes'.
3.2 Trimming, orientation, embedding and cutting of tissues
For the project to provide the desired information, it was necessary that each piece of tissue was
present for PrP immunolabelling and microscopic assessment. In the pilot study the presence or
absence of any tissue could be ascertained using H&E staining. Prior to this, it was necessary to
establish how tissues should be trimmed (sliced up), oriented and embedded in wax so as to be
identifiable on the finished microscope slide. As there were a number of tissues with some sub¬
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and/or maximum amount of tissue was present for microscopic assessment; b) minimised the
amount of section cutting and immunolabelling. Trimming, orientation and cutting schedules
had to be established for all tissues but different procedures were needed for different tissues.
3.2.1 Trimming, orientation and embedding
Brain: After removal, the fixed brains were placed in a commercial brain-slicing matrix
(SEMAT, St Albans) and trimmed throughout their length into two-millimetre thick coronal
slices using a series of thin blades (Figures 3.3A-D & 3.6C). The matrix is a plastic block with a
brain shaped indentation in which vertical slicing grooves are equally spaced at 1mm intervals.
Use of the matrix helped to ensure that brain slices were vertical, symmetrical and of equal
thickness. Each piece was then secured in an embedding cassette to prevent movement,
processed and embedded in paraffin wax. Using this method, the whole of the brain could be
represented in the correct plane and orientation in only one wax block (Figure 3.3E-G).
Spinal cord: Histological preparation is illustrated in Figures 3.4 & 3.5E. The excised fixed
spinal cord comprised at least 21 segments (8 cranial and 13 thoracic) plus some of the lumbar
portion. DRGs were attached to either side of each segment by nerve roots. Firstly, the cord was
laid out flat on its ventral surface and with the aid of the dissecting microscope, bone fragments
were gently removed to avoid damage to tissues and the microtome blade during section cutting.
Dorsal and ventral nerve roots were cut free from the meningeal membranes that bound roots
and cord closely together. The DRG were then spread out at each side of the cord. Vertical cuts
were made between each pair of DRG. The pieces were placed caudal end downwards and
marked on the cranial surface with India ink. Each piece was then put into a labelled six-division
cassette and processed. At embedding the pieces were removed in the appropriate sequence from
the cassettes and laid out in the coronal plane with DRG downwards in rows according to the
following formula. Starting with cervical segment one (CI), the pieces were placed, inked
surface uppermost, in the metal embedding mould in relation to their original position in the
intact cord. i.e. CI was followed by C2, etc. Each row sequentially decreased in number; row
one contained 7 pieces (C1-C7), row two had 6 pieces (C8- T5) and so on. In this way, each
piece had its own unique location in a particular row (Figure 3.5E&F). Once all the pieces were
in position, the embedding mould was cooled slightly to immobilise the pieces and then filled
with hot wax. By using this methodology, the separated pieces were brought together in one wax
block so that each segment could be identified under the microscope by its position in the block.
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Figure 3.3 Trimming (A-D), embedding (E-
G) and cutting (H) of hamster brain. Fixed
brain is cut into slices of equal thickness
using a series of thin blades and a grooved
brain-slicing matrix. The pieces are then
embedded in metal molds that are filled with
paraffin wax. The entire brain is embedded as
one block. Groups of serial sections (semi-
serials) are cut through the whole brain.
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Figure 3.4 Spinal cord; trimming (A-C) marking (D, E), processing (F)
and embedding (G,H)
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Figure 3.5 Methods employed to orient and embed tissue; diagrammatic representation
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Ganglia: The tissues of the PNS could be processed immediately without the need for trimming
but their small size was problematical. The fixed nodose ganglia/vagus nerve complex was so
small (less than 0.25mm in diameter), opaque and difficult to see that it was liable to be
inadvertently discarded with the fixative or washed through the holes of the cassette during
processing. In an effort to ensure their continued existence, the pieces were made more visible
by being weakly stained with haematoxylin and processed within fine nylon mesh envelopes.
To reduce the need to cut each tissue individually, it was desirable that both left and right NG
and the CMGC be incorporated into the one block. However, the left and right NG are
indistinguishable from one another macroscopically and microscopically. To avoid the pieces
being mixed up, after being gently removed from the supporting card, each was positioned and
oriented in the embedding mould in the layout shown in Figure 3.5G. The left NG was placed in
the vertical plane on the left side of the embedding mould with the right NG positioned to its
right lying horizontally above, and parallel to, the CMGC. It was important that the right NG
was not placed on the right side of the mould because cut sections may be rotated while being
mounted on the glass slides. If this happened, left and right could not be distinguished from one
another and their individual identities would be lost.
3.2.2 Cutting schedules.
For the CNS, the final complement of sections had to be representative of the entire brain and
spinal cord. The aim with the PNS was to ensure that as many sections as possible contained the
required components. The ENS is distributed all along the gut wall but care would be needed to
make sure that the separate, and much smaller, mesenteric lymph nodes were present on at least
some of the gut sections. It was desirable that the major part of each tissue was examined.
However, serially sectioning each block would be an overwhelming and unnecessary amount of
work. The pilot study was used to test the validity of using an alternative option that would cut
down on section cutting without (hopefully) the loss of important tissue. Groups of serial
sections taken at regular intervals throughout the tissue (semi-serials) were therefore cut from all
tissues. CNS or PNS tissues from two hamsters were sectioned at six microns, the standard
thickness used in our laboratory (Figure 3.4H). Brain and small intestine sections were cut at
intervals of approximately 200pm, i.e. every 36 sections; spinal cord at 150pm, i.e. every 24
sections and ganglia at intervals of 80pm, i.e. every 14 sections. Six consecutive sections were
taken at each interval. In the proposed study these would be used for PrP immunocytochemistry,
PET blotting or kept as spares. In the pilot these were either stained with H&E to check tissue
integrity and morphology or stained with cresyl violet/luxol fast blue (CV/LFB) to help identify
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the various neuroanatomical groups of neurones. One hamster brain was cut serially so that it
could be used to check the legitimacy of using semi-serial replacements and to judge the
feasibility of further extending the intervals.
3.3 Fixation and immunolabelling trials.
Previous studies had established tissue processing and immunolabelling protocols that gave
sensitive detection of PrP in the CNS. The ICC method used (the indirect two-step peroxidase
method) had produced good staining in mouse brain and hamster brain and spinal cord from
early and late stages of the incubation period (Bruce et al., 1989,94a, Beekes et al., 1998,
McBride et al., 1998). Although this procedure had not been applied to the range of tissues
described above, it allowed adequate labelling of PrPd in the DRG so it was likely that the
existing methodology would also be suitable for other PNS components. However, a stronger
immunolabelling reaction product would be beneficial. Beside this, the original fixation
schedules employed a short fixation period (less than 12 hours) while in the present study,
practical considerations necessitated a three-day delay from the start of fixation before tissues
could be processed and embedded. Therefore, before embarking on the new study, it was
necessary to establish whether the longer fixation time would adversely affect PrP detection.
Two fixation schedules and two immunolabelling methods were compared.
3.3.1 Fixation trials.
Fixation trials were carried out on periodate-lysine-paraformaldehyde (PLP)-fixed sections of
brain from inbred mice or Syrian hamsters. The rodents were intracerebrally injected with brain
homogenates of ME7 (12 mice), 22A (4 mice) or 263K (4 hamsters) scrapie or normal brain
homogenate (7 mice). At clinical end-point of disease or equivalent, animals were culled by
perfusion with PLP under terminal anaesthesia.
Brains were removed and either immersion fixed in PLP for 5 hours and transferred to 70%
ethanol for the remainder of a 4-day period or immersed in PLP for the entire 4-day period (with
regular changes of fixative). The tissues were then trimmed, immersed in 70% ethanol and
processed overnight in an automatic tissue processor (Leica TP1050). Tissues were embedded in
fresh wax the following morning. Sections of six microns thick were cut. The effects of short or
prolonged fixation on PrP were assessed by the Peroxidase anti-Peroxidase (PAP) method. Brain
sections from known positive end-point cases served as controls for the methodology.
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3.3.2 ICC trials
Two ICC methods were used to visualise and compare the sensitivity of PrP detection. These
were; the indirect two-step peroxidase that had been used in the previous study and the PAP
method that, by incorporating an additional step, increases signal detection. For this trial, in
addition to sections from intracerebrally-infected hamsters and mice, brain sections from the
previous time-course study of orally or mock-challenged hamsters were used. The PrP
antibodies used were, 1B3 (Farquhar et al., 1989), a rabbit anti-mouse polyclonal (for mice) and
3F4 (Kascsak et al., 1987), a mouse monoclonal (for hamsters). Details of both methods are
described in Appendix 2.
3.4 Summary of trials undertaken
On the trips to Berlin and subsequently at NPU, dissections were performed in which brain,
spinal cord with DRG, left and right vagus nerve with NG, CMGC, and intestinal loops were
taken into formal saline fixative, processed, and embedded. The tissues from six hamsters were
used to check the presence, integrity and cellular preservation of the desired pieces of tissue or to
establish the most appropriate way to trim, cut and embed the pieces for future studies. All
tissues were stained with the histological dyes H&E or CV/LFB. Separate tissues from infected
rodents were fixed in PLP for differing periods of time and immunolabelled by either the
indirect or PAP methods.
3.5 Results
3.5.1 Dissections
On examination of H&E and CV/LFB stained sections, all tissues had been successfully
removed including the macroscopically invisible CMGC (Figures 3.5B,D,F,H & 3.6E). The
strategy to remove gastrointestinal tissue as 'loops' also worked very well. The loops appeared
intact and included easily identifiable mesenteric lymph nodes and Peyer's patches (Figure
3.5B). Microscopically, all the desired tissue elements were present (Figure 3.6E) and
morphologically well preserved (Figure 3.6E). This finding was welcome because inadequate
penetration of fixative was a possible consequence of preparing gut in this manner.
Even though the tissues were small and hard to excise all were relatively undamaged. This
outcome was important because excessive tissue damage can result in falsely positive
immunolabelling (P. McBride, unpublished observation). In most cases spinal cord segments
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were in good condition but a few suffered scissor damage. This was considered a consequence of
relative inexperience and an occurrence that would be rectified with practise*. It was hoped that
it would be possible to remove the cord with both or at least one DRG remaining attached. In
practice, the cord was always obtained intact with most DRG present (Figure 3.5A). Given the
difficulty of these procedures, results were better than expected.
3.5.2 Trimming, orientation and embedding
The approaches adopted to identify and embed separate tissues and parts of tissues achieved
their objectives of reducing the amount of cutting and immunolabelling. The sub-divided and re-
amalgamated cord segments were easily identified by their unique position in a particular row
(Figure 3.5E&F). For brain, individual identification was unnecessary, as each piece was
different. The advantage to using the layouts described in section 3.2.1 was that whole spinal
cord or brain was available for viewing in one block. The positioning of ganglia and spinal cord
permitted each piece to be individually identified by its relative location to the others both
macroscopically and under the microscope (Figures 3.5F, H). As a result, these layouts were
adopted as standards and reproduced for each animal.
3.5.3 Section cutting
Assessment was carried out using H&E staining and CV/LFB. In combination, CV aids the
identification of neuroanatomical groups by differentiating types of cells by morphology and
staining properties while LFB demonstrates nerve processes. In order to adopt the trial cutting
intervals used in the pilot experiment as standards, it was essential that all tissues were present
on sufficient numbers of sections and that the correct anatomical areas were represented. By
comparing H&E-stained semi-serials with the serial sections, it was found that, in general, the
selected intervals would supply sufficient sections to provide the desired information.
Morphological differences between sensory and autonomic ganglia were clearly seen even when
only a cluster of neurones was present (Figure 3.6 D&F). All three ganglia (left and right NG
plus respective vagus nerves, and the CMGC) were found on every section from individual
hamsters a high percentage of the time. The CMCG was almost always present on each slide, but
fairly regularly, only one of the two NG was present. To increase the inclusion ofNG, the
This was shown to be the case. Removal of the spinal cord/DRG complex was overwhelmingly
successful. In the main project segements were mostly undamaged. Almost 100% of DRG were excised
from each animal at all timepoints. All but one NG and all CMCG were present and intact.
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interval between each group of semi-serials would need to be reduced. This would result in the
production of more sections than necessary but by using H&E staining as a screening device,
only sections adjacent to those containing ganglia need be immunolabelled.
For the brain and spinal cord, all major areas were present and no particular group of neurones
(referred to as nuclei) appeared to be absent from the stained sections. Large neuronal groups of
the thalamus, red nucleus and pons could be identified and tracked in their entirety through the
appropriate brain levels. Smaller brainstem nuclei such as DMNV and SN (Figure 3.7A-D), and
the IML of the spinal cord (Figure 3.7E-F) were also identified in the stained sections. The
various nuclei could be located in the plane of the coronal sections and traced dorsally and
ventrally in sections from adjacent intervals. These results promoted confidence in the methods
employed. Nonetheless, the DMNV, SN and IML are very small focal nuclei whose presence
would be crucial to the success of the designed study. It was, therefore, very important that they
were available for assessment from every animal in the experiment.
As a result of these findings, it was considered pmdent to modify the cutting intervals used in the
pilot. In future, sections of brain and spinal cord would be cut and stained at intervals of 100pm,
and ganglia at 60pm. For small intestine intervals between sections would remain at 200pm but
only 5 sets of sections would be cut and stained. Also, instead of retaining 6 consecutive sections
from each set of sections, 10 sections would be taken at each interval. Of these, one would be
stained with CV/LFB, two each would be used for PrP ICC and PET blotting and the remaining
5 kept as spares to allow for repeat runs, staining artifacts or the occasional human error.
3.5.4 Fixation trials
Extended fixation in PLP proved to be detrimental to good PrP preservation/detection. In short-
fixed brain sections, the different forms of PrP pathology (Bruce et al., 1989,94a, Beekes et al.,
1998, McBride et al., 1998) were present and strongly immunolabelled throughout all regions of
the brain (Figure 3.8A&B). In sections from all brains fixed for 4 days in PLP, PrP
immunolabelling was very much reduced or even absent compared to that seen in brains fixed
for only 5 hours in PLP (Figure 3.8C&D). Diffuse PrPd was particularly weakly stained with
only a few punctate deposits remaining. Only amyloid plaques and large PrP aggregates
remained easily identifiable. Brain sections from known positive controls showed the typical
range and distribution of PrP pathology (data not shown).
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Figure 3.6 CV/LFB and H&E staining in hamster CNS, PNS and ileum. A and B; spinal
cord cervical segments 2 and 3 with attached DRG, C and D; low and high power views
of coeliac and mesenteric ganglion complex - cells are predominantly motor neurones
with smaller glia, E; left nodose ganglion containing sensory neurones and no neuropil,
F; ileum - muscle layers, orange-pink, submucosa, pale pink, villi, dark pink, myenteric
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Figure 3.7 Cresyl violet/luxol fast blue staining of CNS. Coronal sections of caudal medulla (A-
C) and thoracic spinal segment T7 (D-F) from an uninfected hamster. Cell bodies are shades of
purple and nerve fibres are turquoise. A variety of neuronal populations can be identified. A:
Several brainstem nuclei are present, DMNV (arrowheads), solitary tract nucleus (SN), area
postrema (AP) and hypoglossal nucleus (HN), B: Higher power of A showing the differing
morphologies and staining properties of individual cells, C: DMNV motor neurones (oval), D:
Low power view of thoracic segments showing inner grey matter 'butterfly' of cell bodies and
surrounding white matter fibres. Boxes contain neurones of the intermediolateral cell column
(IML) and ventromedial nucleus of the ventral horn (VMN) that are magnified in E and F.
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3.5.5 Immunolabelling trials
Comparison of the indirect and PAP immunolabelling methods on brain section from
intracerebrally infected hamsters or mice showed that, while both worked well on all sections,
the PAP method gave the best results. PrPd accumulated in the same brain areas with each
method but the deposits were darker stained in PAP-labelled sections (Figure 3.9). There
appeared to be more abnormal PrP present with the PAP method but this may be due to the more
intensely stained reaction product giving better contrast and being easier to see. With both
methods, neurones with the appearance typical of PrPc were occasionally seen (not shown).
Figure 3.8 Duration of fixation. Effect of short (A&B) or long (C&D) fixation with
periodate-lysine-paraformaldehyde (PLP). PrPd (brown granular deposits) is very
much reduced in tissue section fixed for 4 days compared to overnight. Disease-
associated PrP in medulla/cerebellum (A&C) and thalamus (B&D) of hamsters
terminally-affected by 263K scrapie.
D
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Figure 3.9 Comparison of indirect (right column) and peroxidase anti-peroxidase
[PAP| (left column) methods of immunolabelling on adjacent sections of brain from
a mouse terminally ill with 87V scrapie. A variety of PrP pathology (brown
deposits) and brain area are compared. A: amyloid plaques in the cerebral cortex,
B: punctate deposits in the CA2 region of the hippocampus, C: diffuse deposition in
the thalamus and D: medulla (midline raphe nucleus at the 4th ventricle). Both
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3.6 Discussion
This Chapter describes the strategies used to dissect specific parts of the hamster CNS and PNS
and the methods devised to allow these tissues to be displayed for staining and viewing on a
microscope slide. It was realised at the outset that the procedures would be complex and
technically demanding but these had to be successfully achieved if experiments to elucidate the
neuroanatomical pathways of TSE spread were to proceed. In practice, most of the difficulties
were overcome and in the main, the methodologies were adopted as being fit for the planned
study. The problems encountered were ultimately beneficial as solutions could be sought during
the trials and so be avoided in the future.
There was a concern that the micro-dissection of peripheral nervous tissue could not be achieved
on small rodents. This was unfounded but some practice was required to become sufficiently
competent. It was essential to become familiar with the relevant anatomy and to be able to locate
the PNS components with confidence. Attaining the ability to recognise the tissues in situ and
the expertise to remove them without damage was only possible by using a dissecting
microscope and magnifying lamp. The micro-dissections needed great care, manual dexterity
and concentration - clumsy use of instruments could destroy valuable material. They also
required having to work in the same position for long periods of time which was time consuming
and physically tiring.
Other factors were crucial to achieving a successful outcome. It was pivotal that the correct
pieces were located and removed undamaged but they also had to be well preserved. Tissues had
to be removed accurately but quickly, before the onset of autolysis. This was particularly
important for the GI tract as digestive enzymes augment autolysis. For this reason perfusion
fixation was the method of choice. Tissues fixed by perfusion are preserved 'from the inside out'
via the blood supply as opposed to immersion fixation where excised tissues are fixed by
diffusion from the surrounding liquid.
The factors outlined above were common to the dissection of all the tissues but certain tissues
had additional specific problems. To obtain comprehensive data from spinal cord, it was
desirable that all segments plus their corresponding DRGs were available for viewing on one
microscope slide. This was a difficult procedure which, to my knowledge, has not been
attempted (or published) previously. The vertebral column encases both spinal cord and DRG so
the aim could possibly have been achieved more easily by excising the whole vertebral column
and cutting between individual vertebrae. Each section would comprise the spinal cord with
79 Chapter 3: Pilot experiments
spinal nerve roots linked to DRG surrounded by the interlocking bones of the vertebral arch. It
could be assumed that intact segments would present a more realistic view of the '/n-vivo'
relationship between the various components. Three factors argue against employing this
strategy:
1) The bones of the vertebrae are locked tightly together. In order to cut between them the
column would have to be decalcified requiring several hours immersion in e.g. strong acid or
chelating agents. These processes are damaging to soft tissues so tissue matrix preservation
and cellular morphology would suffer. While some loss of preservation may be tolerable for
general histology it would not be acceptable for PLP-fixed tissues processed for ICC as the
subsequent immunolabelling results in high background (signal-to-noise) and
uninterpretable analysis.
2) During decalcification the differing tissue elements shrink disproportionately. Consequently,
the hard bone shrinks relatively little compared to the softer nervous tissue and the natural
close contact is not maintained in the resulting block.
3) All vertebral column segments do not exactly correspond to spinal cord segments. After
birth the spinal cord grows at a slower rate than does the vertebral column so that in
adulthood, the cord is shorter than the column. As a result the more caudal spinal roots have
to descend below the corresponding piece of cord to reach their exit point through the
relevant foramen. Therefore, a cut segment of vertebral column may not contain its
corresponding DRG.
The points outlined above support the decision to dissect out the cord and attached DRG from
the surrounding bone of the column even though this is a lengthy procedure. The technique
allows each segment to be represented with its corresponding DRG - a factor considered crucial
for the project's success.
Many lessons were learned from the pilot experiments that prevented technical errors and helped
to save time, materials and experimental animals. Success was due to many elements including
careful planning and execution of the various stages. Sometimes simple schemes proved
effective. For instance, by enclosing the smallest tissues in nylon mesh envelopes they were
protected during processing and prior staining with haematoxylin allowed them to be seen and
manipulated more easily. The idea to embed pieces of GI tract as loops rather than the more
customary linear tubes also proved effective. Enteric ganglia run the length of the gut and are
present between the muscle layers of any chosen piece but PP are present only at irregular
intervals along the small intestine. Both elements could have been present in linear pieces but in
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loops these were available along with their associated nerves, blood vessels and draining
mesenteric lymph nodes.
A number of potential problems were identified during tissue processing. Often pieces of tissue
were indistinguishable from one another and if mixed up, could not be re-identified. Mix-ups
could occur at any stage after trimming but were particularly likely to occur during wax
embedding. It was found that tissues could float from position through inadequate cooling but if
cooled for too long, air bubbles would form causing sectioning difficulties.
A logistical problem arose from the desire to embed multiple pieces of tissue in the same
cassette. Individual identity could have been achieved by embedding in separate cassettes but
this would have been very labour intensive. This was overcome by devising methods to mark
and track the pieces during processing and by embedding each tissue piece according to pre¬
planned layouts. The procedures were fairly complex but the resulting single block outweighed
the time and effort. The strategies greatly reduced the number of final blocks and, in turn,
reduced the amount of section cutting and immunolabelling.
Cutting semi-serials at defined intervals instead of serial sectioning was a large factor in
reducing section preparation. Accurate representation of CNS anatomy was the main
consideration when deciding on CNS cutting intervals. It was necessary to ensure the presence
of small groups of neurones within the larger whole. Conversely, with the PNS any problems
were due to the small component size and ensuring the threadlike ganglia were retained during
processing and were present on a sufficient number of slides. With either CNS or PNS, the
various neuronal groups and cell types were identified and differentiated from one another by
using CV/LFB dyes. The DMNV and IML are restricted to specific locations in brain and
thoracic spinal cord, respectively. These and other important brain stem nuclei were almost
always present in CV/LFB-stained sections. This finding was crucial as frequent absence would
have had been a serious setback. The subsequent identification of these structures was key to
proving the hypothesis of spread.
One important outcome of the pilot trials was to show that it was not possible for one individual
to carry out the perfusions, dissections and histological preparations. Dissection of the four
animals (the number that would be culled at each time point) took two and a half days and spinal
cord preparation, another day. Preparation of the other tissues, processing and embedding
required the rest of the week. As the histological and immunocytochemical expertise lay at NPU,
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it was decided that the scrapie infections and dissections would be carried out at the Robert Koch
Institute and the rest of the procedures (including microscopical analysis) performed at NPU.
This division of labour also allowed a direct comparison with the study described in Chapter 2.
The techniques carried out here were in the main novel and ambitious but as much of the
information regarding peripheral pathogenesis of 263K scrapie derives from our previous studies
using orally-challenged hamsters, failure to establish the necessary expertise would have been
disappointing and a setback to future research. The success of the pilot experiments provided
reasonable optimism that the planned experimental objectives could be achieved. It was now
possible to test the hypothesis of neuroanatomical spread. Chapter 4 describes the work of this
experiment.
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Chapter 4: Oral spread of 263K scrapie: Neuroanatomical routing
from the gastrointestinal tract to the CNS
4.0 Introduction
Although the ultimate target of infection is the central nervous system (CNS), there is
mounting evidence that in natural (Groschup et al., 1996, van Keulen et al., 1999), and
experimental (Kimberlin et al, 1983b, Baldauf et al., 1997, Groschup et al., 1999) scrapie,
BSE (Wells et al., 1998) and vCJD (Ha'ik et al., 2003) the PNS plays a key role in conveying
the TSE agent to the brain and spinal cord from sites of uptake in the alimentary tract.
Regardless of the initial mechanisms of uptake from extraneural sites, spread of infection to
the brain and spinal cord follows a similar trend in many peripherally infected rodent models
of scrapie including this model of oral challenge. Infectivity (Kimberlin & Walker
1982,86,89b, Beekes et al., 1996) and protease-resistant PrP (Beekes et al., 1996, Baldauf et
al., 1997) are detected earliest in hindbrain and mid-thoracic spinal cord. Subsequent spread
of infection occurs in both cranial and caudal directions (Kimberlin & Walker 1982, 89b,
Beekes et al., 1996, Baldauf et al., 1997). The immunocytochemical detection of PrPd
described in Chapter 2 supported these findings and provided additional evidence that after
oral challenge, 263K scrapie is routed to the brain and spinal cord independently. In the
brain, the first target site for PrPd accumulation was the DMNV followed shortly afterwards
by the SN, and in the spinal cord PrPdwas first found between thoracic segments 4 and 9.
Targeting to these specific sites is consistent with transit along the vagus and splanchnic
nerves supplying the viscera. Identification of the initial cerebral target sites showed that the
vagus nerve was a primary pathway to the brain in this model and strongly implicated the
splanchnic nerve as the conduit between the gastrointestinal tract and the spinal cord. Also,
data drawn from the temporal sequence of PrPd deposition provided significant indicators
that initial spread may have occurred along autonomic rather than sensory fibres of these
nerves. Bearing this and the neuroanatomical pathways that link the CNS to the GI tract in
mind, it was possible to hypothesise the route and manner by which the agent would need to
travel to reach these initial CNS target sites. The data suggested that, after ingestion, the
263K scrapie spreads in a retrograde direction, along autonomic PNS fibres and ganglia
supplying the mesentery i.e. along sympathetic and parasympathetic efferents of the
splanchnic and vagus nerves (Figure 4.1). If this were the case, the DMNV and the
splanchnic preganglionic neurones of the intermediolateral cell column (IML) would be
primarily involved. Here autonomic prevertebral ganglia (CMGC) would be intermediate
relay points. Spread could also take place along the sensory afferent fibres and in this
scenario, the SN and dorsal horn would be the initial targets for PrPd deposition with the
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respective sensory neurones of NG and DRG being the intermediaries. Intramural ganglia of
the enteric nervous system are also possible sites in which infectivity (PrPd) could be
replicated. Spread could, however, be more indiscriminate and occur simultaneously along
both sensory and motor fibres.
To investigate this hypothesis it was necessary to assess the involvement of these nerves in
the oral pathogenesis of 263K scrapie. This chapter describes a second time-course
experiment in the same rodent model of oral challenge. The aim was to undertake a detailed
examination of vagus and splanchnic nerve circuitry focusing on tissues previously identified
as being potentially relevant to infectious spread in this model. Specific components of the
PNS were examined for the presence of PrPd along with brain and spinal cord with which
they form relay circuits. Jejunum and ileum were included in the study as they contain
ganglia of the enteric nervous system (ENS) that forms synaptic links with both nerves. The
technical difficulties involved in this undertaking and their resolution were outlined in
Chapter 3.
Tissues were collected at points throughout the incubation period and ICC was used to
identify the location and temporal sequence of PrPd in tissue sections. In addition, in
collaboration with Dr. Walter Schulz-Schaeffer of the University of Gottingen, Germany,
Paraffin Embedded Tissue (PET) blotting was carried out on adjacent sections. This
technique employs pretreatments that involve incubating sections for several hours in
proteinase K and guanidine to destroy cellular PrP. Thereafter, only the PK-resistant
fractions (PrP5®) remain available for immuno-detection (Schulz-Schaeffer et al., 2000a).
There is little or no data reporting how much infectivity exists in nerves and ganglia after
oral TSE infection. For this reason, selective bioassays were also carried out to assess the
level of infectivity in two key PNS components, the cervical vagus nerve and the coeliac and
mesenteric ganglion complex (CMGC). Such information provides comparisons with the
PrPd deposition and can offer clues to mechanisms of agent transportation and spread. The
identity of extraneural reservoirs of infection is also important from a wider perspective as
these provide potential sites for early diagnosis and cross-contamination of, for example,
surgical instruments.
Using these approaches, it was possible to identify the precise temporal sequence and
location of PrPd (and PrPSc) deposition in the CNS, PNS and ENS and thereby to define the
neuroanatomical pathways involved in early pathogenesis. In addition, data from the
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bioassays showed that only minimal levels of infectivity existed in the nerves while
substantially higher amounts were contained in autonomic ganglia.
4.1 Materials and Methods
4.1.1 Experimental design
Outbred Syrian hamsters were fed individual food pellets doused with lOOpl of a 10%
hamster brain homogenate from 263K scrapie-infected donors or uninfected controls as
previously described in Chapter 2. For ICC studies, four or five hamsters were culled by C02
inhalation at specific time points throughout the incubation period; 56, 62, 69, 76, 83, 90, 97,
104, 111, 118, 126, 132 days post infection (dpi) or at clinical end-point of disease (159±4
[S.E.] dpi). Two mock-challenged hamsters, similarly fed with normal brain homogenate,
were sacrificed at 161dpi.
For bioassay experiments, specimens were taken from five terminally ill and two mock-
challenged hamsters. Only tissues from end-point cases were subject to bioassay. Previous
studies using mice have shown low or undetectable levels of infectivity from peripheral
tissues assayed from preclinical stages of disease (M. Bruce, personal communication). As
bioassays are lengthy experiments involving the use of many animals and the presence of
infectivity in endpoint tissues had not been established, the inclusion of early timepoint
tissues could not be justified at this stage.
4.1.2 Histological procedures
Hamsters were transcardially perfused with periodate-lysine-paraformaldehyde (PLP).
Dissections were then carried out as described in Chapter 3.1 and Appendix 1. The brain and
CMGC were removed from all hamsters. Spinal cord with attached DRG, jejunum, ileum
(adjacent to the ileocaecal sphincter), spleen, salivary gland (with associated lymph nodes)
and left and right NG with attached cervical vagus nerve were included from 69dpi to
endpoint of disease. After perfusion, tissues were immersed for 5 hours in PLP, transferred
to 70% alcohol for a further 48 hours, processed over 6 hours in an enclosed tissue processor
and embedded in paraffin wax according to the procedures described in Chapter 3.3.1. Prior
to processing and embedding, brains were trimmed coronally into 2mm thick slices using a
brain-slicing mould. Spinal cords were sliced coronally between nerve roots to provide
individual cervical, thoracic and sometimes lumbar segments with corresponding left and
right DRG. Pieces were marked on their cranial surface with Indian ink, numbered and
processed separately but embedded, in sequence, in one block. Six micron sections of brain
and spinal cord with attached DRG were taken at 100 micron intervals for PrP
immunocytochemistry and cresyl violet/luxol fast blue (CV/LFB) histochemistry. On other
tissues these procedures were carried out either on serial sections or at 50 micron intervals.
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4.1.3 Immunocytochemistry
Immunostaining was carried out according to the ABC method* using the 3F4 mouse anti-
hamster PrP monoclonal antibody or normal serum and diaminobenzidine to visualise the
reaction product. Sections were pretreated with formic acid for 10 minutes to enhance PrP
visualisation. To ensure antibody specificity adjacent sections were incubated with normal
serum in place of primary antibody. Similarly treated sections from mock-challenged
hamsters served as control tissue. (Full method is described in Appendix 2)
4.1.4 Paraffin-Embedded Tissue (PET) blotting
Sections were mounted on nitrocellulose membranes (0.45 micron pore size: Bio-Rad
Laboratories, Hemel Hempstead, Herts, England), dried flat at room temperature (approx.
2hrs.) and incubated overnight at 37°C. PET blotting was carried out according to Schulz-
Schaeffer et al. (Schulz- Schaeffer et al., 2000a). After washing in TBS with 0.05% Tween
20, sections were digested with 250pg/ml proteinase K (PK) in PK buffer (lOmM/L Tris-
HC1, pH 7.8; lOOmM/L NaCl; 0.1% [w/v] Brij 35) for 8hrs. at 55°C. Sections were then
treated with with 3M guanidine isothiocyanate to denature PrPc. Immunostaining was carried
out using 3F4 mouse anti-hamster monoclonal antibody to label PrP and NBT/BCIP to
visualise the reaction product. PET blots were analysed using a dissecting microscope.
4.1.5 Quantification of PrPd
Deposition was assessed in ICC sections using light microscopy according to the following
criteria:
+ Punctate PrPd on the membrane (surface) or within very few cells (neurones or glia).
Visible only at high power (x40 objective).
++ Punctate and granular PrPd deposited diffusely within or in the adjacent neuropil of
several individual cells or localised neuronal groups. Visible using x20 or x40 objectives.
+++ Granular PrPd accumulated fairly extensively in and around substantial numbers of
grouped cells and associated with a number of groups. Obvious using x4 or xlO objective.
++++ Aggregated and/or granular PrPd greatly accumulated in several distinct
neuroanatomical regions or ganglia and diffusely distributed throughout the CNS. Easily
seen at low power with x2 or x4 objectives.
*
The PAP method was replaced by ABC method as further immunolabelling trials showed that ABC
gave greater sensitivity of PrP detection
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4.1.6 Infectivity bioassays
Vagus nerve and CMGC samples were removed from two terminally ill animals (SI and S2)
and two mock-infected controls. From another three terminally ill hamsters (S3-S5) only
vagus nerve samples were taken. To avoid the inclusion of ganglion cell bodies left and right
portions (of approximately 1 cm in length) of cervical vagus were removed at a position that
was remote from the NG and carefully separated from surrounding tissue. The CMGC was
removed attached to the abdominal aorta between the coeliac, superior mesenteric, left renal
and right renal arteries. Two 0.5cm pieces from the abdominal artery cranially and caudally
adjacent to the CMGC were also sampled. Samples were washed three times in Tris-buffered
saline (TBS: 10 mM Tris-HCl, 133 mM NaCl, pH 7.4), incubated at 37°C for 1.5 hr. in
200pl TBS containing 0.25% (w/v) collagenase [Boehringer Mannheim] and 0.025% (w/v)
CaCl2 and heated to 80°C for 10 min. The volume was adjusted to 500pl with TBS. 50pi
aliquots were inoculated intracerebrally into groups of 5 recipient hamsters. Infectivity titres
were estimated from the incubation periods using dose-response curves as previously
described (Beekes et al., 1996). The experiment was terminated at 370dpi. Infectivity assays
were carried out at the Robert Koch Institute by Michael Beekes.
4.2 Results
To accurately reflect the distribution of PrPd, ICC, PET blots and CV/LFB histochemistry (to
aid neuroanatomical identification) were carried out on series of adjacent sections cut either
serially or at intervals through each tissue. Tissues comprised components of splanchnic
sympathetic/CNS/sensory (CMGC - IML - DRG) or vagal parasympathetic/CNS/sensory
(DMNV - SN - NG) relay circuits and the ileal and jejunal ENS. Diagrammatic
representation of the major pathways forming the inter-linking circuitry is shown in Figure
4.1.
4.2.1 Physical appearance of PrP
The cellular appearance of PrPd and PrPc was identical to that described in Chapter 2. PrP
pathology was marked by characteristic punctate, granular or aggregated accumulations in
and around neurones of neuroanatomically distinct CNS regions and peripheral or enteric
ganglia of the ENS (Figure 4.2). In tissue sections of 263K-challenged hamsters, the earliest
PrPd was punctate deposition localised at the surface and in the adjacent neuropil of neurones
and, sometimes, neuroglia (Figure 4.2A-C). In NG and DRG, PrPd appeared as intensely
stained granular inclusions within a proportion of ganglion neurones and adjacent satellite
cells (Figure 4.2D). Labelling of CMGC was similar to the sensory ganglia in initial
appearance and progressive accumulation but, probably reflecting differences in anatomy,
extracellular labelling of CMGC neuropil was also evident from early stages (Figure 4.2E).
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In mock-infected controls, PrPc was seen only in some neuronal cell bodies, mostly of the
brainstem and grey matter of spinal cord. PrPc was non-granular, labelled less intensely and
differed in appearance from any of the (largely extracellular) granular forms of PrPd (see
Chapter 2, Figure 2.7A)
4.2.2 Early temporal and spatial deposition of PrPd in enteric, splanchnic and vagus
nerve relays
The extent of PrPd accumulation varied between individuals culled within any time-point but
the site and sequence of deposition was consistent. PrPd was found earlier and with more
frequency in autonomic components of the circuitry compared to sensory components. In the
splanchnic nerve circuitry, PrPd was found in the CMGC and IML prior to DRG and in the
vagal circuitry, in the DMNV before NG. The ENS contains autonomic and sensory NS
networks. Table 4.1 summarises the temporal and spatial deposition of PrPd in enteric,
splanchnic and vagal relays.
4.2.2i ENS
PrPd was found from the earliest available time point (69dpi) to end-point of disease in and
around neurones of the myenteric and submucosal ganglia of ileum and jejunum of all four
hamsters (Figure 4.2C, 4.3A&B). At this stage of the incubation, deposits were generally
fairly abundant and associated with several but not all ganglia. As the incubation period
progressed, accumulations increased in individual ganglia and the number of affected ganglia
also increased (Figure 4.3C&D, 4.4A).
4.2.2ii Splanchnic nerve circuitry (CMGC -IML - DRG)
PrPd was observed in the CMGC of all four hamsters at the first time point of 56dpi, (Table
4.1). Initial deposits were few but PrPd accumulated rapidly. By 76dpi deposition was
substantial and by 90dpi PrPd was detected throughout most of the complex (Figure 4.4B). In
spinal cord, PrPd was invariably seen in the IML at 69dpi, the earliest time point at which
cord was available. Deposition was present in thoracic cord segments 3-8 with the greatest
amounts in the IML of segments 5, 6 & 7 (Figure 4.4C,D). PrPd was not detected in DRG
until 76dpi when one or two positive cells were observed in mid-thoracic DRG in two out of
four hamsters. In later timepoints, deposition remained either absent or scant and was always
less than that of the corresponding IML (Figure 4.4E). In all cases PrPd was found in DRG
only after accumulations were fairly widespread within the corresponding cord segment.
4.2.2iii Vagus nerve circuitry (DMNV - SN - NG)
In the brain, the first PrPd deposits were seen in and around neurones of the DMNV at 62dpi
(two out of four brains) and the commissural nucleus of the SN (one out of four brains). In
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both areas deposition was minimal but was greater in the DMNV. In later time-points
accumulations were typically heavier in the DMNV compared to the SN (Figures 4.5A-C).
PrPd was either low or undetected in NG until 90dpi (Figure 4.5D). At 69, 76 and 83 dpi,
PrPd was found in only a few cells per ganglion and at 90dpi there were only moderate
numbers of positively labelled cells. As with the DRG (and in contrast to the CMGC),
accumulation was slow and at endpoint of disease several neurones remained unlabelled
(Figure 4.5E).
4.2.3 Subsequent pattern of PrPd accumulation in the PNS and CNS
Subsequent to the IML, PrPd was observed in intermediate zone (69dpi), around the central
canal and then (76dpi) extending from the IML into the adjacent white matter along
processes of radial glia (Figure 4.4D). This pattern of early spread is consistent with
distribution of PrPd along the other sympathetic preganglionic neurones that form links with
the IML (Cabot 1990). Specifically, these are the intercalated nucleus in the intermediate
zone, the central autonomic nucleus located around the central canal and the lateral funicular
nucleus whose dendrites extend into the white matter of the lateral funiculus. Accumulations
became progressively greater in the initial sites and generally more widespread, firstly within
the medial portion of the dorsal grey matter and next within the ventral horn. Concurrent
with this, PrPd appeared in the IML of thoracic segments located cranial and caudal to those
first affected. The presence of PrPd in these latter sites is also consistent with dendritic field
of IML-linked neurones within the transverse plane of the same segment and the 'ladder-
like' attachments with IML 'nests' in adjacent segments that are located longitudinally
(Cabot 1990). This pattern of spread continued with increasing incubation and at late stages
of disease, all infected hamsters showed marked granular deposition of PrPd throughout the
brain and grey matter 'butterfly' of all spinal cord segments (Figure 4.6).
Once accumulation was established in the DMNV and commissural portion of the SN, PrPd
was observed in medial and central regions of the SN and then in other specific brainstem
nuclei, notably those of the medullary reticular formation (76dpi), vestibular complex, pons
and red nucleus (83dpi). Labelling was then rapidly disseminated to several other sites
throughout the brain. (Areas affected and pattern of spread are illustrated in Table 2.1 and
Figure 2.2 of Chapter 2).
Throughout the incubation period, the sequence and spatial precision of targeting was
consistent. The final PrPd distribution pattern was identical in all spinal cords (Figure 4.6)
brains (Figure 4.7) and ganglia. In autonomic and sensory ganglia, the number of PrPd
inclusions and affected cells increased with incubation but even at late-stage disease a
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proportion of neurones remained unlabelled although the percentage of unlabelled cells was
higher in sensory ganglia, i.e. DRG and NG (Figure 4.2D, 4.4E, 4.5D&E). PrPd was mostly
absent from vagus, splanchnic or spinal nerve roots but a tiny amount was found in the vagus
and splanchnic nerve of one terminally-ill hamster (Figure 4.8A&B). Staining was absent
from tissues when normal serum replaced PrP antibody.
Although the dissecting microscope does not provide the resolution necessary to view
cellular detail in PET blots, aggregations of protease-resistant PrP (PrPSc) were found in
specific neuroanatomical areas of infected hamsters only. In all tissue specimens, at all time
points, PrPSc was seen in the same sites as PrPd was observed in adjacent ICC-labelled
sections (Figure 4.9A&B) indicating that the disease-specific deposits seen with ICC are
proteinase K resistant. However, in PET blots, deposits were stained more intensely and
were more easily detected at low power than the corresponding ICC-labelled deposits.
(Compare Figures 4.9A and B with 4.4C and 4.5A). These findings appear to show that the
sensitivity of antigen detection is better with the PET blot than that of ICC. However, it may
be that the superior contrast and heavy blue-black chromagen makes the positive labelling
more easily seen. Either way, the strong reaction product, the ability to detect small amounts
of PrPSc and the fact that a slice of tissue can be quickly viewed makes PET blotting a useful
complementary technique.
Table 4.1 Presence of PrPd (No.affected/No.in group) in ENS and splanchnic














56 nd 4/4 nd nd 0/4 0/4 nd nd
62/63 nd 4/4 nd nd 2/4 1/4 nd nd
69 4/4 4/4 4/4 0/4 4/4 1/4 1/4 0/4
76 4/4 4/4 4/4 2/4 4/4 1/4 3/4 1/2*
83 4/4 4/4 4/4 3/4 3/3* 3/3* 3/4 2/4
90 4/4 4/4 4/4 3/4 4/4 3/4 3/4 4/4
1 Early timepoints; incubation period ~160dpi: nd: not done; * 4 in group; area not present in other animals
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Figure 4.2 Appearance of PrPd (brown granular deposition) in CNS, PNS and
ENS of a 263K orally-challenged hamster. The earliest deposition (A-C) is
localised within, at the surface and in the adjacent neuropil of neurons and glia.
A: DMNV at 76dpi;B: A single neuron with associated glia (arrows) in the
CMGC at 56dpi; C: Myenteric (Auerbach's) plexus at 69dpi. In sensory
ganglia, PrPd is confined to cell bodies and associated satellite cells(arrows)
throughout the incubation period but in sympathetic ganglia PrPd is commonly
deposited on neuronal membranes and accumulates progressively in the
neuropil. D; DRG with satellite glia (arrows) and E; CMGC at endpoint of
disease. Scale bars A,C, E=30pm; B=12.5pm D=25pm.
V
A
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Figure 4.3 Immunolabelling of PrPd (brown granular deposition) in ileal ENS
ganglia of 263K orally challenged hamsters, culled early (A,B) and late (C,D) in
the incubation period. Myenteric (hatched arrowheads) and submucosal (open
arrowheads) plexus at 69dpi (A&B); and 126dpi (C&D). Scale bars: A,C =
20pm, B,D = 10pm.
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Figure 4.4 PrPd in the ENS and splanchnic nerve circuitry of the same
hamster 90 days after oral challenge with 263K scrapie. A; Myenteric
plexus, B; CMGC, C,D; Spinal cord segment T5, D; Detail of IML showing
PrPd accumulating around IML neurones and tracking through the white
matter along radial glia, E; DRG sensory neurones with satellite glia
(arrows). PrPd deposition is already extensive in the ENS and CMGC at this
stage of the incubation but is minimal in DRG. Scale bars: A,D,E = 20pm;
B = 50pm; C = 100pm
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Figure 4.5 PrPd deposition in the vagus nerve circuitry of hamsters orally-
challenged with 263K scrapie. Sequential accumulation in DMNV-SN complex
(A-C) and NG (D and E). A;76dpi, Band C; 90dpi. The amounts of PrPd vary
between individuals culled at any time point but the sequence and site of
deposition is consistent. PrPd is more abundant in the DMNV than in the
adjacent SN. The area postrema and underlying hypoglossal nucleus are largely
unlabel led. D; Right NG at 90dpi - labelling is scant. E; Right NG at end-stage
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Figure 4.6 Pattern of PrPd deposition in spinal cord of terminally-affected hamster
orally challenged with 263K. Sections, A-F, are from cervical (C) or thoracic (T)
segments and are presented in cranial to caudal direction. PrPd is abundant
throughout the entire grey matter 'butterfly' but the white matter is relatively spared.
Deposition is particularly obvious around neurones of the IML (arrow), the first site
of PrP accumulation. Scale bar = 700pm
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Figure 4.7 Pattern of PrPd (brown labelling) in terminally-affected brain of
hamster orally challenged with 263K scrapie. Distribution is shown in in
coronal slices (A - H) throughout the brain in a caudal (medulla) to rostral
(forebrain) direction. Scale bars: A = 400pm, B-H = 800pm
H
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Figure 4.8 PrPd in the (A) vagus and (B) splanchnic nerve of a terminally-ill hamster
orally challenged with 263K scrapie. PrPd is scant, and in splanchnic nerve may be
glia-associated. Scale bars = 12.5pm
A B
Figure 4.9 Early PrPd deposition in the DMNV and IML of hamsters orally challenged
with 263K scrapie, as demonstrated by PET blot (A and C) and ICC (B). A and B;
adjacent sections of DMNV (arrowheads) at 76dpi, C; IML at 90dpi. Specimens are
adjacent or nearly adjacent sections to those shown in Figures 4C and 5A. Scale bars:
A, B = 1mm, C = 200pm
B
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4.2.4 Dynamics of PrPd accumulation during the incubation period
The amount of PrPd present was quantified to establish the relative amount of protein in
different tissues (Table 4.2). The amount of PrPd present in each splanchnic or vagal
component was scored and compared within and between individual animals across the
incubation period. Scores were initially low, i.e. '+' or in all tissues. PrPd accumulated
over time by being detected in a) increasing quantity and number of neurones within a target
site, and b) an increasing number of target sites. At the earliest timepoints, PrPd was present
in some relay components, notably those nearest the source of uptake i.e. the GI tract, but
absent in others. With increasing time, PrPd appeared and progressively accumulated in a
stepwise manner along the linked pathways. Eventually, deposition was detected in all
components of vagal or splanchnic circuitry (Table 4.1, Figures 4.4 and 4.5) but the first
targets contained relatively more PrPd than subsequent ones. When amount of protein in the
vagal components of an individual hamster was compared to that in the splanchnic nerve at
the same timepoint, less PrPd was observed in vagal circuitry, i.e. scores were consistently
lower in DMNV-SN-NG than the CMGC-IML-DRG. Higher scores were achieved at earlier
timepoints in the splanchnic nerve circuitry. Rapid accumulation was particularly apparent in
the enteric ganglia and CMCG where scores rose to and were maintained at high levels from
the earliest stages of detection.
4.2.5 Scrapie infectivity in the vagal and splanchnic nerve circuitry
Two PNS components, the cervical vagus and CMGC, were analyzed by bioassay for
presence of infectivity. Samples of vagus nerve were excised from a position remote from
the NG to avoid the inclusion of ganglion cell bodies. Both were obtained from endpoint
cases only. The reason for this was explained in section 4.1.1.
The results for the vagus samples are summarised in Table 4.3. Mortality and incubation
time of the recipients in the bioassays demonstrate a low but consistent presence of
infectivity in the cervical vagal nerve trunks. The estimated amount of infectivity was
approximately 102ID5oj.c., corresponding to about 105 ID50i.c.per gram of tissue.
Infectivity levels in the two CMGC samples (Table 4.4) were higher (approximately 103 and
104 ID50i.c.) even though this represented only a minor constituent of the homogenised tissue
sample. Absolute disassociation between the CMGC and aorta is very difficult because the
ganglia are invisibly small and adhere closely and at intervals along the much larger aorta.
Two pieces from the abdominal artery were also sampled from the same animals. Artery
samples were located cranially or caudally adjacent to the CMGC. The trace levels of
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infectivity detected from these control specimens probably originate from residual CMGC
nervous tissue.
Table 4.2 Quantification of PrPd. Relative amount and progressive
accumulation of PrPd deposition* in the ENS and splanchnic and vagus nerve











56 1 nd + nd nd - - nd nd
2 nd + nd nd - - nd nd
3 nd + nd nd - - nd nd
4 nd + nd nd - - nd nd
62/63 1 nd ++ nd nd - - nd nd
2 nd + nd nd + - nd nd
3 nd ++ nd nd - - nd nd
4 nd ++ nd nd + + nd nd
69 1 + ++ +/++ - + - - -
2 ++ ++ +/++ - + - + -
3 ++ ++ + - ++ ++ - -
4 ++ ++ + - + - - -
76 1 +++ ++ +++ + + - - NP
2 +++ +++ + - + - + +
3 +++ +++ ++ + ++ + + -
4 +++ +++ ++ - + - + NP
83 1 +++ +++ +++ + ++ ++ + -
2 +++ +++ ++ - NP NP + -
3 ++++ ++++ +++ + ++ ++ + +
4 +++ +++ +++ + ++ + - +
90 1 +++ ++++ +++ ++ ++ ++ + +
2 ++ ++++ ++ + + + - +
3 +++ +++ +/++ - + - + +
4 +++ ++++ ++++ ++ +++ ++ + +
* Semi-quantified according to described criteria; 'Early timepoints; incubation period ~160dpi; nd:
not done, NP = not present
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Table 4.3 Detection of infectivity in cervical trunks of the vagus nerve by bioassay
Donor Sample Mortality Incubation time Estimated titre
Range[days] Mean[days ± S.E.] [ID50i.c. /sample]
SI Left V. 5/5 119-292 162±30 101'3
SI Right V. 5/5 117-155 126±7 102'7
S2 LeftV. 5/5 117-239 144±22 101'8
S2 Right V. 5/5 117-180 134±11 102-3
S3 LeftV. 5/5 120-260 151±25 1016
S3 Right V. 5/5 131-222 167±18 101-3
S4 LeftV. 5/5 131-183 159±10 101-5
S4 Right V. 5/5 127-152 139±4 1020
S5 Left V. 5/5 124-242 153±20 101-6
S5 Right V. 5/5 145-274 190±21 <1012
50|il aliquots of homogenized left and right vagus (V) from terminally-ill 263K orally-challenged
hamsters were i.e. inoculated into groups of five recipients. Recipients similarly inoculated with vagus
from donors previously orally mock-infected with normal brain homogenate showed no clinical signs
of scrapie. Experiment was terminated at 370 dpi.
1 Values refer to the total amount of infectivity in one equivalent of excised tissue, i.e. the entire donor
sample, and calculated by applying mean incubation time to a dose response curve.
Table 4.4 Detection of infectivity in the coeliac and superior mesenteric ganglion
complex and adjacent parts of the abdominal aorta
Donor Sample Mortality Incubation time Estimated titre1
Range[days] Mean[days ± S.E.] [IDsoi.c. /sample]
SI CMGC 5/5 100-107 104±1 1041
SI Cran. A. 1/5 318 - -
SI Caud. A. 1/5 156 - -
S2 CMGC 5/5 107-128 118±4 103-1
S2 Cran. A. 1/5 230 - -
S2 Caud. A. 5/5 120-240 171±24 1012
50pl aliquots of homogenized CMGC and cranially (cran.) / caudally (caud.) adjacent artery (A.) from
terminally-ill 263K orally-challenged donors were i.e. inoculated into groups of five recipients.
Recipients similarly inoculated with CMGC from donors previously orally mock-infected with normal
brain homogenate showed no clinical signs of scrapie. Experiment was terminated at 370 dpi.
1 Values refer to the total amount of infectivity in one equivalent of excised tissue, i.e. in the entire
donor sample, and calculated by applying mean incubation time to a dose response curve.
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4. 3 Discussion
This study used immunocytochemisty, PET blotting and selective infectivity assays to
determine the temporal sequence and location of scrapie infection in the splanchnic and
vagal neural circuitry of orally challenged hamsters. While bioassays provide the gold
standard for detection of scrapie agent per se, ICC and PET blot analyses facilitate studies on
the spread of infection by using disease-associated forms of PrP (PrPd/PrPSc) as surrogate
markers for infectivity. A close correlation between infectivity and PrP50 has been previously
established in this animal model (Beekes et al., 1996, Baldauf et a/., 1997) where one
infectious unit was estimated to contain approximately of 106 molecules of PrP50 (see
Chapter 1.1).
The PrP antibodies that are currently available are unable to discriminate between host and
disease-associated forms of PrP in histologically processed tissues. As was shown in
previous chapters of this thesis and in other studies using mice (Bruce et al., 1989, 94a,
McBride et al., 1998), it is possible to distinguish PrPd from PrPc by differences in
morphological appearance and distribution. However, until now there was no formal proof
that the disease-associated PrP detected by ICC corresponded to protease-resistant PrP50.
PET blot pretreatments destroy PrPc leaving only the PK-resistant fraction (Schulz-
Schaeffer et al., 2000a). Here, the deposits visualised by ICC were consistent with the PrPsc
immunostaining in adjacent PET blots, even at early stages of incubation. This provides
strong evidence that the PrPd detected by our ICC method is PrP50.
Based on the previous study examining the pathogenesis of 263K scrapie after oral
challenge, it was proposed that the infectious agent reaches its initial CNS target sites by
spreading in a retrograde direction along autonomic PNS pathways supplying the
gastrointestinal tract, i.e. along sympathetic and parasympathetic efferents of the splanchnic
and vagus nerve. Large parts of the alimentary canal, in particular the oesophagus, stomach,
small intestine and ascending colon are innervated by these two nerves (Dockray 1999,
Furness 1999) which contain fibres of sensory and motor (efferent) neurones. Efferent fibres
of the vagus have their nerve cell bodies in the DMNV and synapse with neurones of the
ENS in ganglia of the submucosal and myenteric plexuses that are located in the wall of the
alimentary canal. The sensory fibres of the vagus nerve have their origin, i.e. their nerve cell
bodies, outside the brain in the NG and these directly innervate the alimentary canal. The
sensory fibres do not terminate in the NG but run to the SN where they synapse with
interneurones projecting to the DMNV. In this way, the sensory and motor parts of the
vagus nerve form a neuronal circuit involving the solitary tract nucleus.
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With regard to splanchnic nerve neuroanatomy, splanchnic efferents have their origin in the
IML of the spinal cord and synapse with neurones in the CMGC and these, in turn, innervate
the wall of the gastrointestinal tract. The sensory fibres originate outside the spinal cord in
the DRG, run through the CMGC and directly innervate target organs such as the alimentary
canal. Sensory splanchnic neurones can project directly or via spinal cord interneurones to
efferent splanchnic neurones in the EVIL forming a linked circuit.
With this neuroanatomy in mind, the location, timing and progressive accumulation of PrPd
revealed by this study strongly support and expand the hypothesis of spread proposed in
Chapter 2 Figure 2.9. PrPd appeared and accumulated in a predictable temporal sequence in
specific sites that accurately reflect the described autonomic and sensory relays. PrPd was
always present in the CMGC and IML before the corresponding DRG. The same holds true
with respect to the DMNV and NG.
The results also show that, at least in this animal model, the ENS may be a key portal of
entry of the infectious agent into the splanchnic and vagus nerves. PrPd was found in
submucosal and myenteric ganglia in early stages of infection. In several species including
rats, vagal, splanchnic and ENS innervation of the alimentary canal has a complex
neuroanatomy (Dockray 1999, Furness 1999). The ENS ganglia contain cell bodies of
intrinsic motor, sensory and interneurones. Vagal efferents synapse on intrinsic ENS
neurones whose cell bodies are predominantly located in myenteric ganglia. Vagal afferents
are thought to project to the myenteric plexus and to the mucosa.
From the splanchnic nerve, efferent fibres target myenteric ganglion cells and also directly
supply gastrointestinal blood vessels. Afferent splanchnic terminals are located in the
myenteric plexus, the mucosa, smooth muscle and around submucosal blood vessels.
Therefore, from the observations reported here, the most likely explanation for splanchnic or
vagal neuroinvasion is via myenteric ENS ganglia. These neuronal relays provide a common
denominator for retrograde spread of agent along splanchnic and vagal efferents as well as
for centripetal spread via the corresponding afferents. However, neuroinvasion may occur
via intestinal nerve terminals not linked to ENS ganglia or projections from other visceral
tissues.
The findings suggest that after uptake from gastrointestinal mucosa, the infectious agent
primarily spreads by two neuroanatomical pathways: 1) along the vagus nerve to the DMNV
in brain and, 2) along the splanchnic nerve to the IML of mid-thoracic spinal cord.
Intramural ganglia of the gut and the CMGC are respective intervening relay points. From
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the DMNV and IML, the infectious agent probably travels along interneurones and sensory
afferents to the SN-NG and DRG, respectively (Figure 4.10). The reproducibility and
topographical precision of PrP deposition indicates that spread is not random but occurs in a
stepwise fashion along the synaptically linked neuronal populations. The data indicates that
initial spread occurs in a retrograde direction along efferent motor pathways of both nerves.
This mode and pattern of spread has several precedents and shows striking similarities to that
of conventional neurotropic viruses, such as herpes simplex virus type 1 (Krinke & Deitrich
1990, Gesser & Koo 1996), reovirus isolate T3C9 (Morrison et al., 1991) and pseudorabies
virus (Card et al., 1990). However, dual efferent and sensory spread to the brain is also
possible as PrPd was found in the DMNV and NG but not the SN of some hamsters (see
Table 4.1). The sequential pattern of PrPd deposition and passage through functionally linked
neurones shown here is also similar to spread through gustatory pathways after injection into
the tongue (Bartz et al, 2003) or infectivity measurements of visual pathway components
shown by Scott et al 1992 after infection of the eye.
The study did not reveal any evidence for haematogenous spread of infection to the brain.
PrPd was not detected early in infection at sites with an impaired blood-brain-barrier such as
the area postrema (see Figure 4.5) or the choroid plexus. In addition, routing via the blood
would not be consistent with the observed selectivity of targeting.
One way for PrPd to spread along peripheral nerves is by the established retrograde axonal
transport mechanisms. Several studies have reported that scrapie speads within the nervous
system by means of axonal pathways (Kimberlin & Walker 1980, Fraser & Dickinson 1985)
and the suggested rate of spread (0.5-2mm/day) is consistent with that of slow axonal
transport of cytoskeletal proteins or retrograde locomotion of specific axonal proteins
(Kimberlin & Walker 1982, Brady 1991, Scott et al., 1992). It has been claimed that PrPc
can be transported in an anterograde (Borchelt et al., 1994) or retrograde (Moya et al., 2004)
direction along peripheral nerve axons and PrP50 (PrPd) in a retrograde direction (Bartz et al.,
2002). Transportation per se was not formally established in this study but the evidence
presented here would be compatible with this. While an abundance of PrPd was detected in
association with cell bodies of CNS neurones or peripheral ganglia, deposition in nerves (cell
processes) was minimal or undetected even at terminal stages of disease. The low levels of
infectivity found at end-stage disease in vagus nerve compared to that of brain or CMGC is a
further indication that in nerve fibres the agent is in transit rather than being actively
replicated. Similar findings and conclusions were reported for infectivity assays of optic
nerve (Fraser & Dickinson 1985, Scott et al., 1992.)
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Nevertheless, a domino-like mode of spread along nerves by sequential conversion of PrPc
to PrPSc (Glatzel & Aguzzi 2000) cannot be ruled out at present. PrPd has been reportedly
visualised in an extra-axonal compartment of the vagus nerve of sheep using light
microscopy (Groschup et al., 1999). There are difficulties in accurately determining the
subcellular compartmentalisation of tissue constituents by light microscopy but the precise
location of PrPd within sciatic nerve has been determined using electron microscopy. PrPc
was present, localised to the Schwann cell membrane, in transgenic mice that overexpress
PrP five to seven times that of wild-type mice (Follet et al., 2002). Infection of the Schwann
cell line MSC-80 with the Chandler strain of scrapie resulted in the production of PrP50 and
these cells were capable of transmitting disease to mice (Follet et al., 2002). In this and the
previous study PrPd deposition was associated with glia (satellite [Schwann] cells in
peripheral ganglia, astrocytes in brain and radial glia in spinal cord) which sometimes
'tracked' along networks of glial cell processes. Theoretically, scrapie agent could spread
from cell to cell along peripheral nerves but this is not compatible with the predictability of
spread or the precise targeting of PrPd to specific groups of neurones.
Infection via the oral route is strongly indicated (but not formally proven) in vCJD, BSE and
natural scrapie. Disease-specific PrP is found in the DMNV as a characteristic feature of
vCJD (Ironside 2000) and early BSE infection (Schulz-Schaeffer 2000b), natural and
experimental scrapie (Foster et al., 1996, Ryder et al., 2001, Begara-McGorum et al., 2002,
Ligios et al., 2002) and BSE of sheep (Foster et al., 2001, Ligios et al., 2002, Jeffrey et al,
2001b). In addition, the mode of spread along vagal and splanchnic pathways described here
is very similar to those reported in sheep with natural scrapie (van Keulen et al., 2000). As
the pattern of PrPd deposition in these non-experimental infections closely resembles that
observed in orally-transmitted hamster scrapie, the findings presented here provide new
indirect evidence that vCJD in man, BSE in cattle and natural scrapie in sheep were caused
by ingestion of TSE agent. These findings for experimental 263K hamster scrapie strongly
indicate that after oral challenge, infection of the CNS occurs via the splanchnic and vagus
nerves. As similar pathogenic mechanisms are likely to operate in other orally acquired
TSEs, this work provides baseline information about the peripheral routing of infection and a
rodent model in which to study it.
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Figure 4.10 Pictorial representation of the neural pathways used in the oral routing
of 263K scrapie. Initial spread (arrows) occurs in a retrograde direction along
sympathetic and parasympathetic fibres of the splanchnic and vagus nerves. Enteric
and abdominal ganglia (CMGC) have an early involvement in pathogenesis.
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Chapter 5: Disease-specific PrP in the gastrointestinal tract:
Involvement of gut-associated lymphoid tissue and the enteric
nervous system.
5.0 Introduction
The gastrointestinal tract (GI) contains a variety of components that may be involved in
uptake, transport, or replication of infectious agent (see Figure 5.7). These are found in the
enteric nervous system and gut-associated lymphoid tissue (GALT) that includes Peyer's
patches (PP), single lymphoid follicles and mesenteric lymph nodes (MLN). Overlying the
PP is the follicle-associated epithelium (FAE), a single cell layer of specialised mucosal
epithelium whose intercellular spaces are sealed by tight junctions. Embedded within and
under this layer are M (microfold) cells, intraepithelial lymphocytes and dendritic cells (DC).
DC and FAE form part of the immune defence and response mechanisms that protect the
mucosa against pathogens. DC squeeze through the tight junctions to monitor the mucosal
surface for antigens and return by the same route. M cells deliver foreign material from the
gut lumen to lymphoid cells by transepithelial transport. The lymphoid follicle is separated
from the epithelium by a dome containing B cells, T cells, antigen-presenting DC and
phagocytosing macrophages. The follicle has a B lymphocyte-rich peripheral zone and a
germinal centre. B cells support a network of follicular dendritic cells (FDC) and these, in
turn, can support scrapie replication (Brown et al. 1999). PP are interspersed between villi
whose covering epithelium is specialised for digestion and absorption of ingested materials.
Epithelial cells are in close contact with blood and lymphatic vessels contained within the
lacteal of the villus. These elements are innervated by the intrinsic interlinked ganglionated
plexuses of the ENS. Extrinsic fibres of the PNS connect the ENS with the CNS.
The data presented in the previous chapter provided evidence that after oral challenge the
263K agent spreads to the CNS from sites in the GI tract. The neural conduits linking these
tissues are likely to be the vagus and splanchnic nerve. Ganglia of the ENS were identified as
probable key portals of entry of the infectious agent into these nerves. It has long been
assumed that natural scrapie is transmitted orally (Diringer et al., 1994) and that the
infectious agent gains access to its host via the alimentary tract (Hadlow & Kennedy, 1982).
In naturally infected sheep, PrPSc is first detectable in GALT (Heggebo et al., 1999,
Andreoletti et al., 2000) but peripheral and enteric ganglia are also involved at an early stage
(van Keulen et al., 2000). The precise identity of the GI tract cells in which the infectious
agent may reside, accumulate or undergo replication is not established although FDCs of the
GALT and enteric neurones are candidates. In order to elucidate the relationship between the
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ENS and LRS in our model system, spleen, lymph nodes and GALT were included in the
study. The presence, location and cellular involvement of PrPd were investigated using ICC
examination of small intestine where components of both GALT and ENS are in close
association.
5.1 Materials and methods
Experimental design was as described in Chapter 4. Briefly, outbred Syrian hamsters were
fed individual 263K-doused food pellets and sacrificed at specific time points throughout the
incubation period; 56, 62, 69, 76, 83, 90, 97, 104, 111, 118, 126, 132 days post infection
(dpi) or at clinical end-point of disease (159±4 [S.E.] dpi). Two mock-challenged hamsters,
similarly fed with normal brain homogenate, were sacrificed at 161dpi. For this part of the
project small intestine (with associated mesenteric lymph nodes), spleen and salivary gland
(with associated lymph nodes) were investigated from 69dpi to endpoint of disease. The
intestinal specimens comprised 2cm ofjejunum and 2cm of ileum, adjacent to the duodenum
and ileocaecal sphincter, respectively. Histological procedures and ICC were carried out
according to the previously described protocols.
5.2 Results
5.2.1 PrP immunolabelling in lymphoid tissues of orally-challenged hamsters
The presence of PrPd in spleen, gut associated lymphoid tissue and salivary gland is
presented in Table 5.1. The table shows the lymphoid tissues that contained PrPd and the
ratio of hamsters in which PrPd was detected at successive time points throughout the
incubation period. The appearance of PrPd in enteric ganglia is also shown as a comparison
with the LRS.
In the GI tract PrPd was found in lymphoid tissue of all hamsters from the earliest time point
(69dpi) to end-point of disease. The majority of PrPd was found in PP but the protein was
also present in some single follicles in the gut wall. PrPd was most obvious in germinal
centres associated with cells previously identified as FDC (McBride et al., 1992, Brown et
al., 1999) and tingible body macrophages (Brown et al., Jeffrey et al., 2000). PrPd was also
found in 'dome' macrophages and in a proportion of cells in the FAE. Due to the lack of
specific antibodies these cells could not identified unambiguously but their distribution and
morphology was consistent with that of M cells (Davis & Owen 1997) but PrPd may also
have been associated with non-M cell mucosal epithelium. Labelling was also seen in DC
that reside underneath the FAE in close contact with M cells but not in the similarly located
lymphocytes (Neutra et al., 2001),[Figure 5.1]. Corresponding, though generally weaker and
less widespread staining of FDC was also found in MLN (Figure 5.2). MLN were not always
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present but when PP and associated MLN were compared, deposition was more limited in
MLN - both in amount of PrPd observed and in the numbers of follicles involved. At all time-
points some PP lymphoid follicles were unlabelled.
PrPd was not observed in any of the four spleens from hamsters culled at 69dpi. At the next
time point of 76dpi, PrPd was detected in one of the four spleens but deposition was very
scant and only present in the germinal centre of one of the many white pulp follicles. PrPd
was also detected in only one of the four spleens taken at the subsequent time points of 83
and 97dpi but in these slightly greater accumulations were observed. At 111dpi all spleens
showed some positive labelling but only one of these had substantial amounts of deposition.
At terminal stages of disease, when deposition in individual follicles was heaviest and most
widespread, many follicles remained unlabelled. PrPd was associated with FDC networks
and tingible body macrophages.
No PrPd deposition could be detected in either mucous or serous secreting portions of
salivary gland at any time point throughout the incubation period but it was detected in the
FDC network of contiguous submaxillary lymph nodes as incubation period progressed
(Figure 5.2). As with spleen, PrPd labelling was absent in lymph nodes from the early time
points and found only in a proportion of other timepoints until 126dpi. Thereafter all salivary
gland-associated lymph nodes were consistently positive but as with other lymphoid tissue a
proportion of individual follicles within the nodes were negative (Table 5.1).
At 69dpi many PPs contained substantial accumulations of PrPd as illustrated by the intense
labelling and extensive distribution. This indicated that PrPd was likely to be present even
earlier than this. By comparison, MLN had less PrPd deposition at 69dpi (Figure 5.2) and in
spleen and submaxillary lymph noses PrPd was undetected. The presence and amount of
accumulated PrPd in these lymphoid organs continued to lag behind that of the PP for a
considerable time. The order of appearance is consistent with uptake of agent first from PP,
with spread via lymph to nearby draining MLN. The short delay in reaching lymph nodes of
the salivary glands and spleen would fit with subsequent circulation through lymphatic and
blood interconnections.
In uninfected animals some PrP labelling was seen in FDC but not tingible body
macrophages of spleen, PP and mesenteric lymph nodes but the labelling was less intense
and lacked the granularity of PrPd. From its appearance the labelling was consistent with that
of PrPc. With all tissues, including those from scrapie-infected hamsters, staining was absent
when normal serum replaced the 3F4 primary antibody.
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Table 5.1 Presence of PrPd in the LRS and ENS during the incubation period of
263K-fed hamsters
Dpi 69 76 83 97 111 126 -160
Tissue End-point
No. affected/No. in group*
GALT* 4/4 2/2 4/4 3/3 1/1 2/2 3/3
SPLEEN 0/4 1/4 1/4 1/4 3/3 4/4 5/5
SALIVARY GLAND 0/4 nd 0/4 0/4 0/4 0/4 0/5
LYMPH NODE (in sal. gland) 0/4 nd 2/4 3/4 3/4 4/4 5/5
ENTERIC GANGLIA 4/4 4/4 4/4 4/4 4/4 4/4 5/5
nd - not determined, * - 4 or 5 hamsters were culled at each timepoint; GALT was only present
in the proportion of animals shown
5.2.2 PrP immunolabelling in the ENS of orally-challenged hamsters
PrPd was found from the earliest time point (69dpi) to end-point of disease in and around
neurones of the myenteric and submucosal plexuses of ileum and jejunum in all hamsters
(Table 5.1). In accordance with findings for the CNS, the amount of PrPdand the number of
ganglia affected varied between individuals but at 69dpi deposits were already more
abundant in amount than was observed in initial sites of deposition in brain or spinal cord.
This indicated that accumulation was at a more advanced stage than in CNS and that initial
deposition had occurred somewhat earlier than this time point. Labelling was more intense
and deposits more widespread in ganglia of the ileum compared to the jejunum, possibly
signifying that PrPd was taken up from the lumen either more readily or preferentially at this
part of the small intestine. According to data presented in Chapter 4, portals of entry for the
infectious agent may lie in various parts of the alimentary tract including the oesophagus,
stomach, small and large intestine. Only small sections of jejunum and ileum were included
in this study so the range of samples needs to be widened to include these and other GI
tissues.
Physical appearance of ganglia-associated PrPd was also similar to that observed in the CNS
and presented as punctate and granular deposits. Accumulations increased as the incubation
period progressed (see Table 4.1 and Figures 4.2 and 4.3 of previous Chapter) i.e. deposition
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became more abundant around individual ganglia and their associated nerve fibres. Nerve
fibres could be visualised by the punctate labelling along their length (Figure 5.3) and these
were more frequently observed with time. This delineating effect was presumably a
manifestation of PrPd accumulation at synaptic boutons - it corresponds with accounts of
nerve fibre distribution in the circular muscle of small intestine (Furness et al., 1999)
PrPd was also observed on structures indistinguishable from nerves in PP situated above the
muscularis and submucosa. These fibres appeared to extend from the heavily labelled enteric
plexus to lymphocytes of the overlying PP (Figure 5.4). If this image is an accurate in vivo
representation it demonstrates direct contact between FDC-containing lymphoid tissue and
the ENS. Both vagal and splanchnic fibres synapse on ENS neurones providing the
subsequent connections to the CNS.
5.2.3 Temporal relationship between PrPd deposition in PP and ENS
Samples of gut from early stages of incubation were examined to find evidence of a temporal
separation in the emergence of PrPd in PP and enteric ganglia. As was stated above and
shown in Table 5.1, PrPdwas observed in both PP and ENS at the earliest timepoint of 69dpi.
This finding was contrary to expectations that PrPd would not be detected at this time -
(discussed further in section 5.3). Nonetheless, as was also observed in previous Chapters,
there was variation in the extent of PrP immunolabelling between animals and also within
tissues from individuals. Therefore although PrPd was detected in both LRS and ENS
components in all animals, in individual animals the protein was occasionally found in some
tissue elements but not others. The segregation of labelling probably indicated differences in
the timing of onset of PrPd deposition in individual PP.
In animals with extensive PrP labelling throughout the GI samples, PrPd was found in all cell
types described above i.e. enteric neurones, FDCs, macrophages and cells of the FAE that
included DCs and probably M cells (Figure 5.1A&B). In these situations the degree of
deposition was such that it was not possible to determine which tissue elements had been
labelled primarily. However, in tissues with low levels of deposition, it could be seen that
some cell types were more strongly immunolabelled than others. In these cases the FAE was
not or only weakly labelled but the underlying DCs (identified by location and morphology),
FDCs and macrophages were PrPd positive (Figure 5.1C).
FAE was positively labelled on many occasions but staining was more obvious when PrPd
was present in other PP components. PrPd could only be detected by viewing under oil
immersion at the highest magnification so it is possible that PrPd was regularly undetected.
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In one PP, in which the FDC network exhibited the weakly stained, non-granular appearance
indicative of PrPc, only dome macrophages and possibly a few DCs were positive. There
was little evidence of FAE involvement although this may reflect reduced sensitivity of
detection in epithelial cytoplasm. The entire ENS was negative (Figure 5.5). This suggests
that PrPd is present in the dome of the PP prior to the germinal centre and that en route to
FDCs and enteric neurones, PrPd can become phagocytosed by macrophages. As well as DC,
macrophages are found within the intraepithelial pocket formed by M cell cytoplasm (Neutra
et al., 2001) so conceivably, this could occur by direct uptake from FAE, contact with
mobile DCs involved in PrPd transportation or by diffusion of cell-free PrPd between the
various cell populations. The involvement of dome epithelium is not clear.
It was noticeable that as overall PP labelling became heavier, i.e. deposition more abundant
in germinal centres, a greater number of PrPd-positive DCs were observed. DCs were also
distributed more widely within the PP. Initially DCs were commonly seen below the dome
FAE but were later seen near the base of the mucosal crypts (Figure 5.6). DC may play an
early and important role in transporting PrPd around the PP and possibly further afield. Then-
presence in the mucosa in close proximity to the lacteal lymphatic vessels may be a
significant indicator that migration of PrPd-tagged DC takes place in vivo.
Enteric ganglia were often positive at early stages of incubation but intensity of labelling of
these was not noticeably stronger than that of FDC networks and in some cases PrPd
deposition around ganglia was less than that observed in the lymphocyte populations
abutting the muscularis mucosa (in which the ENS is located). Many ganglia were unlabelled
but in some cases, ganglia directly below PP were more heavily labelled than those more
distal to PP (Figure 5.4A) though this was not observed invariably. PrPd deposition was
heavier and more widespread in ileal ganglia. While the relative amounts of PrPd in enteric
ganglia and overlying PP could not be correlated, PP are more frequent in ileum than other
parts of the intestine (Neutra et al., 2001) so this may indicate that PrPd presence in GALT
contributes to this result.
Taken together these results suggest that a variety of lymphoid cells are sequentially
involved in the cellular processing of PrPd and that in some cell populations this precedes
invasion of enteric neurones. However, the opportunity to assess these early events was
hindered by the small number of cases in which low-level staining was present so further
investigation is required for clarification.
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Figure 5.1 PrPd labelling in Peyer's patch of 263K-fed hamsters.
A: Low power view showing PP anatomy and the location of differing cell types
with which PrPd is associated (126dpi), B: PrPd in follicle associated epithelium
(FAE) layer (arrowheads) at 111dpi. A macrophage (arrow) and a dendritic cell (DC
- open arrow) are present beneath the FAE, C; Macrophages (arrows) and DCs (open
arrows) in dome region (83dpi), D; High power of DCs beneath the FAE layer
(83dpi), E; Germinal centre with FDC network (endpoint of disease). A few
macrophages (arrows) and DCs (open arrows) are also present. Bar, A,C = 40um, B
= 12.5um, D = 15um, E = 20um.
113 Chapter 5: PrPd in the gastrointestinal tract
Figure 5.2 PrPd in mesenteric (A-C) and submaxillary (D) lymph nodes of 263K-fed
hamsters. A; Low and B; higher power views of node at 111dpi, C; 97dpe, and D;
126dpi. Relative to incubation time, PrPd accumulation is less in both mesenteric and
submaxillary lymph node than is commonly observed in PP at 69dpi, E. Bar, A =
300pm, B= 40pm, C = 20pm, D = 80pm, E = 100pm.
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Figure 5.3 PrPd in the ENS of
263K-orally challenged hamsters
Punctate synaptic labelling of
nerves (arrowheads) at early (A)
and late (B, C) stages of disease.





















Figure 5.4 Association between PrPd-labelled nerves and the LRS. Nerve-like
structures extend between the neural and lymphocyte domains of PP from hamsters
culled at 97dpi (A, B), 126dpi (C, D) and terminal stage (E) of disease. Note: In A,
the ENS region directly below germinal centre contains the most positively labelled
ganglia. Bar, A = 40um, B, C = 20um, D, E = lOum.
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Figure 5.5 Early stages of PrPd deposition in ileum of hamster culled at 97dpi. A:
Peyer's patch with underlying ENS. Detail of dome region (B), FDCs and ENS (C).
Cellular components display differential PrP labelling. Macrophages (arrowhead)
contain PrPd while the FDC network shows labelling typical of PrPc. The FAE (open
arrows), enteric ganglia and nerves (closed arrows) are unlabelled. Bar, A = 40pm,
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Figure 5.6 Distribution of dendritic cells in Peyer's patch from 263K-fed hamster
culled at 83dpi. A, B, C: PrPd-positive DC are seen in the dome region (arrowheads)
and in the base of the PP near mucosal crypts (short arrows). Long arrows indicate
their presence in a lacteal of an adjacent villus. B: High power to show DC location
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5.3 Discussion
In addition to the PNS and ENS, there is evidence that the lymphoreticular system (LRS)
contributes to peripheral pathogenesis in several rodent TSE models (Fraser et al., 96,
Lasmezas et al., 96, Brown et al., 99, Maignien et al., 99), sheep with natural scrapie (van
Keulen et al., 96,99) and in vCJD (Hilton et al., 1998). Studies using SCID mice or high
doses of infectivity have shown that prior replication in lymphoid tissues is not necessary for
infection (Fraser et al., 96, Lasmezas et al., 96). However, involvement of the LRS appears
to be strain dependent because in BSE infected cows (Somerville et al., 1997b) and sCJD of
man (Hill et al., 99) infectivity was not recovered from lymphoid tissues. Also, in
experimental scrapie of mice (Kimberlin & Walker 86,89a and the hamster model used in
this project, the spleen does not seem to be crucial to neuroinvasion (Beekes et al., 96, Race
et al., 2000). In such instances it is commonly proposed that uptake of infection occurs
directly via peripheral nerves.
One aim of this chapter was to elucidate the relative contribution of the LRS and ENS in
establishing infection in this model. By examining samples of gut from early stages of
infection it was hoped that detection of PrPd in PP and enteric ganglia could be a temporally
separated and thus provide indirect evidence for primary involvement of the ENS.
This was only partially achieved due to PrPd being present in the relevant tissue components
at the unexpectedly early time point of 69dpi. The choice of time points was based on results
from the first study (described in Chapter 2) which showed that PrPd could not be detected
prior to 91dpi in brain or spinal cord in this model system. It was thought that 69dpi would
be early enough to obtain negative results. However, in the second study PrPd was detected
much earlier in the CNS at 62dpi. As preparation of tissues was the same in each study the
enhanced detection was probably due to better sensitivity of detection by ICC or a higher
titre inoculum.
5.3.1 How may the TSE agent access the LRS and PNS of the GI tract?
Although the data showing temporal segregation between lymphoid and neural components
of the PP is limited, the results presented here show that different cell types appear to be
sequentially involved in PrPd uptake/processing/transport after oral infection. The findings
showed that PrPdwas present in association with a number of PP components including FAE
in which M cells are located, DC, FDC, dome and tingible body macrophages, enteric
neurones and their processes but not lymphocytes. The data also appears to show that
involvement of the ENS occurs after that of the PP but this must be substantiated using a
larger number of samples. The possible routes by which the TSE agent may enter the
gastrointestinal tract following oral challenge are represented diagrammatically in Figure 5.7.
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Figure 5.7 Possible routes by which the TSE agent may access the
gastrointestinal tract
The G1 tract contains a variety of cells that may be involved in uptake, transport or
replication of infectivitv. The TSE agent may enter fromthe gut lumen via epithelial
or dendritic cells to be taken up by macrophages and/or transported in a free state
or by e.g. mobile dendritic cells to FDGs for replication and accumulation. The
agent may then spread to and accunulate in enteric ganglia before being
transferred to the CNS via vagus and splanchnic nerves. Ibe agent may also bind to
peripheral nerves either directly or with the aid of cellular intermediaries.
Regardless of whether neuroinvasion occurs after amplification of infectivity in lymphoid
tissue or directly via uptake of agent by nerve endings, the site and mode of uptake remain to
be explained. After oral challenge disease-specific PrP is found in PP and the ENS of both
natural and experimental TSE models. If it is assumed that neurones of the ENS and nerves
of PNS are responsible for neuroinvasion, i.e. binding and transportation of agent to the
CNS, the identity of the cells that interface with nerve endings remains open.
There is now clear evidence that FDCs have an important role in TSE peripheral
pathogenesis. Assisted by complement, FDCs trap antigens that are retained in immune
complexes for long periods (Van Rooijen 1980). PrPc is localised to and PrPd accumulates
on FDC processes and this co-localises with immune complexes in spleen and lymph nodes
of normal or scrapie-infected mice (McBride et al., 1992, Brown et al., 1999, Jeffrey et al.,
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2000). There is now evidence showing that complement may also play a role in fixing and
holding PrPd on mouse spleen FDCs and temporary depletion or genetic deficiency of
complement cascade components delay the onset of disease after peripheral challenge (Klein
et al., 2001, Mabbott et al., 2001). Crucially, the infectious agent replicates in FCDs in
rodent models of experimental scrapie or BSE (Brown et al., 1999, Mabbott et al., 2000a &
b, Montrasio et al., 2000) and the reported association of PrPd with FDCs in many other
TSEs including natural and experimental scrapie (Andreoletti et al., 1999,2000, van Keulen
et al 1999, Fleggebo et al., 2000,02.) CWD (Sigurdson et al., 1999, Williams et al., 2002)
vCJD (Hilton et al., 1998, Hill et al., 1999) and BSE in sheep (Foster et al., 2001, Jeffrey et
al., 2001) suggests that these cells fulfil a similar role in these diseases.
Nevertheless FDCs are non-mobile and there appears to be little evidence showing close
contact of FDC processes with peripheral nerve endings. The alimentary canal is innervated
by sympathetic, parasympathetic and sensory fibres of vagus and splanchnic nerves.
Sympathetic noradrenergic fibres of the splanchnic nerve innervate several lymphoid organs
including PP, MLN and spleen. Many studies show ramification of adrenergic fibres within
lymphocyte domains and synaptic-type contact with lymphocytes and antigen presenting
cells of the periarteriolar sheath (Felton et al., 1985,88) but such fibres do not appear to enter
the follicles to any great extent (Felton et al., 1985, Jolois et al., 1997,99) and direct contact
between FDCs and nerve endings is lacking (Heinen et al., 1995). In studies examining the
proximity of adrenergic nerves to PrPd-labelled cells in spleens from sheep affected with
natural scrapie, tyrosine hydroxylase labelling was seen around blood vessels but there was
scant association with (unspecified) immune cells (Bencsik et al., 2001). The lack of direct
contact is also supported by very recent experiments carried out at Adriano Aguzzi's
laboratory in Zurich. When germinal centres were engineered to re-position mouse FDCs in
close contact with tyrosine hydroxylase positive nerves, survival after peripheral infection
was shortened (Prinz et al., 2003). However, in addition to adrenergic nerves, there are many
other nerves using different neurotransmitters present in these organs including those of
sensory and parasympathetic origin (Fink & Weihe 1988). As well as noradrenalin which is
synthesised and stored in splanchnic nerve terminals, neuropeptide Y, somatostatin,
substance P and vasoactive intestinal peptide have also been observed in lymphoid organs
(Straub et al., 98, Madden & Felton 1995).
Despite the convincing evidence for FDC involvement, the mechanisms that permit the
infectious agent to be taken up from the gut lumen into PP germinal centres remain to be
established. Epithelial M cells, enterocytes, migratory dendritic cells and macrophages may
play a part in this.
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There is data showing that dendritic cells could provide the connection between FDCs and
nerve endings. DCs are mobile and as stated previously sample their environment for
antigens and transport them to draining lymph nodes. DCs, therefore, have the ability to
move from the gut lumen through the FAE and into the PP making contact with a number of
cells including M cells, FDCs, B cells and macrophages. DCs can acquire PrPSc in vitro and
transport it, in vivo, via lymph to mesenteric lymph nodes after intra-jejunal injection (Huang
et al., 2002). They also contain high titres of infectivity and are capable of causing scrapie in
RAG-10/0 mice after intravenous injection (Aucouturier et al., 2001). RAG-10/0 mice lack B
and T lymphocytes and FDCs and resist scrapie infection by peripheral routes (Klein et al.,
1997). The findings presented here support a role for DC in this model. PrPd-labelled DCs
were one of the first cell types to show PrPd labelling. Furthermore their distribution pattern
was observed to extend within the PP from an initial dome-based location towards the
submucosa as PrPd accumulation progressed. As DCs migrate to MLN via lymph, being sited
in close proximity to the lacteal lymphatic vessels would place them in an ideal position for
further migration to draining lymph nodes. Subsequent lymphocyte trafficking would
disseminate agent to other lymphoid populations such as spleen.
The role of M cells is to form an antigenic barrier, of which the first step is pathogen
recognition. Pathogens are processed by mucosal macrophages and DC and presented to B
and T cells to mount a secretory immune response (Davis & Owen 1997). This scenario
presents difficulties for TSEs because as no classical immune response is observed, the agent
is not recognised as an antigen per se. Nevertheless, M cells have been shown to have the
ability to transport the infectious agent across an epithelial monolayer in vitro (Heppner et
al., 2001) but to date these cells have not been specifically identified in vivo. In this study,
cells of the FAE contained PrPd at both early and later time points. Protein trafficking
through M cells can occur in either direction (Davis & Owen 1997), so it is also conceivable
that these cells are involved in transporting PrPd that has undergone germinal centre
replication back out of the PP into the lumen. In any case from the evidence presently
available it is not clear whether M cells are actively, passively or uninvolved in uptake of
PrPd from the gut lumen.
Another possible means of entry is via the epithelium that lines GI tract lumenal surfaces. As
well as M cells, PrPdhas been reported to be present in mucosal epithelium of lemurs prior to
and concurrent with clinical disease after feeding with the BSE agent (Bons et al., 1999) -
although M cells were not specifically identified in that study. As epithelial cells line the
entire length of the GI tract from oesophagus to rectum, enterocytes vastly outnumber the
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pockets of PP-restricted M cells thus providing greater accessibility to the TSE agent.
Immunocytochemical and electron microscopical studies have shown PrPc to be expressed in
epithelium of stomach, small and large intestine of human and hamster (Fournier et al.,
1998, Pammer et al., 2000, Morel et al., 2003). The rodent and human GI tract is highly
innervated (Furness et al., 1999). Nerves (including vagal afferents) course through
epithelium parallel to lymphoid vessels in lacteals of villi (Berthoud 1995). PrPc+ve nerve
fibres have also been found in apposition to lymphoid and epithelial cells in the human ileal
enteric system (Shmakov et al., 2000). The existence of these relationships raises the
possibility that agent could be taken up directly by nerve endings in ileal villi. If PrPd or the
infectious agent can bind directly to nerves this may be a mechanism by which peritoneal
nerves become infected after peripheral routes of challenge with neurotropic (highly
neuroinvasive) strains or high doses of lymphotropic TSE strains. Exploitation of
intramucosal nerve fibres is thought to be the conduit by which neurotropic virus gains
access to the enteric nervous system from the gastrointestinal lumen. Herpes Simplex Virus
Type 1-infected nerve fibres were seen projecting through the mucosal layer to interact
directly with surface epithelial cells (Gesser & Koo 1996).
In this study, the cells in which PrPd was detected earliest were macrophages located in the
dome region of PP. A similar early involvement has been observed in PP of very young
lambs from a Romanov flock with natural scrapie (Andreoletti et al., 2000). Other
researchers have also reported the participation of macrophages in TSE pathogenesis. Using
techniques that temporally deplete macrophage populations, Beringue and co-workers
showed that macrophages functioned in the clearance of PrPres (PrPd) in the early stages of
infection with C506M3 scrapie - a strain with a similar pathogenic course to ME7. Chemical
depletion of macrophages with clodronate prior to or 28 days after scrapie challenge lead to
raised levels of inoculum in spleen and accelerated PrPd deposition (Beringue et al., 2000).
These studies suggest that phagocytosis sequesters PrPd rendering it no longer available for
replication. The capacity of macrophages to reduce infectivity was first reported over twenty
years ago (Carp & Callahan, 1982) when macrophages were isolated and cultured with ME7
scrapie. More recently, PrPd has been found within the lysosomes of tingible body
macrophages in spleens of ME7 infected mice (Jeffrey et al., 2000) and in PP macrophages
of BSE-fed cattle (Terry et al., 2003). These cells probably acquire PrPd by ingestion after its
release from the surface of FDC processes (Jeffrey et al., 2000, Manuelidis et al., 2000).
Macrophages, therefore, exhibit an innate immune response to invasion.
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5.3.2 Involvement of the LRS in orally-acquired 263K scrapie
It has long been established that spleen removal around the time of i/p infection prolongs the
incubation period in several mouse models of experimental scrapie (Fraser & Dickinson
1970, Fraser et al., 1992b). In contrast, previous data show that agent replication in spleen is
not obligatory for disease progression in oral 263K hamster scrapie (Beekes et al., 1996,
Race et al., 2000). Splenectomy following intraperitoneal or intragastric challenge of
hamsters failed to lengthen the incubation period (Kimberlin & Walker 1986,89a) leading to
the suggestion that neuroinvasion can occur directly via peripheral nerves. However, as is
shown by findings presented in this thesis, with regard to oral challenge, the spleen may not
be the most relevant LRS component on which to base these conclusions. Studies where
transgenic mice expressing hamster PrP were peripherally-infected with 263K scrapie
confirmed that spleen cells were not required for either agent amplification or transport and
that peripheral nerves could support replication independently of LRS involvement (Race et
al., 2000). Infectivity (Kimberlin & Walker, 1988,89b) or PrPres (Maignien et al., 1999) is
found in Peyer's patches and MLN of mice very shortly after intragastric challenge but only
later in spleen. Evidence has been presented here showing that PrPd detection in the LRS of
scrapie-fed hamsters also follows this sequence of events. While this data supports the
evidence that the spleen does not appear to be crucially involved in pathogenesis after
peripherally administered 263K, PP and MLN appear to be involved at an early stage. In this
model, rather than providing a site for the extraneural replication necessitated by
lymphotropic strains such as ME7 or C506M3, GALT may function as a reservoir of
infectious agent which can be taken up by enteric neurones and/or peripheral nerves.
Similar mechanisms may operate with other TSE strains. In cows experimentally infected
with BSE, infectivity was not detected in spleen or lymph nodes but was detected in distal
ileum at six and ten months post infection (Wells et al., 1994, 96). GALT involvement in
pathogenesis was presumed but as the inoculum used in these studies was prepared from
intestinal wall, the ENS seems another obvious source for the detected BSE-infectivity
particularly since infectivity is not recovered from lymphoid tissues of BSE infected cows
(Somerville et al., 1997b).
Even with a relatively early involvement of GALT in 263K-scrapie pathogenesis existing
evidence is compatible with the LRS being an optional mediator rather than an obligatory
key player of neuroinvasion in this experimental model. Neuro-immune mechanisms may
also operate but because 263K scrapie is highly neuroinvasive, the infectious agent probably
invades the ENS and PNS either before or concurrent with replication in GALT. However
this view will have to be reassessed if the observed temporal lag between the involvement of
PP and ENS can be substantiated.
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Chapter 6: Discussion
The aims of this study were to discover the early sites of PrPd accumulation in the CNS and
to define the neuroanatomical pathways involved in CNS invasion in hamsters orally-
infected with 263K scrapie. The findings have established that the vagus and splanchnic
nerves are involved in the routing of 263K from the GI tract to brain and spinal cord in
hamsters. They provide good evidence that the infectious agent reached the brain and spinal
cord, independently, by autonomic fibres of these nerves. PrPd was found at early stages of
the incubation period simultaneously in vagal and splanchnic nerve cell bodies and
components of their circuitry. Such involvement implies that both sympathetic and
parasympathetic nerves are important conduits of peripheral spread.
The splanchnic nerve was originally implicated in the spread of peripherally-administered
scrapie in mice through infectivity assay data (Kimberlin & Walker 1989a&b) and this has
been supported more recently in studies showing an extended incubation period after
chemical or immunological sympathectomy of intraperitoneally infected mice (Glatzel et al.,
2001). Conversely, mice with sympathetic hyperinnervation of lymphoid organs showed
shortened scrapie survival times (Glatzel et al., 2001). The presence of abnormal PrP in
sympathetic ganglia of natural, experimental and accidentally transmitted TSEs (Andreoletti
et al., 2000, Foster et al., 2001 Groschup et al., 1999, Van Keulen et al., 2000, McBride &
Beekes 1999, Hai'k et al, 2003) suggests that the sympathetic NS may also participate in
conveying the agent to the CNS in these diseases. However, conclusions drawn from
findings in terminally-ill animals may be unreliable because centrifugal spread from CNS is
almost certain to contribute to the observed PrPd accumulation in peripheral ganglia at late
stages of disease.
The pattern of spread along vagal and splanchnic pathways described in Chapter 4 is very
similar to that reported for sheep with natural scrapie (van Keulen et al., 2000). It therefore
seems possible that as well as the splanchnic nerve, the vagus is important in peripheral
pathogenesis. Vagal involvement may be especially pertinent to oral TSE transmission since
food digestion and absorption are under vagal control.
The involvement of the vagus nerve has been reported in the pathogenesis of vCJD (Ironside
2000), early BSE infection (Schulz-Schaeffer et al., 2000b), natural and experimental scrapie
(Foster et al., 1996, Jeffrey et al., 2001b) and BSE of sheep (Foster et al., 2001, Jeffrey et
al., 2001a). In these, and the rodent model used here, DMNV-associated PrPd deposition was
a characteristic and/or early pathological feature. However, the relevance of the DMNV to
124 Chapter 6: Discussion
the subsequent dissemination of 263K throughout the brain is difficult to determine from
these studies. Although the DMNV has neural connections with other brainstem nuclei
exhibiting early PrPd accumulation, these could also be reached by projections arising from
the IML that ascend to the brain from the spinal cord (see Figure 4.11). Therefore the
observed pattern of agent spread and replication within the brain could originate via either
vagus or splanchnic nerve connections. The relative importance of either nerve to disease
progression could be investigated by employing procedures that disrupt the autonomic
connections between the GI tract and CNS. Surgical or chemical disablement of the vagus
and splanchnic nerves may result in lengthened incubation period and/or alterations to the
known pattern of PrPd targeting.
The vagal and splanchnic involvement in oral pathogenesis illustrated here parallels that
reported for sheep with natural scrapie (van Keulen et al., 2000). This shows that the
described routing is not confined to experimental scrapie of rodents and has a wider
relevance for TSE peripheral spread. Nevertheless it is by no means certain that these neural
pathways are ubiquitous to all TSE stains or the only conduits involved in peripheral spread.
It is therefore important to discover if these nerves feature in the peripheral spread of TSE in
other rodent models, especially those such as ME7 in which the LRS has a key role.
In Chapters 4 and 5, data was presented showing that PrPd is present in enteric nerves and
ganglia at an early stage in the incubation period and it is likely that in this experimental
model neuroinvasion occurs via their nerve endings. The process by which this happens is
unknown but composition and type ofnerve may be relevant.
Experiments carried out by Outram in the 1970s implied that immature nerves were
vulnerable to scrapie invasion (Outram et al., 1973, Outram unpublished). Using doses of
scrapie that were lethal to adults, he showed that while some neonatal mice either survived or
had extended incubation periods after i/p or subcutaneous challenge, a proportion developed
scrapie after incubation periods that were significantly shorter than that of adults. Similar
results were obtained more recently using ME7 infection of SCID mice in which the LRS
component is compromised (Michelle Ierna, PhD thesis). The lengthened survival times in
newborns were shown to relate to FDC maturation and absence of PrPc, i.e. LRS under¬
development. Shortened incubations could be explained by direct uptake of the infectious
agent by developing nerves. The extent of peripheral innervation is greater in the newborn
compared to those in the adult (Brown et al., 1976). PrPc levels are also high in developing
axons and during synaptogenesis (Sales et al., 2000). Either of these factors may facilitate
entry of infection or enhance the efficiency of admission. Peripheral nerves remain
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underdeveloped until two weeks after birth (Jessen & Mirsky 1999) during which time
myelinating Schwann cells are immature and not fully functional. In maturity, these cells
encircle and protect the axon from damage and infection (Mirsky & Jessen 1999) so it is
possible that access is more easily gained via the compromised myelin sheaths of developing
nerves compared to intact ones. This scenario fits well with results showing shortened
incubation periods in mice with mechanically or chemically damaged nerves (Kimberlin et
al., 1983). Nerve injury has been proposed as a factor in increased access of human
poliovirus (Morrison & Fields 1991). Experimental nerve injury causes, among other things,
demyelination and hyper-innervation (Mirsky & Jessen 1999) and as was stated above, in
experiments designed to show sympathetic nerve involvement, mice with hyperinnervated
lymphoid organs succumbed more readily to peripheral challenge with RML scrapie (Glatzel
et al., 2001).
While the data presented in this thesis suggests that the LRS does not significantly influence
peripheral pathogenesis of the rodent model used in this study, in many models agent
replication in lymphoid organs is crucial for successful neuroinvasion. Interaction between
immune and neural cells could play an important role in transfer of the infectious agent. The
mechanism by which the infectious agent passes from lymphoid tissue to nerve endings has
yet to be elucidated but may involve a chemically mediated local interaction between nerves
and immune cells. Lymphoid organs are innervated largely by branches of the splanchnic
nerve and are under sympathetic nervous system control (Felton et al., 1985, Felton & Felton
1988) but sensory afferent fibres of the vagus nerves are also present (Elfvin et al., 1992,
Berthoud & Neuhuber 2000). Cytokines such as IL-1, IL-6 and TNF-alpha released from
immune cells can modulate the CNS either directly or via receptors on sensory afferent fibres
of the vagus nerve (Stein et al., 1990, Cabot et al., 1997). Studies investigating the nature of
the chemical messengers that permit communication between the nervous system and the
immune system may provide much needed information about the mode of transmission and
avenues for therapeutic intervention.
The vagus nerve communicates with the immune system to provide an effective host defence
against pathogens (Goehler et al., 2000) and acts in a T-cell independent manner through
Toll-like receptors (TLRs) located in the cell wall of sentinel cells such as dendritic cells
(Reis e Sousa et al., 1999). As well as being present in all tissues of the body including skin
and the gastrointestinal tract, DCs are also prominently located in the abdominal vagus
(Geohler et al., 1999). DCs are capable of internalising pathogens or pathogen-associated
particles and were identified in this study associated with PrPd accumulations in Peyer's
patches and the GI lamina propria at early stages of the incubation. When activated, DCs
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release cytokines that activate afferent neurons of the sensory vagus (Banchereau &
Steinman 1988). Vagal afferents are widely distributed in visceral and the gastrointestinal
tract ensuring that pathogenic activation of the immune system is detected early.
Interestingly, activation of TLRs (by CpG oligonucleotide treatment) after i/p administration
of scrapie to mice was found to almost double the incubation period (Sethi et al., 2002)
implying that these molecules may act to bind infectious agent/PrPd on DCs and other cells
of the innate immune system on which they are expressed.
Once access has been achieved the agent travels along peripheral nerves to the brain. In this
model the routing follows synaptically linked pathways of splanchnic and vagus nerves but
the mode of spread is still a matter for debate. Axonal or non-axonal transport is feasible.
Axonal transport of infectivity (Scott et al., 1992, Kimberlin et al. 1983c, Kimberlin et al.,
1987), and both PrPc (Borchelt 1994, Rodolfo et al., 1999, Moya et al., 2004) or PrPSc (Bartz
et al., 2002,03) have been reported in CNS and peripheral nerves. In these studies the rate
and direction of spread varied. In some studies the rate was reportedly very slow (between
0.5-2mm per day) - a velocity that is compatible with slow anterograde axonal transport
(Brady 1981). The direction of trafficking was also variable. Accumulated data from the
papers cited above shows that both PrPc and infection-specific PrP can travel in an
anterograde or a retrograde direction and at least in some rodent scrapie models (Scott et al.,
1992, McBride et al., 2001, Bartz et al., 2002,03) both transport systems appear to operate
simultaneously. Inconsistencies exist between the suggested rates of agent/PrP spread and
those for axoplasmic transport of e.g. cytoskeletal proteins, lectins, viruses and tracers such
as horseradish peroxidase (Brady 1981, Weiss 1982, Goldstein & Yang 2000). In the studies
carried out by Bartz et al, 2002, PrP50 was estimated to spread in a retrograde direction at a
rate of approximately 3.3mm per day but this is still much slower that the rate of retrograde
axonal transport which varies between 70 to 430mm per day (Goldstein & Yang 2000,
Brown 2003). Discrepancies may be due, in part, to the method of assessment. The slow
rates of spread measured by infectivity assays are almost certainly inaccurate. Transportation
may occur fairly quickly but a major part of the estimated time is probably accounted for by
uptake and replication in target neurones. Another possible explanation is that the reduced
transport rates observed in TSE-infected rodents reflect infection-induced transport defects.
Similar protein transport deficits have been shown in Alzheimer's disease (Morfini et al.,
2002) linked to presenilin-1 modulation of motility (Naruse et al., 1998, Cai et al., 2002).
It has been suggested that fast axoplasmic transport is not the primary mechanism by which
the TSE agent spreads along nerves. Aguzzi and co-workers propose that 'prions' are not
transported within axons but spread along axons ad-axonally, possibly via Schwann cells
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(Follet et al., 2002), by the sequential conversion of PrPc molecules into PrPSc (Glatzel &
Aguzzi 2000). A later report from Aguzzi's laboratory appeared to support this theory.
Transgenic mice with a fast axonal transport impairment (a consequence of four-repeat
human tau over-expression) showed similar incubation times to control mice after intranerval
challenge of RML scrapie (Kunzi et al., 2002). However, doubts have been expressed as to
the validity of the conclusions drawn from this work (Moya et al., 2004) due to the lack of
evidence to show that rapid axonal transport is affected. Although this line of mice displays
axonopathy in brain and spinal cord, Moya et al., argue that deviation from normal range of
anterograde or retrograde transport velocities was not proven.
Although axonal transportation was not formally established in this study the evidence
presented here indicates convincingly that the infectious agent uses axonal pathways to
spread through the nervous system. In this respect, the current data supports the old 'slow
virus' concept of TSE infection, after which scrapie and related diseases were originally
named, i.e. unconventional slow virus encephalopathies. Axonal transport is established as
the mechanism by which neurotropic viruses such as Herpes Simplex virus, pseudorabies
and Borna disease virus spread between neuronal populations (Cook & Steven 1973,
Carbone et al., 1987, Card et al., 1990,93, Gesser & Koo 1996). Initially, Boma disease
virus travels in a retrograde direction but in late stages of infection the virus is transported
centrifugally by anterograde axonal transport and consequently many tissues become
infected (Gosztonyi and Ludwig 1995). The temporal pattern of PrPd deposition was
compatible with this scenario and bi-directional transport was also suggested to occur after
intraocular (Scott et al., 1992) or sciatic nerve (Bartz et al., 2002) infection.
As well as parallels in transportation and spread, neurotropic viruses share many other
features of TSE pathogenesis including strain selectivity, tropism, cell-specific targeting and
astrocyte involvement (Krinke & Dietrich 1990, Gesser and Koo 1996, Card & Enquist
1994, Vahine et al., 1978), making neurotropic viruses interesting models to obtain insights
into TSE pathogenesis. PrPSc is derived from a host glycoprotein and given its role in TSE
pathogenesis, it is note-worthy that specific glycoproteins also influence the pathogenesis of
neurotropic viruses. Differences in pseudorabies virus tropism (Whealy et al., 1993), reduced
virulence (Heffner et al., 1993) and neuronal access (Peeters et al., 1993) have been
produced by deletion of viral genes encoding particular envelope glycoproteins.
The neurotropic properties of viruses such herpes, polio, pseudorabies, reovirus and Boma
disease have long been used to characterise neuronal circuitry and virally-induced
pathogenesis. These viruses invade and replicate in neurones and spread through synaptically
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linked chains. The sequential pattern of PrPd deposition through functionally linked neurones
shown here is similar to spread through gustatory pathways after injection into the tongue
(Bartz et al, 2003) or infectivity measurements of visual pathway components shown by
Scott et al 1992 after infection of the eye. Taken together, the data indicates that these TSE
agents also spread in a similar stepwise manner along synaptically linked neuronal
populations. Indeed the delineation of vagal and splanchnic neural circuitry exhibited by
orally-administered 263K scrapie accurately replicates the transneuronal tracing which
would be obtained by intra-gastric administration of a pseudorabies virus (Enquist et al.,
1994, Loewy 1995). Further, the correlation between PrPd and infectivity suggests that the
progressive accumulation of PrPd in the sequentially targeted sites is a consequence of local
replication at these locations.
The selectivity of differing strains of the same virus for specific neural populations is
particularly interesting. For example, the spread of the enteric reovirus strain T3C9 from the
intestinal lumen to the CNS (Krinke & Dietrich 1990, Morrison et al, 1991, Morrison &
Fields 1991) is remarkably similar to that theoretically possible for TSE agent. Two
pathways are known to be exploited by reoviruses; 1) spread into the PP through M cells
with infection of enteric ganglia and subsequent spread to brain via the vagus nerve or; 2) via
the bloodstream (after accessing draining lymph node and thoracic duct). Both polio and
reovirus have been shown to bind selectively to M cells of Peyer's patches then to be
transcytosed into and replicate in lymphoid cells of PP and tonsils (Sicinski et al., 1990,
Wolf et al., 1981). Some virus is shed into the blood in most systemic infections with enteric
viruses and in the latter route skeletal or heart muscle is eventually infected. Low levels of
scrapie or sCJD agent have been seen in blood of rodents (Manuelidis et al., 1978, Kuroda et
al., 1983, Diringer 1984) and this could account for the low levels of infectivity seen in
various tissues after scrapie infection (Eklund et al 1967). There is no strong evidence that
viraemia contributes significantly to CNS invasion but low level viraemia could explain
reports of PrPd presence in muscle (Bosque et al., 2002, Thomzig et al., 2003). Strain
specific viral tropism is determined by factors that include genetic susceptibility to infection
and immunocompetence (Mims & White 1984, Tyler & Fields 1990).
Findings from this study indicated selectivity of the 263K agent for particular neuronal
subpopulations. For example, in peripheral ganglia, some neurones contained very heavy
accumulations of PrPd but others were completely unlabelled. Such selectivity is a
recognised feature of PrP pathology in the brain; PrPd is targeted to particular
neuroanatomical areas and accumulates in a strain specific pattern of distribution (Bruce et
al., 1989,94a, DeArmond et al., 1997, Beekes et al., 1998). Scrapie strains, therefore,
129 Chapter 6: Discussion
recognise and selectively target certain groups of neurones for replication. As has been
described above neurotropic viruses also show preferential targeting to specific neuronal
populations.
The basis of targeting is not clear and is difficult to clarify in an organ as complex as brain.
A more simplified way to investigate the types of neurones that are permissive to infection
could be to examine components of the peripheral and enteric rather than the CNS as these
are more readily manipulated experimentally. The enteric ganglia may a particularly useful
model. The organisation of enteric ganglia is very similar to that of the CNS. Glial cells and
neurones are in close relationship and a blood-ganglion-barrier exists similar to the blood-
brain-barrier. There are several types of neurones present in the ENS identifiable by their
morphological, chemical and electrophysiological properties (Fumess 2000, Furness &
Sanger 2002). The cell type to which virus initially binds may determine the ultimate course
of infection and disease (Morrison & Fields 1991). It is possible that cell specific targeting
for e.g. neurotransmitter receptors (Lipkin et al., 1988) or cell-attachment proteins (Kauffman
et al., 1983) are affected by TSE infection indicating that these are necessary for cell-cell
spread or the accessibility of particular nerve fibre pathways (Bodkin & Fields 1989). An
understanding of the pathophysiological role of neurotransmitters and their receptors could
also suggest therapeutic targets.
In this study, as with other rodent models (Bruce et al., 1989,94a, McBride et al., 1998) the
greatest abundance of PrPd was found in or around neurones but from the earliest stages of
disease, PrPd was associated with a variety of glial cells including astrocytes and microglia.
Histopathological studies have linked the distribution and range of glial activation with
scrapie strain variation. Experimentally transmitted BSE or vCJD (Brown DA et al., 2003)
and mouse-derived BSE strains 301V and 301C (P. McBride unpublished) show a similar
glial cell involvement and widespread distribution to 263K scrapie (this thesis, Ye et al.,
1998). Others, like ME7 and 87V (Bruce et al., 1994a) or 139H (Ye et al., 1998) have less
glial pathology and astrocytic and microglial activation is largely confined to areas of
vacuolar and PrPd deposition. With 22A, 22L and 79A scrapie (Fraser 1979, Deidrich et al.,
1991, Bruce et al., 1994a) microglia are upregulated and PrPd is seen within or as a 'blush'
around activated astrocytes but there is no overt association with ependymal or blood vessel
linings. The causes of differential glial cell involvement are unknown. Potentially, glial
specificity could provide clues to understanding aspects of strain targeting but at present this
is being used as a diagnostic tool to differentiate between TSE strains in ruminants (Jeffrey
et al., 2001b, Ligios et al., 2002, Gonzales et al., 2003).
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PrPd can accumulate within both astrocytes and microglia (Deidrich et al, 1991, Bruce et al,
1994, Ye et al., 1998, P. McBride unpublished). In relation to microglia, internalisation
probably occurs in response to PrPd toxicity and triggers the release of cytokines and free
radicals whose effects ultimately cause neuronal death (Ye et al., 1998, Bate et al, 2001,
Brown 2001). Cytokine expression correlates with degree of inflammation and neurological
disease (Williams et al., 1997a,b, Brown 2001, Brown et al., 2003). An astrocyte-associated
marker of oxidative stress has been shown at late stages of the TSE disease (Andreoletti et
al., 2002) but astrocytic involvement may be as a secondary response to the primary
microglial reaction (Brown et al., 1996).
As glial activation occurred after PrPd deposition this indicates that astrocytes, microglia and
satellite cells were responding to rather than initiating the related pathology. What is not
clear is whether glial activation causes or acts to limit neuronal damage. In the healthy or
injured brain, astrocytes function to protect and supply nutrients to neurones. In the
aftermath of stroke-induced CNS impairment, astrocytes and microglia release growth
factors that promote the growth of axons and dendrites of undamaged neurones in the anoxic
region (Gluckman et al., 1992). Astrocytes may also have a beneficial role in Alzheimer's
disease through their amyloid-degrading capability (Wyss-Coray et al., 2002) and in
pseudorabies infection, glial cells, whose involvement is also secondary to viral infection
(Carbone 1991), act to restrict rather than amplify the spread of the virus ( Card et al., 1994).
In addition, glutamine synthetase (GS), a marker of glial function, has been reported to be
increased in the brains of scrapie infected mice (Lazarini et al., 1994) or sheep with natural
scrapie (Lefranfois et al., 1994). Since high levels of glutamate are toxic to neurones, GS
release by astrocytes is a neuroprotective measure.
Understanding the cells that express PrPc is necessary to discovering where agent replicates
and spreads. PrPc is present on many cell types including those of the LRS, blood and GI
tract that are potentially involved in uptake, replication and dissemination of the infectious
agent. PrPc is also expressed on other cells e.g. heart, lung, salivary gland, adrenal, thymus,
pancreas, kidney, skeletal muscle, and those of reproductive system (McBride & Bruce
1993) whose association with TSE pathogenesis is not readily apparent. For TSE infection,
there is a requirement for PrPc expression in the host (Manson et al., 1994b, Beuler et al.,
1993, Brandner et al., 1996, Prusiner et al., 93). Nevertheless, competency of expression
does not necessarily indicate that a cell is receptive to infection.
Both PrPc mRNA (Bendheim et al., 1992) and protein (McBride & Bruce 1993) are widely
distributed in the body. PrPd can be found in a variety of cells during the incubation period of
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experimental mice (McBride & Bruce 1993, McBride et al., 1992), hamsters (McBride &
Beekes 1999, Beekes & McBride 2000) or sheep with natural scrapie (van Keulen et al,
1999, Heggebo et al., 2002) and BSE (Jeffrey et al., 2001a). Other than neurones, there is no
indication that these cells are fatally injured by TSE infection. PrP-expressing FDCs which
can support scrapie replication (Brown et al, 1999, Montrasio et al., 2000) are not obviously
functionally abnormal. Even at end-stage disease, FDC capacity for immune complex
trapping remains intact (McBride et al., 1992) but some structural abnormalities are apparent
at the ultrastructural level (Jeffrey et al., 2000). PrP pathology is also found in association
with astrocytes. PrPc is expressed by astrocytes and both PrPSc and PrPc have a great affinity
for glial fibrillary acidic protein (GFAP) an astrocyte-specific intermediate filament protein
(Oesch et al., 1990). PrP knockout mice expressing hamster PrP under the GFAP promoter
can accumulate infectivity and develop scrapie (Raeber et al., 1997). However, the finding
that mice devoid of GFAP develop normally and are susceptible to scrapie (Gomi et al.,
1995) conflicts with a crucial role for astrocytes in TSE pathogenesis. Certainly, at end
stages of scrapie infection in wild-type rodents, astrocytes appear healthy and have retained
the ability to respond to trauma, and it is not clear whether the PrPd deposits observed within
reactive astrocytes (Deidrich et al, 1991, Bruce et al, 1994, Ye et al., 1998, P. McBride
unpublished observation) are due to replication or phagocytosed accumulations. The
documented role for macrophage participation in TSE pathogenesis would suggest the latter
applies (Carp & Callahan, 1982, Beringue et al., 2000, Terry et al., 2003).
Collectively, these data suggest that the neurone is the ultimate target of the TSE agent - or
at least the only target that succumbs to infection. Indeed, in i/c infected transgenic mice,
neurone-specific PrP expression was sufficient to maintain scrapie infection while PrP
expression in non-neuronal cells (including glia and those of the LRS) was not (Race et al.,
1995). It is not known why neurones are susceptible to TSE infection when PrPc can be
found in many other cell types. Compared to neurones, other cells have lower or
undetectable levels of PrP mRNA (Oesch et al., 1985, Kretzschmar et al., 1986, Manson et
al., 1992) so the level of PrP production and rate of turnover may be relevant to initiating
and/or sustaining pathogenesis; but neurone susceptibility is likely to be multifactorial. The
characteristics that make (some) neurones vulnerable or resistant to TSE infection may well
be an important factor in the selectivity of targeting. Discovering the reasons for the basis of
neuronal targeting would help our understanding of these diseases and provide a means of
pursuing avenues of therapeutic intervention.
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Appendix 1: Dissection protocols
1.1 - Dissection of spinal cord and DRG removal
1. Remove skin, open torso and remove heart, lungs and abdominal viscera.
2. Remove overlying chest muscles to expose ribs.
3. Excise the entire spinal column by cutting up either side. Leave the proximal stumps of
the ribs attached to aid subsequent identification of cervical and thoracic regions.
(Thoracic cord segment one lies adjacent to first rib).
4. Using the dissecting microscope, lay spinal column dorsal side up with cervical portion
to the north. Anchor the cervical portion with tape or pins and starting from sacral end,
remove top layer of bone to expose cord.
5. Once bone has been removed cut as close as possible with bone cutters around DRGs
then pull nerves through to cord side.
6. Work systematically up the cord removing DRGs from each side before going on to the
next segment.
1.2 - Dissection of cervical vagus nerve and nodose ganglion
1. Lie hamster face downwards on a dissecting board. Snip hair from head, neck and snout.
Snip down mid back then peel back skin almost down to tail
2. Turn hamster over. Cut away exterior tissue from neck and remove arms from shoulder
by cutting through the tendons holding joints in place. There should be no necessity to
cut through bones. Snip off any protruding ribcage.
3. Remove legs to prevent the tendency of the torso to roll out of position.
4. Lie torso on its back with the head on left of the working area. Roll up a piece of tissue
and use this to prop up the animal so that the torso lies on its side with neck facing
upwards. Remove exterior fat and salivary glands and any other connective tissue to
expose muscle. All muscle groups around neck area should be intact. Remove ear socket.
The ear cavity remains exposed.
5. Gently remove the first muscle encountered - the sternocleidomastoid (most southerly of
group) by delicately paring away with scalpel (No 11). The accessory nerve can now be
seen running in an east-west direction embedded in the underlying levator scapulae
muscle. Carefully cut the distal end of this nerve and retain it by folding it back on top of
muscle. Snip off rest of same muscle below.
6. Remove next muscle, the scalenus medius - lies above the first one in an east/west
direction. Then remove the smaller digastric muscle lying under and higher up (small
muscle). Vagus is under this lying next to the large carotid artery that travels in a
160 Appendix 1
north/south direction. Remove the tiny hyoid muscle at northern end of this and take
away excess tissue down to bone.
7. Remove carotid by stripping it away from nerve. Approximately 1cm of vagus nerve can
now be removed.
To remove nodose ganglion:
8. Ganglion lies surrounded by bone at ear socket. Carefully cut away at bone at position
where the trio of nerves (vagus, accessory and laryngeal) entering nodose converge. This
takes some time and you must ensure that the nerves are held together and away from
bone cutters
9. Gently pull out the ganglion attached to a section of vagus nerve. This will emerge with
some bone attached. Leave the stumps of the other two nerves attached as to remove
them would damage the ganglion.
10. Lay the excised tissue on a glass slide. With the aid of a dissecting microscope, tease
away bone pieces.
11. Attach to a small piece of card to maintain shape and protect against damage ifhistology
is required.
1.3 - Removal of coeliac-mesenteric ganglion complex (CMGC)
1. Remove skin from abdomen. Remove entire liver carefully without destroying
surrounding structures - particularly oesophagus and aorta. Cut connections liver has
with surrounding tissue. Remove lower ribs and skin.
2. Lie torso on right side with the head pointing towards the right of the working area. Push
aside the lungs. The aorta can be observed running down inside the chest cavity. Remove
diaphragm and follow aorta down to left kidney.
3. Push the exposed intestines towards the back for easier access to region around kidneys.
Remove any superficial fat. Three vessels (4 ,5, 6 in diagram) can be seen running from
the kidneys to mesentery and aorta in a north/south direction.
4. Two blood vessels (1,2) connecting the mesentery to the aorta should now be apparent.
Free these gently from the associated connective tissue with scalpel but do not cut.
5. Take a hold of aorta (3) at right hand side and free it from surrounding tissue. Cut it at
right but keep a hold of this end. All further dissections lie to the left of this cut.
6. Still holding onto aorta, cut from underneath to release aorta from deeper mesenteric
connections and follow aorta caudally to beyond the kidney. Vessels 4, 5 & 6 are still
attached.
7. Free vessels 4, 5 & 6 from each other and surrounding connections. Cut these at southern
end (close to kidney) and then cut vessels 1 & 2 (northern end) and left side of aorta.
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8.
CMGC lies attached to and spanning this structure of supporting vessels.
Maintaining its shape, attach the entire complex (CMGC + BVs) to a small piece of card
to for protection during fixation and processing
Kidney
1: Coeliac artery








Appendix 2: Immunocytochemistry methods and reagents
2.1 Indirect, PAP and ABC methods for immunolabelling hamster PrP.
Indirect Method
1. Take sections to water i.e Remove paraffin wax by immersion in xylene, graded
alcolohols (IMS 99) and water - 5 mins.
2. Immerse in 98 % Formic Acid 10 mins.
3. Wash in water.
4. 1% H202 in methanol 10 mins
5. Wash in water then 5 mins in PBS/BSA
6. Block in normal donkey serum (1/20 dilution) - 15 mins.
7. Tap off serum and apply primary antibody i.e.lB3 rabbit anti-mouse polyclonal at 1/400
for one hour at room temp. Apply normal rabbit serum (1/1000) to adjacent sections and
known positive control.
8. Wash 3x5mins in PBS/BSA buffer (see below)
9. Incubate in peroxidase conjugated donkey anti-rabbit 1/100 for lhour.
10. Wash PBS/BSA 3x5 mins.
11. Incubate in DAB (see below) for 5-10 mins.
12. Counterstain with haematoxylin 30 sees - lmin. Blue nuclei in Scott's tap water.
13. Dehydrate in alcohol, clear in xylene and mount in DPX.
PAP Method
Follow directions of Indirect Method to 7.
8. Wash 3x5mins in PBS/BSA buffer (see below)
9. Incubate in donkey anti-rabbit 1/40 for lhour
10. Wash PBS/BSA 3x5 mins.
11. Apply rabbit PAP 1/100 for 1 hour
12. Wash PBS/BSA 3x5 mins.
13. Incubate in DAB (see below) for 5-10 mins.
14. Counterstain with haematoxylin 30 sees - lmin. Blue nuclei in Scott's tap water.
15 Dehydrate in alcohol, clear in xylene and mount in DPX.
ABC Method
Follow directions of Indirect Method to 5.
6. Block in normal rabbit serum (1/20 dilution) - 15 mins.
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7. Tap off serum and apply primary antibody i.e.3F4 mouse anti-hamster monoclonal,
1/400 for one hour at room temp. Apply normal mouse serum (1/1200) to adjacent
sections and known positive control.
8. Wash 3x5mins in PBS/BSA buffer (see below).
9. Incubate in rabbit anti-mouse biotinylated (Jacksons) 1/200 for lhour.
NB: At this point make up Avidin- Biotin-Complex (ABC) -10pl A + lOpl B to PBS/BSA
lml buffer. This must be prepared at least 30mins before use.
10. Wash PBS/BSA 3x5 mins.
11. Incubate in ABC for 30 mins.
12. 3x5min washes in PBS/BSA DAB for 5-10mins.
13. Counterstain with haematoxylin 30 sees - lmin. Blue in Scott's tap water
14. Dehydrate in alcohol, clear in xylene and mount in DPX.
2.2 Immunolabelling Reagents
PBS/BSA wash buffer
Dissolve 5g BSA (bovine serum albumin) in 250mls stock PBS (lOx PBS)




57.5g DiSodium Hydogen Orthophosphate
lOg Potassium DiHydrogen Orthophosphate
5 litres of deionised water
1% PBS/BSA -antibody diluent
lg BSA in 100ml PBS
Methanol/HjQ?
232 ml methanol + 8mls H202
DAB chomagen
lg 3,4,3,4, Tetra amino biphenyl hydrochloride
40 ml de-ionised water
Scott's Tap Water






Phosphate buffer (0.05M) pH 74.
7.10g Disodium hydrogen orthophosphate anhydrous (soln. A)
500 ml de-ionised water
7.80 Sodium dihydrogen orthophosphate dihydrate (soln. B)
500 ml de-ionised water
To make up 400mls of phosphate buffer (0.05M)
Add 324mls of soln. A to 76 mis of soln. B and adjust to pH 7.4 using soln A to increase the pH or
soln B to decrease the pH. Use this to make the Working Solution (WS) for PLP.






Add 40g of Paraformaldehyde to 500mls of deionised water, heat to 60-65°C in the fumecupboard,
add approximately 1 ml of 40% NaOH dropwise until the precipitate clears. Allow the solution to cool
before labelling the bottle with the pre-printed label and store for up to 2 months in the fridge at 2-
8°C.
• Preparation of Working Solution (WS) for PLP
Column A Column B Column C










To make the above amounts of Working Solution (column A) measure the appropriate amounts of
columns B and C, mix thoroughly and store in the fridge at 2-8°C. Label container with the pre¬
printed label and store for up to 2 weeks in the fridge at 2-8°C. Discard after two weeks if unused.
• Final Preparation of PLP fixative: This solution must be used within 10-12 hours.
(50 mis is sufficient for the fixation of 5 tissues in individual polypots.)













To the appropriate amount of working solution add the appropriate amounts of sodium m-periodate
and DL-Lysine then mix well.
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Cerebral targeting indicates vagal spread of infection in
hamsters fed with scrapie
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The pathogenesis of scrapie and other transmissible
spongiform encephalopathies (TSEs) following oral
uptake of agent is still poorly understood and can
best be studied in mice and hamsters. The experi¬
ments described here further extend the under¬
standing of the pathways along which infection
spreads from the periphery to the brain after an oral
challenge with scrapie. Using TSE-specific amyloid
protein (TSE-AP, also called PrP) as a marker for
infectivity, immunohistochemical evidence sugges¬
ted that the first target area in the brain of hamsters
orally infected with scrapie is the dorsal motor
nucleus of the vagus nerve (DMNV), rapidly followed
by the commissural solitary tract nucleus (SN). The
cervical spinal cord was affected only after TSE-AP
had been deposited in the DMNV, SN and other
medullary target areas. For the first time, these
results demonstrate conclusively that, in our animal
model, initial infection of the brain after oral in¬
gestion of scrapie agent occurs via the vagus nerve,
rather than by spread along the spinal cord.
Introduction
Following the BSE epidemic in Great Britain and the recent
emergence of a new CJD variant, transmissible spongiform
encephalopathies (TSEs) are a matter of great public concern.
The oral route of infection is the epidemiologically most
relevant pathway for natural transmission of scrapie and
related diseases within and between different species (Diringer
et al., 1994). However, little is known about the pathogenesis
of TSEs following uptake of infectious agent via the gastro¬
intestinal tract. Previous approaches addressing the dynamics
of scrapie pathogenesis by tracing the spread of agent after a
parenteral or intragastric challenge in small rodents revealed
that infection enters the CNS at the thoracic spinal cord and
then spreads rostrally to the brain (Kimberlin & Walker, 1979,
1982, 1986, 1989). However, preliminary observations by
Kimberlin & Walker (1982), Muramoto et al. (1993) and van
Keulen et al. (1995) also indicate an alternative spreading
pathway, possibly along the vagus nerve. While the existence
of an access to the brain bypassing the spinal cord was
corroborated recently (Baldauf et al., 1997), the precise
Author for correspondence: Michael Beekes.
Fax +49 30 4547 2609. e-mail BeekesM@rki.de
anatomical identity of the bypass remained the subject of
speculation. Due to the close association between infectivity
and TSE-specific amyloid protein (TSE-AP, also called PrP;
McKinley et al., 1983) established in our animal model (Beekes
et al., 1996; Baldauf et al., 1997), spread of infection in hamsters
can be investigated by tracing the deposition of TSE-AP. In the
study described here, we used immunohistochemistry to
identify the presence and anatomical location of TSE-AP as an
indicator for the spread of infection to and within the brain of
hamsters orally challenged with scrapie. This approach allowed
an exact localization of the initial cerebral target areas and
provided strong evidence for the vagus nerve as the primary
pathway to the brain in our model animals.
Methods
■ Oral infection of outbred Syrian Golden hamsters with scrapie (strain
263K) was performed as described previously (Baldauf et al., 1997). Four
animals were sacrificed at 84, 91, 98, 105, 113, 119, 126 and 133 days
post-infection (p.i.), and also at 156 days p.i. (terminal stage of disease).
Four uninfected controls were sacrificed after having reached an age of
between 180 and 210 days. Brain and vertebral column were removed.
Two of the brains from each group were dissected mid-sagitally, the two
others were dissected coronally into five segments. The spinal column
0001-5204 © 1998SGM 601
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Fig. 1. Immunohistochemical appearance of TSE-AP in the CNS. (a) Unaffected control. Cellular precursor protein
(homogeneous brown staining) within neurons. Some neurons remain unstained, (b) Early stage of infection. Punctuate
deposits of abnormal protein appear within and on cell surface of individual cells, (c) Inclusions progressively increase in
number and staining intensity, (d) As incubation period advances, heavier deposits accumulate around cells and appear
scattered in the neuropil, (e) Terminal stage of disease. TSE-AP deposition is consolidated within the neuropil. Bar, 10 pm
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(a) Medulla oblongata
Dorsal vagal motor nucleus



















91 days p.i. < > > 105 days p.i.
Temporal sequence
Fig. 2. Early target areas in the CNS found to be affected between 91 and
105 days p.i. Dots indicate the temporal sequence of TSE-AP deposition.
Spinal cord segments C1-C3 and T12-T13 showed no immunostaining
for the pathological protein until 105 days p.i. (a) 'Further areas' in the
medulla oblongata: IO and DAO, PRN, LPGN, SpVN and MVN. (6)
'Reticular formation': RaN and PoN.
was dissected transversally into segments corresponding to vertebrae
C1-C3, C4-C7, T1-T3, T4-T6, T7-T9, T10-T11 and T12-T13 and the
spinal cord was removed. Tissue samples were fixed in paraformal¬
dehyde—lysine—periodate (2 % paraformaldehyde in final concentration),
dehydrated over 6 h and embedded in paraffin wax. Serial and/or semi-
serial sections were cut at 6 pm. Immunostaining was carried out
according to the peroxidase antiperoxidase (PAP) and/or ABC method
using MAb 3F4 (Kascsak et al., 1987) to label TSE-AP and its normal
precursor and diaminobenzidine (DAB) to visualize the reaction product.
Prior to immunostaining, sections were pretreated with formic acid (98 %)
for 10 min to enhance staining. Adjacent sections were stained with
cresyl violet (0-1%) and haematoxylin and eosin to facilitate neuro-
anatomical identification.
1997), formation of TSE-AP in the CNS was first seen at 91
days p.i., but onset varied between individuals. However, the
sequence of areas targeted in the brain and spinal cord was
remarkably consistent (Figs 2 and 3 a—f, g-l).
The first area showing deposition of TSE-AP in the brain
was the dorsal motor nucleus of the vagus nerve (DMNV; Fig.
4 a), followed by the commissural solitary tract nucleus (SN)
and ependymal linings of the adjacent central canal (CC; Fig.
Ab). Positive immunostaining extended caudally to the area
postrema (AP) although the AP was itself negative. Shortly
after detection in the DMNV and SN (Fig. 4 c), TSE-AP
appeared in the superior vestibular nucleus (SVN) and in the
gigantocellular nucleus (GN) of the reticular formation.
Subsequently, TSE-AP was seen in other nuclei of the
medulla [spinal and medial vestibular nuclei (SpVN, MVN),
parvocellular reticular nucleus (PRN), inferior and dorsal
accessory olives (lO, DAO), lateral paragigantocellular nucleus
(LPGN); Fig. Act], in the pons and midbrain [red nucleus (RN),
substantia nigra, raphe and pontine nuclei of the reticular
formation (RaN, PoN)] and in the cerebellum [medial and
interposed nuclei (MCN, 1CN); Fig. Ae], The rapid spread of
infection did not allow the identification of a clear temporal
sequence in these later target areas. The trend of further spread
was in a caudal to rostral direction. At 113 days p.i., TSE-AP
could be detected for the first time in the ventromedial
thalamic nucleus (VmTN) and by 119 days p.i. it was seen in
the medial geniculate nucleus (MGN) and throughout the
thalamus (Fig. 4f) and hypothalamus. At this time TSE-AP also
appeared in the parietal, cingulate (CCo) and frontal cortex
(FCo). At 133 days p.i. deposition of TSE-AP had spread
considerably within individual areas. By 156 days p.i., when
the disease reached its clinical stage, the pathological protein
was widespread throughout all brain areas except the olfactory
lobes.
In the spinal cord, the first deposition of TSE-AP appeared
in and around the neuronal cell bodies of the grey matter
between vertebrae T4-T9. Timing of appearance coincided
with that in the brain: the first deposition was seen at 91 days
p.i. in the same cases and with corresponding relative amounts
as had been identified in the brain. Subsequent spread within
the spinal cord (Fig. 2) occurred in a rostral and caudal direction
as reported previously (Kimberlin & Walker, 1979, 1982, 1986,
1989; Beekes et al., 1996; Baldauf el al., 1997). However, TSE-
AP was found in the cervical spinal cord (Cl—C3) only after it
had been identified in a number of target areas in the medulla.
Results
TSE-AP presented as granular accumulations of immuno-
reactive material within or around neurons. These infection-
specific deposits could be clearly distinguished from the
normal precursor protein and were absent in uninfected control
animals (Fig. 1).
As in previous studies (Beekes et al., 1996; Baldauf el al.,
Discussion
These findings suggest that the onset of infection in the
medulla oblongata is not accounted for by rostral spread along
the grey matter of the spinal cord. Early infection of the
DMNV and SN via white matter tracts also appears to be
unlikely as no tracts directly link the thoracic spinal cord with
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119 days p.i.
91 days p.i.
156 days p.i. (terminal stage)
Fig. 3. For legend see facing page.
91 days p.i.
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these medullary nuclei. Thus, the initial appearance of TSE-AP
in the DMNV and SN strongly indicates that infection enters
the brain via anatomical projections outside the CNS. Spread
via parasympathetic efferent or associated afferent fibres of the
vagus nerve (cranial nerve X) best fits the observed sequence of
initial target areas in the medulla oblongata. Vagal efferents
and afferents have their respective nerve cell bodies in the
DMNV and in the nodosal ganglion (NG). However, the
afferent fibres do not terminate in the NG but run to the
solitary tract nucleus where they synapse with perikarya of
interneurons directly projecting to vagal motor neurons in the
DMNV (see Card et al., 1993; Standish et al., 1994). Efferents
and afferents of this vagal circuit innervate the heart and the
lung and visceral organs of the digestive system such as the
stomach, pancreas, small intestine and ascending colon.
Therefore, neuroanatomically, the sequence of target areas
can best be explained by a retrograde spread of infection along
parasympathetic vagal efferents to the DMNV and sub¬
sequently to the solitary tract nucleus as described for
pseudorabies virus (Card et al., 1993; Standish et al., 1994).
However, direct spread to the SN along visceral vagal afferents
from the gastro-intestinal tract or along afferents of the vagus
and other cranial nerves from the pharynx (IX, X), larynx (X)
and tongue (VII, IX, X) is also possible, but not suggested by
the observed timing of events.
Other areas showing early deposition of TSE-AP in the
brain, i.e. the SVN, GN and ependymal linings of the CC and
fourth ventricle, may well be infected via neuronal pathways
originating or terminating in the DMNV and SN. The onset of
infection observed in target areas located within the vestibular
nuclei could be explained by spread from the DMNV and SN
along fibres of the vestibulo-autonomic reflex (Balaban &
Beryozkin, 1994; Ito & Honjo, 1990). Projections from the GN
to pancreatic parasympathetic neurons originating in the
DMNV (Loewy et al., 1994) could account for spread to the
GN. Early deposition of TSE-AP in the ependyma of the CC at
the fourth ventricle could possibly also be explained by
projections to or from the DMNV (Navaratnam & Lewis;
1975) and SN. However, these areas lie anatomically adjacent
to one another (Fig. 3g) and direct cell-to-cell spread also
appears possible. In any case, subsequent spread of infection
from the early target sites in the medulla to prominent nuclei
in the pons, midbrain, cerebellum and thalamus seems to follow
well-established neuroanatomical pathways (Andrezik & Beitz,
1985; Flumerfelt & Hrycyshyn, 1985).
The findings reported here expand our understanding of
scrapie invasion of the CNS which, until recently (Baldauf et al.,
1997), focused predominantly on the spinal cord (Kimberlin &
Walker, 1979, 1982, 1986, 1989). Our results indicate an
important role of the autonomic nervous system in the spread
of infection and striking similarities between the routing
pathways of scrapie agent and pseudorabies virus (Card et al.,
1993; Standish et al., 1994). Further studies will be necessary to
investigate more thoroughly the relationship between TSEs
and neurodegenerative diseases caused by conventional
viruses.
Most recently, Blattler et al. (1997) reported that neuro-
invasion of the scrapie agent is dependent on 'PrP expression'
in a tissue compartment interposed between the lympho-
reticular system and the CNS. The findings outlined above
strongly point to the vagus nerve as an integral part of this
compartment.
We would like to extend our special thanks to Prof. Dr H. Diringer for
critical reading of the manuscript and for helpful discussion. The skilful
technical assistance of Ms M. Wilson is gratefully acknowledged. This
work was supported by grants to H. Diringer from the European Union,
the Bundesministerium fur Bildung, Wissenschaft, Forschung und
Technologie, and the Hertie-Stiftung.
Fig. 3. (a~f) Sequence of cerebral target areas observed in semi-serial mid-sagittal sections. Deposition of TSE-AP (shaded
regions) is represented in brain maps of selected individual slices covering the range between first appearance (91 days p.i.)
and terminal accumulation (156 days p.i.). A, DMNV; B, SN; C, PRN; D, GN; E, IO; F, RN; G, MCN; H, SpVN, MVN and SVN; I,
medullary and pontine reticular nuclei (10, GN, PoN); J, MCN and ICN; K, retrorubral field; L, central grey matter; M,
ventrolateral thalamic nucleus and VmTN; N, superior colliculus; and 0, CCo (layers 4 and 5). (g-/) Initial target areas at
different coronal levels. Deposition of TSE-AP (shaded regions) is represented in brain maps of selected individual slices
demonstrating the caudal to rostral spread observed between 91 and 119 days p.i. A, DMNV; B, SN; C, GN; D, SpVN; E, SVN;
F, MCN and ICN; G, MGN; H, retrorubral field; I, VmTN; and J, CCo and FCo (layers 4 and 5).
Fig. 4. Immunolabelling of TSE-AP (brown staining) in various target areas of the brain. Photographs were taken from selected
slices of brains from individual animals sacrificed at different times p.i. (a) and (b), Earliest target sites. DMNV (a) and SN
(larger arrowheads) and CC (smaller arrowhead) (b) at 91 days p.i. Bar, 20 pm. (c) Accumulation in the DMNV (larger
arrowheads) and in the SN (smaller arrowheads) later in incubation period, 126 days p.i. Bar, 200 pm. (d) Deposition in
several medullary nuclei, 119 days p.i. Bar, 400 pm. (e) Cerebellar target sites in the MCN and ICN (larger arrowheads) and
portions of the granular layer (smaller arrowheads), 119 days p.i. Bar, 200 pm. (f) Widespread brainstem deposition at
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Pathological PrP is abundant in sympathetic and sensory ganglia of
hamsters fed with scrapie
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Abstract
Although the ultimate target of infection is the CNS, there is evidence that the peripheral nervous system (PNS) is
involved in the pathogenesis of Transmissible Spongiform Encephalopathies (TSEs). We used immunocytochemistry to
identify the presence of pathological accumulations of a host protein, PrP, in the CNS and PNS (sensory and autonomic
ganglia) of hamsters orally infected with 263K scrapie. All hamsters showed pathological deposition of PrP in most brain
areas, along the length of the spinal cord, in nodose (NG) and dorsal root (DRG) ganglia and in the coeliac mesenteric
ganglion complex (CMGC). In one case, scant deposition was observed along a few axons of the vagus nerve. This
finding suggests that, after oral challenge, TSE infectious agent uses neural pathways and ganglia of the peripheral
nervous system to reach target sites in the CNS. © 1999 Elsevier Science Ireland Ltd. All rights reserved.
Keywords: Hamster scrapie; Peripheral nervous system; PrP; Neuroanatomical targeting; Routing of infection
The need to identify how oral infection of TSE leads to
CNS disease has become scientifically and politically
important following the emergence of bovine spongiform
encephalopathy (BSE), a new variant of CJD (vCJD) and
the demonstration that the two are linked [4,9], presumably
through consumption of BSE-contaminated beef.
There is evidence that the PNS is involved in the spread
of infection to the CNS in natural [7] and experimental
scrapie [3,12,15], experimental CJD [17], and BSE [18].
The presence of infectious agent in peripheral nerve ganglia
in preclinical stages of disease in cows orally-infected with
BSE [18] raised concern and contributed towards the British
government's decision to ban the sale of beef-on-the-bone
in December 1997. We now report that abnormal PrP (prion
protein), the protein marker for TSE infection, is abundant
within sensory (DRG, NG) and sympathetic (CMGC) PNS
components of hamsters orally-infected with scrapie.
Five outbred Syrian hamsters were orally-infected with
scrapie by being fed single pellets doused with 100 p.1 of a
10% 263K brain homogenate. Two hamsters were similarly
mock-challenged with normal brain homogenate. At the
terminal stage of disease at 159 ± 6 days post infection,
* Corresponding author.Tel.: +44-131-667-5204;fax: +44-131-
668-3872.
E-mail address: tricia.mcbride@bbsrc.ac.uk (P.A. McBride)
all hamsters were sacrificed and perfused with periodate
lysine paraformaldehyde (PLP) [16]. Brain, cervical and
thoracic spinal cord with attached DRG, left and right NG
with attached vagus nerve and the CMGC were removed,
left overnight in PLP then 48 h in 70% alcohol. Brains were
sliced through coronally. Spinal cords were sliced coronally
to provide individual segments with corresponding left and
right DRGs. Immunocytochemistry was performed on semi-
serial, paraffin-embedded tissues according to the ABC
method using 3F4 mouse anti-hamster PrP monoclonal anti¬
body [10] and diaminobenzidine (DAB) to visualise the
reaction product. Prior to immunostaining, sections were
pretreated with formic acid for 10 min to enhance visualisa¬
tion of PrP. Cresyl violet/luxol fast blue histochemistry was
carried out on adjacent sections to aid neuroanatomical
identification.
All scrapie-infected hamsters showed marked granular
deposition of pathological PrP in most brain areas and
along the length of the spinal cord as previously described
[3], Strong immunoreactivity was seen in several brainstem
nuclei including the dorsal motor nucleus of the vagus nerve
(DMNV) and adjacent solitary tract nucleus (SN) and
throughout the entire 'butterfly' of dorsal and ventral horn
gray matter of each cervical and thoracic spinal cord
segment (Fig. 1).
Immunolabelling of PNS components showed that in all
0304-3940/99/$ - see front matter © 1999 Elsevier Science Ireland Ltd. All rights reserved.
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Fig. 1. Immunolabelling of pathological PrP (brown granular accumulations) in CNS of a hamster terminally affected with 263K scrapie.
(A) Cerebellum and medulla. Labelling is particularly strong around DMNV and SN (arrows) Scale bar, 250 |xm. (B) cervical (C8), (C)
thoracic (T4), (D) thoracic (T9) segments of spinal cord. PrP labelling is seen primarily in 'butterfly' of dorsal and ventral horn gray
matter. Note: Pathological PrP is also seen in attached DRGs. Scale bar, 650 g,m.
NG and DRG, PrP was seen as intensely stained pathologi¬
cal granular inclusions within a substantial proportion of
ganglion cells and adjacent satellite cells (Fig. 2A,B). Gang¬
lia of the CMGC showed additional extracellular staining
(Fig. 2C).
Mostly, PrP immunolabelling was not found in either
vagus nerve or spinal nerve roots. However, in one section
from a single case, scant punctate deposition was observed
along a few axons of the vagus nerve (Fig. 3).
In brain and spinal cord from mock-challenged hamster,
PrP immunolabelling was present only in a small proportion
of neuronal cell bodies. PrP was more weakly stained and of
homogenous appearance, contrasting markedly to 'granular'
pathological forms [3]. All ganglia were unlabelled. In all
adjacent control sections where normal serum replaced 3F4,
staining was absent.
Although the ultimate target of TSE infection is the CNS,
there is evidence that the lymphoreticular [5,6,8,11,13] and
PNS [3,12,14,15] are involved in the replication and trans¬
port of infectious agent after natural or peripheral challenge.
However, the relative contributions of the two systems in
establishing disease appears to differ between various
models. Regardless of the initial pathogenic mechanisms,
neural spread of infection to the brain and spinal cord shows
a consistent pattern in several peripherally-infected rodent
models of scrapie including this model of oral challenge.
Initial targeting of infectivity [11-14] and the earliest
deposits of pathological PrP [1-3] are localised to mid-thor¬
acic spinal cord. The first target site for abnormal PrP accu¬
mulation in the brain is the DMNV followed shortly
afterwards by the SN [3]. These data indicated that, after
peripheral challenge, scrapie infection may reach the CNS
by retrograde spread along autonomic nerves supplying the
mesentery, i.e. along sympathetic and parasympathetic
efferents of the splanchnic and vagus nerves, respectively.
Subsequent spread through the CNS occurs rostrally and
caudally [2,3,11,14] and as we now show, at the terminal
stage of disease, the NG and CMGC as well as all cervical
and thoracic segments of spinal cord and corresponding
DRG contain substantial pathological PrP accumulations.
Although the presence of pathological deposits of PrP in
such peripheral ganglia at late-stage disease does not estab¬
lish the direction of spread, i.e. whether infection spreads to
the CNS from abdominal nerves or vice versa, the finding
fits perfectly into the model of spread outlined above and
shows that spread along peripheral nerves is possible and
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Fig. 3. Immunolabelling of pathological PrP (brown granular
accumulations) in PNS of a hamster terminally-affected with
263K scrapie. Pathological PrP deposits along nerve fibres in
the cervical vagus nerve. Scale bar, 10 |xm.
port along sensory (afferent) fibres of the vagus or splanch¬
nic nerves (Fig. 4).
The finding of pathological PrP in sensory and autonomic
ganglia and associated peripheral nerves further strengthens
the supposition that, after peripheral challenge, TSE infec¬
tious agent uses neuronal pathways and ganglia of the
peripheral nervous system to reach target sites in the CNS.
Such involvement raises the possibility that nerve fibres and
ganglia serve as early reservoirs for infectivity after an oral
challenge.
If this is so, findings in our hamster model will also be
relevant to peripheral pathogenesis of non-experimental
TSEs such as BSE and vCJD.
The skilful technical assistance of Marion Joncic, Stepha¬
nie Collishaw and Maura Wilson is gratefully acknowl¬
edged. The authors also wish to thank Dr. Walter Schulz-
Schaeffer (Institute for Neuropathology, University of Goet-
Fig. 2. Immunolabelling of pathological PrP (brown granular
accumulations) in PNS of a hamster terminally-affected with
263K scrapie. (A) DRG, (B) NG, (C) CMGC. PrP accumulates
within and around a large proportion of individual ganglion
and adjacent satellite cells. Scale bar, 50 urn (A), 40 p.m (B,C).
<• <* spinal cord T5 -T12
CMCG
occurs during scrapie pathogenesis. Neuroanatomically,
infection of the NG and DRG can best be explained by
spread of agent from as yet unidentified mesenteric sites
via (i) retrograde transport along vagal and splanchnic effer¬
ent fibres to neuronal cell bodies in the DMNV and inter-
mediolateral nuclei (IML), respectively, and then via SN or
dorsal root interconnections; (ii) direct anterograde trans-
sditsry tract nucleus (SN)
Fig. 4. Schematic representation of possible routes for the
spread of infection from mesentery to CNS after oral challenge
of 263K scrapie. Available data suggests spread occurs via rele¬
vant efferent or afferent nerve fibres and ganglia.
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tingen) for demonstration of hamster ganglia dissection.
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Early accumulation of pathological PrP in the enteric nervous
system and gut-associated lymphoid tissue of hamsters orally
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Abstract
Infection of the central nervous system (CNS) is a defining feature of scrapie. Several findings suggest that scrapie
agent invades the CNS via the splanchnic and vagus nerve after ingestion of infectivity. Here we address the involvement
of the enteric nervous system (ENS) and gut-associated lymphoid tissue (GALT) in this pathogenetic process. Immuno-
cytochemistry was used for the detection of pathological PrP in the duodenum and ileum of hamsters fed with 263K
scrapie and sacrificed at different stages of incubation. The experiments revealed early infection of various GALT
components and of submucosal and myenteric ENS ganglia. These results provide evidence for an important role of
the ENS in scrapie neuroinvasion and for centripetal vagal spread of infection from the gut to the brain after oral uptake
of agent. ©2000 Elsevier Science Ireland Ltd. All rights reserved.
Keywords: Hamster scrapie; Oral infection; Pathogenesis; PrP; Enteric nervous system; Gut-associated lymphoid tissue
Transmissible spongiform encephalopathies (TSEs) such
as Creutzfeldt-Jakob disease (CJD) in man, bovine spongi¬
form encephalopathy (BSE) in cattle and scrapie in sheep
are infectious and invariably fatal neurodegenerative disor¬
ders of the central nervous system (CNS). After the emer¬
gence of BSE and 'new variant' CJD (vCJD) and the
discovery that the two are linked [5,8], presumably through
consumption of BSE-contaminated foodstuffs, the patho¬
genesis of orally transmitted TSEs has become a matter of
great scientific and public interest.
Accumulating data from experimental time-course
studies on the pathogenesis of scrapie in rodents strongly
suggest that after an intragastric or oral challenge infection
spreads from sites in the gastrointestinal tract via the
splanchnic and vagus nerve to the spinal cord and brain,
respectively [1-3,10,11,15], Portals of entry for the infec¬
tious agent from the alimentary canal into these neuronal
circuits may lie in the esophagus, stomach, small intestine
and large intestine.
There is a long-standing assumption that natural scrapie
in sheep is transmitted by the oral route [6] and that the
* Corresponding author. Tel.: +49-30-4547-2396; fax: +49-30-
4547-2609.
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infectious agent invades its natural host via the alimentary
tract [7] but the precise identity of the digestive system
tissues and cells in which infectivity is either supported or
replicated remains to be established. Deposition of patholo¬
gical PrP, the protein marker for TSE infection, in myenteric
and submucosal plexuses of the gut wall, stomach and
caudal esophagus of sheep with clinical signs of natural
scrapie suggests that the enteric nervous system (ENS) is
involved [20], However, the presence of pathological PrP in
ENS ganglia at late-stage disease does not indicate from
which source these sites were infected or to which targets
they direct the infectious agent.
To address the involvement of the ENS and non-neural
gut components in early pathogenesis, we have carried out a
sequential study in hamsters orally challenged with 263K
scrapie. Immunocytochemistry was used to determine the
timing and location of the deposition of pathological PrP in
the duodenum and ileum early in the incubation period and
throughout the progression of infection.
Outbred Syrian hamsters were orally infected with 263K
scrapie as described elsewhere [15]. Three or four animals
were sacrificed at 69, 76, 83, 90, 97, 104, 111,118, 125,132
days post infection (dpi), and also at 153 dpi (terminal stage
of disease) by COi euthanasia and perfused with periodate
0304-3940/00/$ - see front matter © 2000 Elsevier Science Ireland Ltd. All rights reserved.
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lysine paraformaldehyde (PLP) [14]. Two control animals
were fed normal brain homogenate and sacrificed at 161
days after mock-infection. From the small intestine, 2 cm
of duodenum and 2 cm of ileum were removed adjacent to
the jejunum and the ileocecal sphincter, respectively. The
specimens were left overnight in PLP, 48 h in 70% ethanol,
dehydrated and embedded in paraffin wax. After pretreat-
ment with formic acid, 6 |xm semi-serial sections of gut
were immunocytochemically stained for PrP with MAb
3F4 [9] and diaminobenzidine as recently described [15].
Hematoxylin/eosin histochemistry was performed on adja¬
cent sections to facilitate identification of anatomical struc¬
tures.
Pathological PrP presented as characteristic immunoreac-
tive granular depositions within or around neurons and non-
neuronal cells. This pathological form of PrP accumulation
differs markedly from the pattern of PrP immunostaining
seen in normal brains [3,15] and was absent in mock-
infected control animals. No immunostaining was observed
in adjacent control sections where normal serum replaced
MAb 3F4.
In the duodenal and ileal muscularis and submucosa,
pathological PrP was consistently found in myenteric and
submucosal plexuses from 69 dpi (Fig. la,b), the earliest
time point investigated in this study, until the terminal
stage of disease. The amount of PrP deposition and the
number of ganglia affected varied between individuals. In
three out of four hamsters sacrificed at 69 dpi labelling was
stronger and more widespread in ganglia of the ileum than
in the duodenum, i.e. heavier granular deposition appeared
around a greater number of individual ganglion cells with
more ganglia affected. At subsequent time points, accumu¬
lations of pathological PrP became increasingly more abun¬
dant in ENS ganglia (Fig. lc,d) and their associated nerve
fibers (Fig. 2a) and along anatomical structures indistin¬
guishable from nerves in individual lymphoid follicles
(Figs. 2b and 3a) and Peyers's patches. At end-point of
disease, all ganglia were heavily labelled.
From the earliest time point available (69 dpi), immunos¬
taining for pathological PrP also occurred in gut-associated
lymphoid tissue (GALT), i.e. in mesenteric lymph nodes,
mucosal lymphoid follicles (Fig. 3a) and Peyer's patches.
Labelling was most obvious in follicular dendritic cells
(FDCs) (Fig. 3b) within germinal centers but could also
be clearly seen at 69 dpi and later in several macrophages
of the dome and in cells of the follicle-associated epithelium
(Fig. 3c). Although the latter were not specifically identi¬
fied, their location and morphology was consistent with that
of M cells.
Previous time-course studies on the pathogenesis of scra¬
pie in orally infected hamsters revealed strong evidence for
vagal spread of infection to the brain and indicated that
initial cerebral invasion probably occurs by retrograde
transport of agent along parasympathetic efferents to the
Fig. 1. Immunolabeling of pathological PrP (brown granular accumulations) in ileal ENS ganglia from hamsters sacrificed at different
time points after oral infection with 263K scrapie. (a,b) Submucosal (small arrowheads) and myenteric (large arrowheads) plexus at 69
dpi. (c,d) Submucosal (small arrowheads) and myenteric (large arrowheads) plexus at 153 dpi. Scale bar, 30 p.m (a,c); 10 p.m (b,d).
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Fig. 2. Immunolabeling of pathological PrP associated with
nerve fibres and nerve-like structures in ileum from hamsters
terminally affected with 263K scrapie, (a) 'Tracking' along
nerve fibres in ileal muscularis. (b) Nerve-like structures extend¬
ing from the submucosal/muscular layer into an overlying
lymphoid follicle. Scale bar, 10 p.m.
dorsal motor nucleus of the vagus nerve [3], Using the same
animal model we now report early infection of the ENS and
GALT after uptake of 263K scrapie via the gastrointestinal
tract.
According to the observed sequential pattern of spread,
i.e. the time of onset and the quantitative increase of patho¬
logical PrP deposition in intestinal and cerebral [3] target
areas, the involvement of myenteric and submucosal
plexuses at early stages of incubation is extremely unlikely
to result from centrifugal spread of agent. Rather, the
observed sequence of events indicates centripetal propaga¬
tion of infection from the ENS to the brain. Since pregan¬
glionic motor fibers of the vagus nerve originating in the
dorsal motor nucleus synapse with ENS postganglionic
neurons in the gut this further strengthens the evidence for
retrograde transport of scrapie agent along vagal efferents.
A striking similarity to this pattern of spread is exhibited by
reovirus serotype 3, isolate T3C9 [16] which, after oral
administration, causes lethal encephalitis in newborn
mice. Our findings strongly point to the ENS as an important
site for neuroinvasion following ingestion of infectivity.
However, the vagus nerve also sends fibers to viscera
other than the alimentary tract. If scrapie agent were disse¬
minated by blood or lymphatic drainage to such organs,
these may possibly provide additional sites for neural pene¬
tration. Further studies will be necessary to address this
question.
The same holds true with respect to whether and to what
degree neuroinvasion of the ENS depends on GALT and/or
other non-neuronal gut components. In our animal model,
deposition of pathological PrP in follicle-associated epithe-
i)
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Fig. 3. Immunolabeling of pathological PrP in ileal lymphoid
follicles from hamsters sacrificed at different time points after
oral infection with 263K scrapie, (a) Individual follicle at 125
dpi. Immunostaining in the 'dome' (small arrowheads) and in
the germinal center (large arrowheads) is associated with
macrophages and FDCs, respectively. Note heavy labelling of
nerve fibres (arrows), (b) Germinal center FDCs at 153 dpi. (c)
Macrophage (large arrowhead) of the 'dome' and cells of the
follicle-associated epithelium (probably M cells, small arrow¬
heads) at 111 dpi. Stars indicate luminal surface. Scale bar, 50
p.m (a); 10 p.m (b,c).
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Hum (probably associated with M cells), macrophages and
FDCs of intestinal lymphoid follicles and Peyer's patches
occurred at early and late stages of incubation. Previously,
pathological PrP was found in lymphoid tissues of the diges¬
tive system of sheep with natural scrapie [19] and of lemurs
experimentally or accidentally fed with BSE [4]. For the
lemurs, the authors reported that the protein could be
detected in epithelial cells, M cells, lymphocytes and
lymphoreticular tissue compartments of the gastrointestinal
tract prior to and concurrent with clinical disease.
At present, the available data suggest three options:
GALT and/or other non-neuronal gut components are: (i)
obligatory key players; (ii) optional mediators; or (iii) by¬
standers of neuronal infection after oral uptake of infectiv-
ity. Which of these possibilities apply may well depend on
the combination of host species, strain of agent, dose or
other unknown factors. Although several findings argue
against a sole by-stander role of at least the FDCs
[12,13,17,18], the mechanisms of neuroinvasion in orally
transmitted TSEs have only begun to unfold.
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Technical aspects of tracking scrapie infection in orally dosed rodents
4.V1. I. Wilson. P. A. McBride
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Abstract
The sheep and goat disease scrapie belongs to a group of diseases known collectively as Transmissible
'Spongiform Encephalopathies (TSEs). These are fatal neurodegenerative diseases, which affect many species,
'and are transmissible either naturally or experimentally to a number of others. A disease specific protein, known
as PrPSc, PrPres or Prion protein, can be used as a tool for tracking the spread of infection in these diseases. The
purpose of this study was to establish protocols, which would enable identification of precise neuroanatomy
'groups and sensitive detection of PrP in the brain and spinal cord of Syrian hamsters, orally infected with scrapie,
"issue preservation and structure were optimised by varying the length of fixation in periodate-lysine-
oaraformaldehyde and immersion in 70% alcohol. Precise histological techniques were devised for the trimming,
embedding and orientation of the tissues. Two immunocytochemistry methods were used ana compared to
detect early and terminal stage PrP accumulations in the brain and spinai cord. Histological staining methods
were also used to identify the specific cell types involved. The procedures established in this study could be used
as standards for detailed investigations of the spread of scrapie infection from the gastro-intestinal tract to the
central nervous system.
Keywords
Scrapie; PrP protein; Syrian hamsters; immunocytochemistry
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INTRODUCTION
Scrapie is a naturally occurring disease of sheep
and goats. It was first recognised over 250 years
ago and acquired us name from the unusual
behaviour exhibited by clinically affected sheep,
i.e. scraping or scratching themselves against
fence posts, etc. Scrapie was also the first recog¬
nised member of a group of fatal degenerative dis¬
eases of the central nervous system (CNS) known
as Transmissible Spongiform Encephalopathy
(TSE) diseases.
Correspondence :o: M. I. Wilson BSc Hons. Neuropathogenesis Unit.
Institute for Animal Health. Ogscon Building. West Mains Road.
Edinburgh EH9 31F. Scotland.
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To date, the precise nature of the infectious agent
tor TSE diseases remains unidentified. Pathological
examination reveals vacuolation. gliosis and neu¬
ronal loss in the brain and spinal cord. TSEs also
result in the accumulation of an abnormal form of a
host protein, PrP. sometimes also referred to as
PrP* PrPrL's or Prion protein. Investigative studies
in mice have demonstrated that abnormal PrP pro¬
tein is expressed in several forms. Widespread dif¬
fuse type or granular PrP accumulates into the CNS
of affected mice throughout the incubation of the
disease. These deposits are found within precisely
targeted brain areas such as defined neuronal
groups; within microglia and in the neuropil.
Several types of amyloid PrP plaques can also be
found in infected animals. These plaques can be
small and diffuse or larger with a fibrillar core.1
The role or function of PrP protein in normal
animals is not fully understood. However, its
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presence has been shown to be instrumental in
the development of clinical disease after infection
with scrapie, as PrP gene "knockouts' do not
develop the disease.2-3 The detection of abnormal
PrP provides a useful tool to track the spread of
scrapie disease.
The public and political awareness of TSE dis-
4 eases has been raised by recent scientific revelations
concerning Bovine Spongiform Encephalopathy
(BSE) in cattle and new variant Creutzfeldt Jakob
Disease (nvCJD) in man. Transmission studies of
nvCJD into mice results in a pattern of vacuolation
in the brain identical to that produced by BSE.4 This
' provides very strong evidence that BSE has trans¬
mitted from cattle into humans. Epidemiological
4 studies show that the most likely route of transmis¬
sion of BSE to man is the oral route, through the
consumption of infected beef products.5
The aim of this study was to establish protocols
to investigate the accumulation ofabnormal PrP in
a hamster model, which could then be used in a
subsequent study tracking the spread of scrapie
infection from the gastro-intestinal tract to the
CNS.
This has involved fixation trials and the estab¬
lishment ot specific trimming, processing and
embedding methods for several different tissues.
Two immunocvtochemistry (ICC) techniques
were compared to determine the most sensitive
method for labelling the abnormal PrP deposits.
Combinations of histological stains were used to
identify the specific cell types involved.
METHODS
Experimental Design
Syrian hamsters were orally infected by feeding
with lOmg pellets of 263K strain of scrapie brain
homogenate. The control hamsters were fed with
a lOmg pellet of normal brain homogenate.
At predetermined time points after infection,
four hamsters were perfused with periodate-lysine-
paraformaldehyde (PLP) under terminal anaesthe¬
sia. Culls were carried out at 56 days post infection
(dpi) and thereafter at weekly intervals up to termi¬
nal stage of the disease at 159 dpi (mean figure).
Tissues were dissected out in Berlin. Germany, and
transported to Edinburgh for histopathology. This
involved a necessary 3-dav delay before tissues
could be processed. Previous studies using PLP
employed only short periods of fixation (<12
hours). A trial was therefore carried out to establish
whether tissues fixed for longer times gave equally
good results. Immediately after perfusion of the
hamster, with PLP fixative, several tissues were dis¬
sected out. They were then either:
a. Fixed by immersion in PLP for a further 5
hours then transferred to 70 % alcohol for the
remainder of the 3-day period, or
b. Immersed in PLP for the entire 3-day period.
Alter this, these tissues were trimmed, immersed
in 70% alcohol: processed overnight through a
scries ofgraded alcohols, xylene and wax, and were
embedded the following morning into fresh paraf¬
fin wax. Six micron serial sections were cut from
the wax blocks, floated out on tap water and
mounted onto superfrost plus slides (General
Scientific).
A number of tissues were removed from the
hamsters for examination. The brain and spinal
cord were taken tor the purpose ot this study, as
they are the ultimate target sites for the scrapie
infection. The spleen was also taken for a future
ICC study as it has been found to be important in
some models ot scrapie for the early replication or
accumulation of the disease.'1-7
Immunocytochemistry
Two ICC techniques were used to visualise and
compare PrP between normal and infected ani¬
mals. These methods were the indirect two-step
peroxidase method and the avidin biotin complex
(ABC)-elite peroxidase (Vector laboratories)
method. Prior to both methods, the slides were
immersed in a solution ot 99% tormic acid for ten
minutes to unmask antigenic sites. Endogenous
peroxidase staining was then blocked by a 10
minute pre-treatment with a 1 per cent solution ot
hydrogen peroxide in methanol. The wash and
dilution buffer used throughout was phosphate
buffered saline with either 0.2% or 1% bovine
serum albumin added respectively. All incubations
were carried out in a humidity chamber. A normal
rabbit blocking serum (from the Scottish antibody
production unit) was used prediluted to 1/20. The
primary antibody was an appropriately diluted
mouse anti-hamster-PrP monoclonal antibody
produced bv Michael Beekes at the Robert Koch
Institute in Berlin. Germany. A normal mouse
serum was applied at an appropriate dilution to
adjacent sections as a serum control.
Diaminobenzidine (DAB) substrate was used to
18 Journal of Cellular Patholoy Vol.5 No. 1 ©GMM 2000
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visualise the peroxidase staining. The slides were
then lightly counterstained with Haematoxylin
and were coverslipped with DPX mountant.
The effects of prolonged fixation in PLP or
extended incubation in 70% alcohol post fixation
were assessed by ICC methods. Tissues, which
underwent these treatments, were compared with
control tissues, from short fixation regimes in




Brain pieces all laid out
trimmed face down into
embedding cassette
Histopathological procedures
Protocols were established for the trimming, pro¬
cessing and embedding of the brain and spinal
cord. Each brain was sliced in a caudal to rostral
direction at 2 mm intervals using a rat brain mould
(purchased from SEMAT Ltd., St. Albans) and the
slices were laid proximal surface down into a sin¬
gle processing/embedding cassette (Fig. 1). The
spinal cords were dissected out, with all dorsal root
ganglia (DRG) attached, by the dorsal and ventral
nerve roots. Firstly, using a dissecting microscope,
tiny fragments of bone were gently removed to
prevent scoring during section cutting. The nerve
roots were then separated from each other. This
involved separating meningeal membranes, which
bound roots and cord closely together. The spinal
cord was then sliced between each pair of roots
from cervical to lumbar regions to form individual
segments. Each segment of cord was marked with
indian ink on the rostral side, placed in a sequen¬
tially numbered cassette for identification and
processed according to standard laboratory proce¬
dures. The processed segments of cord for each
case were then embedded together in one wax
block, rostral surface uppermost, using a desig¬
nated standard pattern (Figs. 2a-d).
Figure i. Coronal trimming of the hamster brain.
Figure 2c. Trimmed segments of spinal cord being marked with
indian ink on the dorsal surface.
Combinations of histological stains were used
for cellular recognition. Flaematoxylin and Eosm
(H&rE) was used to assess general cellular mor¬
phology and to check the quality of fixation. Luxol
Fast Blue (LFB) was combined with Cresyl Violet
(CV) to demonstrate myelinated fibres and to
identify differing neuronal populations.
Figure 2a. Intact hamster spinal cord with dorsal rootganglia attached.
Figure 2b. Spinal cord being trimmed coronally between nerve roots.
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Figure 2d. Cervical and thoracic segments of hamster spinal cord,
in an embedding cassette.
RESULTS
The effects of prolonged exposure to PLP fixative,
or 70%, alcohol provided unexpected results. Long
fixation in PLP (approximately 3 days) was detri¬
mental to PrP demonstration by ICC. The trans¬
fer of tissues into 70% alcohol after a short fixation
in PLP (5 to 7 hours) substantially improved ICC
results. The latter protocol was therefore adopted
for use in subsequent experiments.
The routine protocols established for the brain
and spinal cord worked very well. Two-millimeter
thick coronal slices of brain gave good representa¬
tion of all major areas on one slide and allowed
comparisons between slices within a single sec¬
tion. The preparation and orientation of the spinal
cords were highly time consuming and required a
great deal of attention to detail. However, every
segment of the spinal cord, and most pairs of asso¬
ciated dorsal roots and ganglia, could be identified
from cervical through to lumbar. Surprisingly, the
spinal cord roots and the DRGs withstood all the
histological procedures that they were subjected
to, despite their microscopic size and their
fragility. The morphology and cellular detail
observed with the light microscope in both ICC
and conventional histology sections were good.
The indirect two step and ABC elite ICC meth¬
ods produced excellent labelling of both early
deposits and late stage accumulations of PrP. At
terminal stage, of the disease, abnormal PrP stain¬
ing occurred in all sections of brain and spinal
cord. All forms of PrP pathology were present and
the distribution was as described in a previous
study8 (Fig. 3). Abnormal PrP was also labelled in
the DRGs and appeared as small granular inclu¬
sions within several neurons and adjacent satellite
cells. The indirect two step peroxidase method
achieved good immunostaining results with a clear
background. However, the ABC elite method was
far more sensitive for detecting early deposits and
subtle staining. A light brown background also
occurred with the ABC method, but this was
clearly distinguishable from PrP immunostaining
and did not interfere with interpretation of the
results.
The histological staining methods employed in
this study, produced results appropriate to our
aims. H&E demonstrated good cellular morphol¬
ogy. The LFB differentiated between myelinated
fibres (stained blue) and unmyelinated fibres
(unstained), and the CV counterstained neuronal
populations violet (Fig. 4).
DISCUSSION
TSEs have been well researched over the years but
little is understood about natural transmission of
these diseases within and between species. It is
known that after peripheral infection, including oral
challenge, the brain and spinal cord are the ultimate
target sites for TSEs. However, the exact route by
which infection enters the CNS remains uncertain.
The aim of this study was to create protocols,
which can be used in combination with ICC and
conventional histological techniques, to accu¬
rately pinpoint the entry sites of scrapie disease
into the brain and spinal cord and track the spread
of the infection within these tissues: this has been
successfully achieved.
Figure 3. Strong PrP labelling throughout the grey matter of the
spinal cord and tracking alongfibres in the white matter.
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Figure 4. Dorsal root ganglion, from a hamster. LFB staining up
myelinated nerve fibres, and CI" staining up neuronal populations.
The importance of precise tissue fixation was
highlighted by the preliminary ICC trials. These
indicated that prolonged exposure of hamster tis¬
sues to PLP resulted in a detrimental effect on PrP
immunolabelling. The transfer of tissues into 70%
alcohol, after approximately 5 hours, allowed the
sensitive detection of PrP, which was crucial to
accurately pinpoint early deposits of protein.
The trimming, processing and embedding tech¬
niques developed for the brain and spinal cord
accomplished high quality sections with good
morphology and cellular detail. In the brain it was
found that embedding thin coronal slices consec¬
utively in a caudal to rostral direction allowed easy
identification and comparison of adjacent regions.
Semi-serial sectioning of the wax block also meant
that all major brain areas were represented.
This study also proved that it was practicable to
remove the spinal cord from hamsters and dissect
between each pair of cervical and lumbar roots.
Remarkably, the dorsal root ganglia remained
attached via the nerve roots to the spinal cord and
every segment of cord and associated ganglia could
be accurately identified. These sections of cord
could, with very steady hands, be embedded in
paraffin wax, using a designated standard pattern
for ease of subsequent recognition.
Histological demonstration ofmyelinated fibres
and contrasting neuronal populations, within
spinal cord sections, was achieved by LFB and CV.
These reagents provided valuable information
about the distribution of PrP in relation to the
white and grey matter areas, when applied to adja¬
cent ICC sections. H&E were chosen to show
overall morphology. This familiar stain enabled
the quality of the sections and the fixation to be
analysed. The histology stains were useful for
ascertaining the exact locations of early abnormal
PrP deposits.
ICC studies confirmed that the ABC elite
method was more sensitive than the indirect two
step method for detecting early or subtle PrP
deposits in orally infected hamster. The ABC elite
method would therefore be adopted for future
studies, using PrP as a marker for target sites and
timing of the infection.
The technical methods defined in this study
could be used to significantly improve understand¬
ing of the route taken by scrapie infection into the
CNS. However, the protocols established need not
be limited to hamster studies, nor to investigation
of the oral route of scrapie disease. This study
demonstrated that it is possible to pinpoint nerve
routes and ganglia associated with every segment of
spinal cord and to accurately label any infection
present in these tissues. The potential application
for these techniques in the field of scrapie research
and other diseases of the CNS is considerable.
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Although the ultimate target of infection is the central nervous system (CNS), there is evidence that the
enteric nervous system (ENS) and the peripheral nervous system (PNS) are involved in the pathogenesis of
orally communicated transmissible spongiform encephalopathies. In several peripherally challenged rodent
models of scrapie, spread of infectious agent to the brain and spinal cord shows a pattern consistent with
propagation along nerves supplying the viscera. We used immunocytochemistry (ICC) and paraffin-embedded
tissue (PET) blotting to identify the location and temporal sequence of pathological accumulation of a host
protein, PrP, in the CNS, PNS, and ENS of hamsters orally infected with the 263K scrapie strain. Enteric
ganglia and components of splanchnic and vagus nerve circuitry were examined along with the brain and spinal
cord. Bioassays were carried out with selected PNS constituents. Deposition of pathological PrP detected by
ICC was consistent with immunostaining of a partially protease-resistant form of PrP (PrPSc) in PET blots.
prpSc could be observed from approximately one-third of the way through the incubation period in enteric
ganglia and autonomic ganglia of splanchnic or vagus circuitry prior to sensory ganglia. PrPSc accumulated,
in a defined temporal sequence, in sites that accurately reflected known autonomic and sensory relays. Scrapie
agent infectivity was present in the PNS at low or moderate levels. The data suggest that, in this scrapie model,
the infectious agent primarily uses synaptically linked autonomic ganglia and efferent fibers of the vagus and
splanchnic nerves to invade initial target sites in the brain and spinal cord.
Although the clinical signs and pathological damage arc
indicative of central nervous system (CNS) disease, the most
likely natural portal of entry of nonexperimcntal transmissible
spongiform encephalopathy (TSE) infection is via the gastro¬
intestinal (GI) tract. Bovine spongiform encephalopathy
(BSE) and a new variant of Creutzfeldt-Jacob disease (vCJD)
are linked (13, 25) and almost certainly entered their hosts via
the food chain. However, little is known about how the patho¬
genic agent enters the GI tract and subsequently spreads to
target sites in the CNS.
Evidence from natural (23, 46, 47) and experimental (2, 4, 5,
24, 30, 39) scrapie and BSE (48) implicates the peripheral
nervous system (PNS) and the enteric nervous system (ENS) in
the spread of the infectious agent to the CNS. In several
peripherally infected rodent models of scrapie, including ham¬
ster 263K scrapie, the model of oral challenge used in this
study, neural targeting of infection shows a pattern consistent
with spread along visceral nerves.
A membrane-bound glycoprotein, PrP, is fundamental to the
development of scrapie and related diseases (7, 11, 36). PrP
mRNA and the normal cellular form of the protein (PrPc ) are
widely expressed in the CNS (33, 35) and, less abundantly, in a
number of adult and embryonic peripheral tissues (6, 15, 35,
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41). A partially protease-resistant form of PrP (PrPSc) ex¬
tracted from infected brains copurifies with infectivity (2, 3, 8,
16, 45). Disease-associated forms of PrP (variously termed
abnormal or pathological PrP or PrPSc) accumulate in the CNS
and a variety of extraneural tissues during the incubation pe¬
riods of experimental and naturally occurring TSEs (5, 12, 18,
19, 37, 38, 39). When such disease-associated forms are shown
to be associated with infectivity, as is the case in this study (2,
3), they may also be considered surrogate markers for an
infectious agent.
Regardless of the initial mechanisms of uptake from extra-
neural sites, infectivity (29, 31) and pathological PrP (2, 3, 4)
are first seen in the hindbrain and spinal cord of the CNS of
rodents peripherally infected with scrapie. After oral challenge
of hamsters with 263K scrapie, the earliest CNS target sites for
pathological PrP deposition are the dorsal motor nucleus of
the vagus nerve (DMNV) and the solitary tract nucleus (SN) of
the brain and the gray matter of thoracic vertebrae 4 to 9 of the
spinal cord (4). Subsequent spread of infection in the spinal
cord occurs in both cranial and caudal directions (2, 3, 4, 29,
32), and at the end point of disease, most brain areas and all
cervical and thoracic segments of the spinal cord and the cor¬
responding dorsal root ganglion (DRG) contain substantial
accumulations of pathological PrP (39). The presence of BSE
agent in sensory ganglia of preclinical, orally challenged cows
(48) or pathological PrP in sympathetic, sensory (39, 47) and
enteric (1, 5, 46) ganglia of scrapie-fed hamsters and sheep
with natural scrapie suggests that the PNS and the ENS harbor
the infectious agent early in the disease process.






FIG. 1. Diagrammatic representation of the neural pathways that link the GI tract with the brain and spinal cord. Circuitry has been simplified
to show major routes only. The infectious agent may reach the CNS by spreading along either efferent (motor) or afferent (sensory) fibers of vagus
or splanchnic nerves. Efferent fibers of the vagus nerve have their nerve cell bodies in the DMNV and synapse with neurons of the ENS in ganglia
of the submucosal and myenteric plexuses in the wall of the alimentary canal. The nerve cells of vagus nerve afferent fibers are located in the NG
and directly innervate the alimentary canal. These fibers run to the SN, where they synapse with intcrneurons projecting to the DMNV. The cell
bodies of splanchnic nerve efferent fibers are located in the IML and synapse with CMGC neurons that, in turn, innervate the GI tract. Afferent
fibers of the splanchnic nerve originate in the DRG, run through the CMGC, and directly innervate target organs such as the alimentary canal.
Adapted from reference 39, with permission from Elsevier Science.
It was previously proposed (4, 39) that the 263K scrapie
agent reaches its initial target sites in the CNS by spreading, in
a retrograde direction, along autonomic PNS pathways and
ganglia supplying the viscera, i.e., along sympathetic and para¬
sympathetic efferents of the splanchnic and vagus nerves (Fig.
1). To investigate this further, we carried out a time course
study using our hamster model of 263K oral challenge and
immunocytochemistry (ICC) and paraffin-embedded tissue
(PET) blotting to identify and compare PrP deposition in the
ENS, PNS, and CNS. Specific components of the vagus and
splanchnic nerve circuitry were examined in addition to the
brain and spinal cord, with which they form neuronal relay
circuits. Jejunal and ileal ENS was included, as it forms syn¬
aptic links with both nerves. Selective bioassays were also car¬
ried out to assess the levels of infectivity in two key PNS
components, the cervical vagus nerve and the celiac and mes¬
enteric ganglion complex (CMGC).
Using these approaches, it was possible to identify the tem¬
poral sequence and location of PrPSc deposition within the
CNS, PNS, and ENS and thereby to define the neuroanatomi-
cal pathways involved in early pathogenesis. The findings
strongly support and expand our hypothesis that the infectious
agent primarily uses autonomic ganglia and efferent fibers of
the vagus and splanchnic nerves to reach and invade initial
CNS target sites.
MATERIALS AND METHODS
Experimental design. Outbred Syrian hamsters were fed individual food pel¬
lets doused with 100 pi of a 10% hamster brain homogenate from 263K scrapie-
infected donors or uninfected controls as previously described (2). For PrP
studies, four or five hamsters were humanely sacrificed at specific time points
throughout the incubation period: at 56, 62, 69, 76, 83, 90, 97, 104, 111, 118, 126,
and 132 days postinfection (dpi) or at the clinical end point of disease (159 ± 4
[mean and standard error] dpi). Two mock-challenged hamsters, similarly fed
with normal brain homogenate, were sacrificed at 161 dpi. For bioassay experi¬
ments, specimens were taken from five terminally ill and two mock-challenged
hamsters.
Histological procedures. Hamsters were transcardially perfused with perio-
date-lysine-paraformaldehyde (PLP) (39). The brain and CMGC were removed
from all hamsters. Spinal cord with attached DRG, jejunum, ileum (adjacent to
the ileocecal sphincter), and left and right nodose ganglion (NG) with attached
cervical vagus nerve were included from 69 dpi to the end point of disease. After
perfusion, tissues were immersed for 5 h in PLP, transferred to and kept in 70%
alcohol for a further 48 h, processed for 6 h in an enclosed tissue processor, and
embedded in paraffin wax. Prior to processing and embedding, brains were
trimmed coronally into 2-mm-thick slices using a brain slicing mold (SEMAT, St.
Albans, United Kingdom). Spinal cords were sliced coronally between nerve
roots to provide individual cervical, thoracic, and sometimes lumbar segments
with corresponding left and right DRG. Pieces were marked on their cranial
surface with India ink, numbered, and processed separately but embedded, in
sequence, in one block (49). Sections (6 pm) of brain and spinal cord with
attached DRG were taken at 100-pm intervals for PrP ICC, PET blot analysis,
and cresyl violet-Luxol fast blue histochemistry. For other tissues these proce¬
dures were carried out either with serial sections or with sections taken at 50-|xm
intervals.
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FIG. 2. PrPSc in the ENS and splanchnic nerve circuitry of the same hamster 90 days after oral challenge with 263K scrapie. (A) Myenteric
ganglion. (B) CMGC. (C) Spinal cord segment T5 (arrow indicates IML). (D) DRG from segment T5. PrPSc deposition is already extensive in the
ENS and CMGC but minimal in DRG. Scale bars: A and D, 20 |xm; B, 50 |xm; C, 100 pm.
ICC. Immunostaining was carried out according to the ABC method using
mouse anti-hamster PrP monoclonal antibody 3F4 (27) or normal serum and
diaminobenzidine to visualize the reaction product. Sections were pretreated
with formic acid for 10 min to enhance PrP visualization. Similarly treated
sections from mock-challenged hamsters served as control tissue.
PET blotting. Sections were mounted on nitrocellulose membranes (0.45 pm
pore size; Bio-Rad Laboratories, Hemel Hempstead, Herts, United Kingdom),
dried flat at room temperature (approximately 2 h), and incubated overnight at
37°C. PET blotting was carried out as described by Schulz-Schaeffer et al. (42).
After being washed in Tris-buffered saline (TBS; 10 mM Tris-HCI, 100 mM NaCl
[pH 7.8]) with 0.05% Tween 20, sections were digested with 250 pg of proteinase
KJm\ in a buffer containing 10 mM Tris-HCI (pH 7.8), 100 mM NaCl, and 0.1%
(wt/vol) Brij 35 for 8 h at 55°C. Sections were then denatured with guanidine
isothiocyanate. Immunostaining was carried out with mouse anti-hamster PrP
antibody 3F4 and nitroblue tetrazolium (NBT)-5-bromo-4-chloro-3-indolylphos-
phate (BCIP) to visualize the reaction product. PET blots were assessed using a
dissecting microscope.
Infectivity bioassays. Vagus nerve and CMGC samples were removed from
two terminally ill animals (SI and S2) and two mock-infected controls (N1 and
N2). From another three terminally ill hamsters (S3 to S5) only vagus nerve
samples were taken. Left and right portions (approximately 1 cm) of cervical
vagus nerves were removed remote from the NG and carefully separated from
surrounding tissue. The CMGC was removed attached to the abdominal aorta
between the celiac, superior mesenteric, left renal, and right renal arteries. Two
0.5-cm pieces from the abdominal artery cranially and caudally adjacent to the
CMGC were also taken. Samples were washed three times in TBS (10 mM
Tris-HCI, 133 mM NaCl, pH 7.4), incubated at 37°C for 1.5 h in 200 pi of TBS
containing 0.25% (wt/vol) collagenase (Boehringer Mannheim) and 0.025% (wt/
vol) CaCl2, and heated to 80°C for 10 min. The volume was adjusted to 500 pi
with TBS. Aliquots (50 pi) were inoculated intracerebral^ (i.e.) into groups of
five recipient hamsters. Infectivity titers were estimated from the incubation
periods using dose-response curves as previously described (3). The experiment
was terminated at 370 dpi.
RESULTS
Early temporal and spatial deposition of PrPSc in enteric,
splanchnic, and vagus nerve relays. Although the amounts of
PrPSc varied between individuals culled at a given time point,
the site and sequence of deposition were consistent. PrPSc was
found earlier and with more frequency in autonomic (i.e.,
efferent) components of the circuitry than in sensory compo¬
nents. In the splanchnic nerve circuitry, PrPSc was seen in the
CMGC and intermediolateral cell column (IML) of the spinal
cord before DRG; in the vagus nerve circuitry, it was seen in
the DMNV before NG. The ENS contains autonomic and
sensory NS networks. Table 1 summarizes the temporal and
spatial deposition of PrPSc in enteric, splanchnic, and vagus
nerve relays.
(i) ENS. PrPSc was found from the earliest available time
point (69 dpi) to the end point of disease in and around
neurons of the myenteric and submucosal plexuses of the ileum
and jejunum of all four hamsters (Fig. 2A). As the incubation
period progressed, accumulations increased in individual gan¬
glia, and the number of affected ganglia increased.
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(ii) Splanchnic nerve circuitry (CMGC-IML-l)RG). PrPSc
was observed in the CMGC of all four hamsters at the first time
point of 56 dpi (Table 1). Initial deposits were few, but PrPSc
accumulated rapidly. By 76 dpi, deposition was substantial, and
by 90 dpi, strongly labeled PrPSc was apparent throughout
most of the complex (Fig. 2B). In the spinal cord, PrPSc was
invariably seen in the IMF at 69 dpi, the earliest time point at
which the cord was available. Deposition was present in tho¬
racic cord segments 3 to 8, with the largest amounts in the IML
of segments 5, 6, and 7 (Fig. 2C). PrPSc was not detected in
DRG until 76 dpi (two out of four hamsters). At later time
points, deposition remained scant and the amount was always
less than that in the corresponding I ML (Fig. 2D). In all in-
B _4P stances, PrPSL' was found in DRG only after accumulations
were fairly widespread within the corresponding cord seg¬
ments.
(iii) Vagus nerve circuitry (DMNV-SN-NG). In the brain,
the first PrPSo deposits were seen in and around neurons of the
§j\f DMNV at 62 dpi (two out of four brains) and the commissural
V -. \ c . - portion of the SN (one out of four brains). Deposition was
•/'ii-'iiv minimal in both areas but was greater in the DMNV. At later
v time points, accumulations were typically greater in the
A A A DMNV than in the SN (Fig. 3A to C). PrPSc was either present
at low levels or undetected in NG until 90 dpi (Fig. 3D), and
even at this time the numbers of positively labeled cells were,
at best, only moderate. As with DRG (and in contrast to the
CMGC), accumulation was slow, and at the end point of dis¬
ease, several neurons remained unlabeled (Fig. 3E).
Subsequent pattern of PrPSt' accumulation in the PNS and
the CNS. Subsequent to the IML, PiPSl' was observed in the
intermediate zone at 69 dpi and then extending from the IML
into the adjacent white matter at 76 dpi. Accumulations be¬
came progressively greater in the initial sites and generally
more widespread within ventral and dorsal gray matter. Con¬
currently, PrPSc appeared in the IML of thoracic segments
located cranial and caudal to those first affected. This pattern
of spread continued with increasing incubation, and at late
^ ' stages of disease, all infected hamsters showed marked gran¬
ge ular deposition of PrPSc throughout the brain and entire gray
matter "butterfly" of each cervical, thoracic and, where
present, lumbar spinal cord segment.
Once accumulation was established in the DMNV and com-
. * missural portion of the SN, PrPSc was observed in medial and
intermediate regions of the SN and then in other specific brain
. * stem nuclei, notably the medullary reticular formation (76 dpi)
and vestibular complex, pons, and red nucleus (83 dpi). Label¬
ing was then rapidly disseminated to several other sites
throughout the brain.
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aggregations of protease-resistant PrP (PrPSc) were seen at the
same sites in all tissues and at all time points that immuno-
staining was detected in adjacent ICC sections. However, in
PET blots, deposits were stained more intensely by the blue-
black chromogen and were more easily detected at low power
than corresponding ICC-labeled deposits (Fig. 4).
Scrapie infectivity in the vagus and splanchnic nerve cir¬
cuitry. Two PNS components, the cervical vagus nerve and the
CMGC, were analyzed by bioassays for the presence of infec¬
tivity. Samples of the vagus nerve were excised from a position
remote from NG to avoid the inclusion of ganglion cell bodies.
The results for the vagus nerve samples are summarized in
Table 2. Mortality and incubation time for the recipients in the
bioassays demonstrated a low but consistent presence of infec¬
tivity in the cervical vagus nerve trunks The estimated amount
of infectivity was approximately 102 50% i.e. infective doses
(ID50i c ), corresponding to about 105 ID50ic per g of tissue.
Infectivity levels in the two CMGC samples (Table 3) were
higher (approximately 103 and 104 lD50i.c.)' even though the
CMGC represented only a minor constituent of the homoge¬
nized tissue samples. Artery samples were located cranially or
caudally adjacent to the CMGC. The trace levels of infectivity
detected for these control specimens probably originated from
residual CMGC nervous tissue.
DISCUSSION
FIG. 4. Early PrPSc deposition (blue-black) in the IML and DMNV
of hamsters orally challenged with 263K scrapie, as demonstrated by
PET blotting. (A) IML at 90 dpi. (B) DMNV (arrowheads) at 76 dpi.
Specimens represent sections adjacent or nearly adjacent to those in
Fig. 2C (A) and 3A (B). Scale bars: A, 200 gm; B, 1 mm.
precision of targeting were consistent. The final PrPSc distri¬
bution pattern was reproduced in all brains, spinal cords, and
ganglia and was identical to that described previously for ham¬
sters orally infected with 263K (4, 39). PrPSc was not found in
vagus, splanchnic, or spinal nerve roots, apart from a tiny
amount in the vagus nerve of one terminally ill hamster. In
mock-infected control hamsters, PrPc, which differs in appear¬
ance from the characteristic granular forms of PrPSc (4, 5, 38,
39), was seen only in some neuronal cell bodies of the brain
and the spinal cord. Staining was absent from tissues when
normal serum replaced PrP antibody.
Although cellular detail cannot be resolved with PET blots,
We used ICC, PET blotting, and selective infectivity assays
in a time course study to determine the temporal sequence and
location of scrapie infection in the ENS, splanchnic and vagal
PNS, and CNS of hamsters after oral challenge with scrapie
strain 263K. While bioassays provide the gold standard for
detection of the scrapie agent per se, ICC and PET blot anal¬
yses facilitate studies on the spread of infection by using dis¬
ease-associated forms of PrP (pathological PrP or PrPSc) as
surrogate markers for infectivity. A close correlation between
infectivity and PrPSc has been previously established in our
animal model (2, 3).
Available antibodies are unable to discriminate between
host- and disease-associated forms of PrP in histologically pro¬
cessed tissues. We can distinguish pathological PrP from PrPc
by differences in morphological appearance and distribution
(4, 38, 39), but until now there was no formal proof that the
disease-associated PrP detected by ICC corresponded to PrPSc.
PET blot pretreatments destroy PrPc, leaving only the protein¬
ase K-resistant fraction (42). Here, the deposits visualized by
TABLE 1. Presence of PrPSc in enteric, splanchnic, and vagus nerve relays after ingestion of 263K scrapie
No. of hamsters affected/no. challenged
dpi" Enteric ganglia CMGC Mid-T IML'' Mid-T DRG" DMNV SN Right NG Left NG
56 ND 4/4 ND ND 0/4 0/4 ND ND
62or63 ND 4/4 ND ND 2/4 1/4 ND ND
69 4/4 4/4 4/4 0/4 4/4 2/4 1/4 0/4
76 4/4 4/4 4/4 2/4 4/4 1/4 3/4 1/2"
83 4/4 4/4 4/4 3/4 3/3" 3/3" 3/4 2/4
90 4/4 4/4 4/4 3/4 4/4 3/4 3/4 4/4
" Early time points are shown (the incubation period was — 160 dpi).
b Mid-T IML and mid-T DRG, = IML from thoracic cord segments 3 to 8 with corresponding DRG; ND, not done.
c There were four animals in the group, but the region was present only in the specified number of animals.
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TABLE 2. Detection of infectivity in cervical trunks of the vagus
nerve by bioassays"
Donor Vagus nerve
Incubation time (days) Estimated titer









































" Aliquots (50 |jl1) of homogenized left and right vagus nerves from terminally
ill hamsters orally challenged with 263K were inoculated i.e. into groups of five
recipients. Mortality was 100%. Recipients similarly inoculated with vagus nerves
from donors previously orally mock infected with normal brain homogenate
showed no clinical signs of scrapie. The experiment was terminated at 370 dpi.
h Total amount of infectivity in one equivalent of excised tissue, i.e., the entire
donor sample, calculated by applying mean incubation time to a dose-response
curve.
ICC were consistent with the PrPSc immunostaining in adja¬
cent PET blots, even at early stages of incubation. These re¬
sults provide strong evidence that pathological PrP detected by
our ICC method is PrP'Sc.
Based on a series of studies examining the pathogenesis of
263K scrapie after oral challenge in hamsters, we proposed
that the infectious agent reaches its initial CNS target sites by
spreading in a retrograde direction along autonomic PNS path¬
ways and ganglia supplying the viscera, i.e., along sympathetic
and parasympathetic effercnts of the splanchnic and vagus
nerves (4, 39). Large parts of the alimentary canal, in particu¬
lar, the esophagus, stomach, small intestine, and ascending
colon, are innervated by these two nerves (17, 21), which con¬
tain fibers of autonomic (efferent) and sensory (afferent) neu¬
rons. With the neuroanatomy of the splanchnic and vagus
nerve circuitry in mind (Fig. 1), the location, timing, and pro¬
gression of PrPSc deposition revealed by this study strongly
support and expand our hypothesis. PrPSc appeared and accu¬
mulated in a predictable temporal sequence in specific sites
that accurately reflect the described autonomic and sensory
relays. Deposition was always present in the CMGC and IML
before the corresponding DRG. The same holds true with
respect to the DMNV and NG. The results also show that, at
least in this animal model, the ENS may be a key portal of
entry for the infectious agent into the splanchnic and vagus
nerve circuitry. As efferent and afferent fibers of both vagus
and splanchnic nerves contact myenteric ganglia (17, 21), these
would be the most likely sites for ENS-mediated neuroinva-
sion. However, infection may occur via intestinal nerve termi¬
nals not linked to ENS ganglia or other visceral tissues.
Our findings suggest that after uptake from the GI tract, the
infectious agent primarily spreads by two neuroanatomical
pathways: (i) along the vagus nerve to the DMNV in the brain
and (ii) along the splanchnic nerve to the IML of the midtho-
racic spinal cord. Intramural ganglia of the gut and the CMGC
are respective intervening relay points (Fig. 5). Within the
CNS, the infectious agent probably travels along interneurons
and sensory afferents to the SN-NG and the DRG, respec¬
tively. The reproducibility and spatial precision of PrPSc dep¬
osition indicate that spread is not random but occurs in a
stepwise fashion along the synaptically linked neuronal popu¬
lations. The observations indicate that initial spread occurs in
a retrograde direction along efferent motor pathways, but dual
efferent and sensory spread to the brain is also a possibility.
The observed pattern of spread shows striking similarities to
that of conventional neurotropic viruses, such as herpes sim¬
plex virus type 1 (22, 34), reovirus serotype 3 isolate T3C9 (40),
and pseudorabies virus (14).
The most logical way for PrPSc to spread along peripheral
nerves is by established axonal transport mechanisms. Several
studies have reported that scrapie spreads within the nervous
system by means of axonal pathways (20, 28), and the sug¬
gested rate of spread (0.5 to 2 mm/day) is consistent with that
of slow axonal transport (10, 29, 44). It has been claimed that
PrPc can be transported in an anterograde direction along
peripheral nerve axons (9), but it is not known whether PrPSc
is so transported. Transportation per se was not formally es¬
tablished in this study, but the evidence presented here would
be compatible with this. While an abundance of PrPSc was
detected in association with cell bodies of CNS neurons or
peripheral ganglia, deposition in nerves (cell processes) was
minimal or undetected, even at the terminal stage of disease.
The low levels of infectivity found at the end stage of disease
in vagus nerves compared to those found in the brain or
CMGC are a further indication that in nerve fibers, the agent
is in transit rather than being actively replicated.
The study did not reveal any evidence for hematogenous
spread of infection to the brain. PrPSc was not detected early in
infection at sites with an impaired blood-brain barrier, such as
the area postrema (Fig. 3) or the choroid plexus. In addition,
routing via the blood would not be consistent with the observed
selectivity of targeting.
Infection via the oral route is strongly indicated (but not
formally proven) in vCJD, BSE, and natural scrapie. Disease-
TABLE 3. Detection of infectivity in the CMGC and adjacent parts
of the abdominal aorta"
Donor Sample Mortality inbioassay
Incubation (days)
Range Mean ± SE
Estimated titer
(IDJUUi/sample)6
SI CMGC 5/5 100-107 104 ± 1 IO4-1
Cran.A. 1/5 318
Caud. A. 1/5 156
S2 CMGC 5/5 107-128 118 ± 4 103J
Cran. A. 1/5 230
Caud. A. 5/5 120-240 171 ± 24 10'~
" Aliquots (50 |xl) of homogenized CMGC and cranially (Cran.) or caudally
(Caud.) adjacent artery (A.) from terminally ill donors orally challenged with
263K were inoculated i.e. into groups of five recipients. Mortality is given as
number of hamsters that succumbed to infection/number challenged. Recipients
similarly inoculated with CMGC from donors previously orally mock infected
with normal brain homogenate showed no clinical signs of scrapie. The experi¬
ment was terminated at 370 dpi.
h Total amount of infectivity in one equivalent of excised tissue, i.e., in the
entire donor sample, calculated by applying mean incubation time to a dose-
response curve.



















FIG. 5. Pictorial representation of the neuronal pathways used in the oral routing of 263K scrapie. Initial spread (arrows) occurs in a retrograde
direction along sympathetic and parasympathetic fibers of the splanchnic and vagus nerves. Enteric and abdominal ganglia (CMCG) have an early
involvement in pathogenesis.
specific PrP is found in the DMNV as a characteristic feature
of both vCJD (26) and early BSE (43) infections, and spread¬
ing pathways similar to those described here have been 'de¬
scribed recently for sheep with natural scrapie (47). As the
pattern of pathological PrP deposition in these nonexperimen-
tal infections closely resembles that observed in orally trans¬
mitted hamster scrapie, our findings provided new indirect
evidence that vCJD in humans, BSE in cattle, and natural
scrapie in sheep were caused by ingestion of TSE agent. The
findings reported here for experimental 263K hamster scrapie
strongly indicate that after oral challenge, infection of the CNS
occurs via the splanchnic and vagus nerves. As similar patho¬
genic mechanisms are likely to operate in other orally acquired
TSEs, this work provides baseline information about the pe¬
ripheral routing of infection and a rodent model with which to
study it.
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